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	Abstract 
Membrane pyrophosphatases (M-PPases) couple pyrophosphate hydrolysis to the 
translocation of sodium ions/protons, using the resulting ion gradients to drive abiotic 
stress resistance and in the infectivity of protozoan parasites. I have solved two M-PPase 
structures in different catalytic states, combining these with previous structures to update 
the model of the catalytic cycle of M-PPases.  These new structures confirm previous 
findings that substrate binding breaks interactions between K12.50 and D6.43 due to motion 
of helix 12, leading to a rearrangement of helix 6 and priming the enzyme for hydrolysis.  
Previously this information was only visible between the structures of two-distinct M-
PPases, a H+-PPase and Na+-PPase.  The current structures allow for comparisons to be 
made between structures of the same type of M-PPase.  Electrometric data was acquired 
using the Nanion SURFE2R technique, which showed a proton-pumping signal was 
generated by the non-hydrolysable inhibitor, imidodiphosphate.  This provided sufficient 
information to update the model of the complete catalytic cycle, favouring the 
hypothesised Binding change mechanism, in which substrate binding induces a series of 
conformational changes during which ion pumping occurs first, followed by substrate 
hydrolysis.   
 
Additionally, crystal optimisation techniques improved the resolution of the 
Pyrobaculum aerophilum M-PPase structure to 3.8, providing an overview of the K+-
independent M-PPase. The hydrolytic centre and ion gate regions showed similar 
coordination to previous structures, with differences seen in the conformation of several 
outer ring helices, potentially linked to K+-independence.  I also carried out mutational 
studies investigating K12.46 and T12.49, both involved in K+-independence and found that 
both mutations were required to generate a K+-dependent variant of PaPPase.  Overall, 
this information has improved our understanding of the structure and function of the 
membrane pyrophosphatases, providing a basis for drug-design programmes targeting 
protozoan parasites, to which the membrane pyrophosphatases are a vital part of growth 
and infectivity. 
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1.1 Types of Pyrophosphatase 
Inorganic pyrophosphatases (PPases) are proteins found in all forms of life. They catalyse 
the hydrolysis of pyrophosphate (PPi) into two phosphate (Pi) molecules (Kornberg, 1962; 
Moe & Butler, 1972).  PPi is a product of many vital anabolic processes such as 
nucleotide, lipid and protein synthesis. By removing PPi, PPases provide a 
thermodynamic driving force that pushes these metabolic processes in the biosynthetic 
direction by rapidly reducing the PPi pool in the cytoplasm (Kornberg, 1962).  In this 
way, they prevent a toxic build-up of PPi that would inhibit essential biosynthetic 
pathways.  
 
There are two main groups of PPases: soluble PPases (S-PPases) and membrane PPases 
(M-PPases). The S-PPases are found in all known living organisms and are essential for 
life. Decreased S-PPase expression in gene disruption experiments led to an increase in 
intracellular PPi concentration and reduced cellular growth rates (Chen et al., 1990) and 
gene knockout experiments resulted in non-viable cells (Lundin et al., 1991). 
 
In contrast, M-PPases are found only in plants, protozoan parasites and some species of 
bacteria and archaea.  They hydrolyse PPi into Pi at a significantly slower rate (20-200x 
slower than S-PPases) (Hsu et al., 2009; Parfenyev et al., 2001) but couple this to the 
translocation of cations such as sodium ions or protons across the membrane in order to 
establish an ion gradient (Malinen et al., 2007). Pyrophosphate synthesis (Pi2 to PPi) has 
also been observed, generally occurs at much slower rates and is only capable of 
generating an equilibrium rather than performing active transport (Belogurov et al., 
2005). 
 
1.1.1 Type I Soluble Pyrophosphatases 
S-PPases were first discovered in 1928 from extracts of mammalian tissue culture that 
had a detectable pyrophosphatase activity (Kay, 1928) and later from preparations of 
yeast fermentations, where the addition of pyrophosphate led to an  increase in phosphate 
concentration (Boyland, 1930). The first extracted forms of the enzymes were obtained 
by Kunitz (1951) who was able to repeatedly isolate crystalline forms of the protein for 
use in various studies.  
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Hydrolysis of the substrate was found to occur due to direct nucleophilic attack from a 
water molecule, transferring the oxygen from a water molecule to the PPi, resulting in 
two phosphate molecules (Cohn, 1958; Kunitz, 1951).  An electrophilic phosphate 
contains the oxygen atom from the water molecule and the leaving group phosphate 
contains the oxygen atom from PPi. It was noted that metal ions were essential for 
substrate binding and hydrolysis, negating the charge of the pyrophosphate (Cohn, 1958), 
with further studies revealing that two metal ions could bind to the native S-PPase in the 
absence of substrate (Rapoport et al., 1973) along with a third in the presence of Pi 
(Cooperman et al., 1981; Springs et al., 1981). Various metal ions were tested but only 
four showed any activity, which in descending order of activity are: magnesium, zinc, 
cobalt and manganese ions (Butler & Sperow, 1977; Höhne & Heitmann, 1974; Janson 
et al., 1979). A simplified scheme of the hydrolysis mechanism of S-PPases was 
generated (Scheme 1). 
 
 
Scheme 1: Simplified reaction scheme for Pyrophosphatases, showing the hydrolysis of PPi and 
sequential product release. 
 
Experiments were performed measuring the effect of phenylglyoxal (a compound that 
specifically modifies arginine), on the active site residues of S-PPases. These found that 
the active site contained an essential arginine (Bond et al., 1980; Cooperman & Chiu, 
1973).  Other inactivation and protection experiments (wherein the protein activity is 
measured following treatment with compounds with different chemical properties) were 
also carried out on the S-PPases.  Compounds, such as N-acetlyimidazole (Negi et al., 
E:Mg2 E:Mg4:P2O7
H2O*
E:Mg4:(HPO3O*+HPO4)E:Mg3:HPO4
Mg:HPO3O*
Mg:HPO4
Mg2:P2O7
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1972) and iodoacetamide (Yano et al., 1973) showed that the active site might contain 
aspartate/glutamate, tryptophan and methionine residues (Cooperman & Chiu, 1973). 
 
 
Figure 1.1: Structural overview of the Type-I Soluble Pyrophosphatases.  
View of the type-I S-PPase from S. cerevisiae showing (a) dimer of 1.1 Å Pi2-bound structure (PDB ID: 
1E9G) showing monomers A (green) and B (cyan) and (b) close up of the active site coordination of fluoride 
inhibited PPi-bound structure (PDB ID: 1E6A), where Fluoride occupies position of the nucleophilic water.   
 
In 1974 it was shown that crystals of the yeast S-PPase would be suitable for x-ray 
crystallography experiments (Bunick et al., 1974). In 1978 the first structure was solved 
of a yeast S-PPase (Bunick et al., 1978) followed independently by a structure from 
Harutyunyan, et al in 1981, which was not published (data unavailable).  Structures of 
the E. coli S-PPase were solved in 1994 and 1995 (Kankare et al., 1994) (Salminen et al., 
1995) with additional structures of the yeast S-PPase in 1996 (Harutyunyan et al., 1996), 
including high resolution structures at 2 Å (Heikinheimo et al., 1996) and 1.1 Å 
(Heikinheimo et al., 2001).  The overall structure consists of multiple helices and strands 
with the highly conserved core of the protein forming an “OB-fold” domain, consisting 
of 5 beta strands forming a closed barrel with the active site present on one face of the 
barrel (Heikinheimo et al., 1996) (Figure 1.1a). The active site consists of several 
predicted metal ions coordinating the substrate and being vital for activity (Figure 1.1b).  
In addition, many of the predicted residues can be found in the active site, including 
several aspartate, glutamate, lysine, tyrosine and arginine residues, but no methionine was 
present.  
K193
Y192
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1.1.2 Type II Soluble Pyrophosphatases 
A second type of S-PPase was discovered, originally identified in Bacillus subtilis 
(Shintani et al., 1998) and was found to be sequentially distinct from the type-I S-PPases, 
with the structure being later solved in Streptococcus mutans (Merckel et al., 2001) and 
B. subtilis (Ahn et al., 2001). These are structurally distinct but functionally analogous to 
the type-I S-PPases and are part of the DHH family of phosphoesterases, named after the 
conserved Asp-His-His motif (Aravind & Koonin, 1998). They consist of two distinct 
domains, the N-terminal domain containing a 5-strand b-sheet, upon which the active site 
is located facing the domain interface, along with seven helices (Figure 1.2a).  The C-
terminal domain also consists of a 5-strand mixed b-sheet and several helices.  This global 
structure and the related folds are completely different from those forming the type-I S-
PPases, but they still perform the same function, the hydrolysis of PPi to Pi2.  The active 
site is the most conserved region of the type-II S-PPases and contains 4 aspartate and 2 
histidine residues that are completely conserved (Figure 1.2b).  These proteins also bind 
3 or 4 metal ions (Parfenyev et al., 2001), with a propensity for manganese ions over 
magnesium.  The structure shows several water molecules, including one believed to be 
the nucleophile, bound at the active site coordinated by three manganese ions and the 
substrate/product, which are in turn coordinated by a histidine residue within the active 
site (Merckel et al., 2001). 
 
Figure 1.2: Structural Overview of the Type-II Soluble Pyrophosphatases. 
View of the 1.75 Å fluoride inhibited IDP-bound structure of type-II S-PPase from Bacillus subtilis (PDB 
ID: 1E6A) showing (a) dimer composition with monomers A (green) and B (cyan) and (b) close up of the 
active site coordination between residues, metal ions and IDP, where Fluoride occupies position of the 
nucleophilic water.   
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The superimposition of this structure with the type-I yeast S-PPase showed a high degree 
of similarity in the coordination of the metal ions, substrate and water molecules, leading 
the authors to conclude that the mechanism of action was likely the same as in type-I S-
PPases, despite the differences in the global structure (Merckel et al., 2001). However, 
later studies found evidence to suggest that the two types functioned in completely 
different ways.  They have a similar rate of activity in the presence of Mg2+, but type-II 
S-PPases have a much higher rate of activity in the presence of Mn2+ compared with the 
Type-I S-PPases (Zyryanov et al., 2004), likely due to the histidine residues in the active 
site, which preferentially bind Mn2+ over Mg2+. The rate of catalysis was around 10-fold 
higher in type-II PPases (~3,000 s-1) compared with type-I S-PPases (~200 s-1) (Parfenyev 
et al., 2001). 
 
1.1.3 Type III Soluble Pyrophosphatases 
Two distinct S-PPases have also been discovered in the thermophilic archae: 
Thermococcus onnurineus (Lee et al., 2009) and in Bacteroides thetaiotaomicron 
BT2127 (Huang et al., 2011).  Both of these enzymes have been grouped into a third 
category of S-PPases, termed type-III S-PPases.  Unlike the other types, these enzymes 
are Ni2+-dependent (Lee et al., 2009) and have so far only been located in a few bacterial 
species.  Structurally these proteins resemble other members of the haloalanoic acid 
dehalogenase superfamily (HADSF), to which this class of proteins appears to belong 
(Huang et al., 2011).  These proteins have an a/b Rossmann-like fold composed of a six-
stranded b-sheet surrounded by six helices and with a four-helix cap domain (Huang et 
al., 2011) (Figure 1.3a). The active site differs greatly from the other S-PPases, with an 
aspartate nucleophile attacking the pyrophosphate (Figure 1.3b). The remaining catalytic 
residues are located on a series of 4 loops that form the active site.  The main catalytic 
mechanism therefore more closely resembles other members of the HADSF than that of 
other pyrophosphatases. 
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Figure 1.3: Structural Overview of the Type-III Soluble Pyrophosphatases 
View of the 1.6 Å phosphate-bound E47N mutant of Type-III S-PPase from Bacteroides thetaiotaomicron 
(PDB ID: 3QYP) showing (a) monomer showing bound phosphate and magnesium ion and (b) close up of 
the active site coordination between residues, metal ions and Pi.  
 
All types of S-PPase, despite the structural differences, have identical functions in 
recycling intracellular PPi in order to maintain the equilibrium of biochemical reactions 
and allow biosynthetic reactions to continue.  In addition to the S-PPases, a distinct class 
of PPases was also discovered, the membrane pyrophosphatases (M-PPases).  
 
1.1.4 Membrane Pyrophosphatases 
The M-PPases have additional function in cells compared to S-PPases, coupling the 
pyrophosphatase activity with the active membrane translocation of protons (Moyle et 
al., 1972) and/or sodium ions (Malinen et al., 2007) (Figure 1.4).  The catalytic rate of 
these enzymes is much slower than any of the S-PPases, 10-fold slower than the type-I 
S-PPases and ~100-fold slower than the type-II S-PPases (Hsu et al., 2009; Parfenyev et 
al., 2001). However, their ability to pump cations contributes to cell homeostasis by 
establishing membrane potentials and is particularly important during periods of 
environmental stress (García-Contreras et al., 2004; López-Marqués et al., 2004; Nyrén 
& Strid, 1991). This confers a significant advantage to organisms frequently subjected to 
these stresses, as PPi released as a waste product during primary anabolic processes can 
N47
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K147
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be used to generate ion gradients (Kornberg, 1962).  By activating these enzymes, vital 
homeostatic mechanisms (such as pH and osmoregulation) can be maintained using these 
gradients, even in ATP-deficient environments such as in plants during drought stress 
(Venancio et al., 2014). 
 
 
Figure 1.4: Generalised Overview of Membrane Pyrophosphatase Function. 
Cartoon representation of a generalised M-PPase dimer showing the PPi to Pi2 hydrolytic activity and Na+ 
and/or H+ translocation function. 
 
M-PPases are primary ion pumps, meaning that the energy utilised to pump ions across 
the membrane is obtained directly from the hydrolysis of PPi, in this case occurring in the 
same active site channel (Kim et al., 1994). This differs from secondary pumps where 
this energy would be from ion or proton gradients established by other proteins or 
domains.  Having all the required machinery in the same subunit provides a greater degree 
of control over enzyme function, ensuring that all of the energy generated from 
pyrophosphate hydrolysis goes towards establishing the ion gradient.  
 
M-PPases were first identified in Rhodospirillum rubrum, a photosynthesising bacteria 
found in water sources following studies performed on chromatophores in which PPi was 
produced during photophosphorylation (Baltscheffsky et al., 1966). This process was 
later attributed to a single enzyme, the M-PPase when translocation of protons across the 
membrane was observed in the presence of PPi and was not attributable to other enzymes, 
Na+/H+ Na+/H+
PPi
Pi2
PPi
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such as H+-ATPases (Moyle et al., 1972). M-PPases have so far been found in a selection 
of different species, including plants (Bucke, 1970; Karlsson, 1975), protozoan parasites 
(Scott et al., 1998), some bacteria (Baltscheffsky et al., 1966) and archaea (Drozdowicz 
et al., 1999).   
 
The localisation of this protein differs between species. In bacteria and archaea they are 
generally located in the plasma membrane or in organelle-like structures (Seufferheld et 
al., 2003), whereas in plants and protozoan parasites they are predominantly found in the 
vacuole (Rea et al., 1992) and acidocalcisome organelle (Scott et al., 1998), respectively. 
Thus far, no similar enzymes have been found in other high-order Eukaryotic species.  
Since their discovery, work has focussed on understanding the mechanism of action and 
respective roles of these proteins in specific organisms.  
 
1.2 Classification of M-PPases 
1.2.1 Types of M-PPase 
The primary categorisation of M-PPases is based on cation specificity, with some M-
PPases exclusively pumping protons (H+-PPases), others exclusively pumping sodium 
ions (Na+-PPases) and a third group that is capable of pumping both sodium ion and 
protons (Na+/H+-PPases) (Luoto et al., 2013) (Table 1.1).  These types of M-PPase can 
be further sub-divided on the requirement of K+ for activity.  All Na+-PPases and the 
Na+/H+-PPases are K+-dependent, along with some H+-PPases (K+-dependent H+-PPases) 
(Karlsson, 1975), but there are a distinct group of H+-PPases that are insensitive to K+, 
showing full activity even in the absence of K+ (K+-independent H+-PPases) + 
(Drozdowicz et al., 1999). Moreover, the Na+/H+-PPases can also be subdivided, as some 
can only pump protons in low sodium concentrations (Na+-dependent Na+/H+-PPases) 
and others can pump both sodium ions and protons regardless of sodium concentration 
(True Na+/H+-PPases) (Nordbo et al., 2016) (Table 1.1).  
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Table 1.1: Types of Membrane Pyrophosphatase 
List of all known types of membrane pyrophosphatase, showing name and characteristics of each type 
Type Pumping 
substrate 
K+-
sensitivity 
Examples 
Na+-PPase Na+ Yes Thermotoga maritima 
K+-dependent H+-
PPase 
H+ Yes Vigna radiata, 
Plasmodium falciparum 
VP1 
K+-independent H+-
PPase 
H+ No Pyrobaculum 
aerophilum, Plasmodium 
falciparum VP2 
Na+-dependent 
Na+/H+-PPase 
Na+ and H+ 
(Only H+ at low 
[Na+]) 
Yes Clostridium leptum 
True 
Na+/H+-PPase 
Na+ and H+ Yes Bacteroides vulgatus 
 
M-PPase capable of pumping Na+ (either exclusively or alongside protons) are only found 
in prokaryotes, with examples in bacteria, such as Thermotoga maritima (Belogurov et 
al., 2005; Pérez-Castiñeira et al., 2001), and archae, such as Methanosarcina mazei 
(Malinen et al., 2007). Neither plants nor protozoan parasites contain Na+-PPases or 
Na+/H+-PPases. H+-PPases are not exclusive and can be found in plants, protozoan 
parasites and prokaryotes, as can both K+-dependent and K+-independent variants of M-
PPases.  Overall, this means there are 5 types of M-PPase: K+ -dependent H+ -PPases, K+ 
-independent H+ -PPases, Na+ -PPases, Na+-dependent Na+/H+-PPases and true Na+/H+ -
PPases.  These differences are key to understanding how these proteins function and the 
respective role they have in each class of organism. 
 
1.2.2 M-PPases in Prokaryotes 
As discussed earlier, prokaryotes are the only group of organisms to contain all variants 
of M-PPases, and are the only group in which the Na+-PPases and Na+/H+-PPases can be 
found.  In these organisms, the M-PPase is generally located in the cell membrane but 
can also be found in the membranes of acidocalcisome-like organelles (Seufferheld et al., 
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2003).  The substrate always binds on the cytoplasmic side of the protein, pumping 
Na+/H+ either into the periplasmic space across the prokaryotic inner membrane or into 
organelles. 
 
Thermotoga maritima is a hyperthermophilic marine bacterium that thrives near undersea 
volcanic vents. It has an optimal growth temperature of between 70 ˚C and 80 ˚C, with a 
maximum growth temperature of 90 ˚C (Huber et al., 1986). The M-PPase of T. maritima 
(TmPPase) was first characterised in 2001 (Pérez-Castiñeira et al., 2001) and originally 
thought to pump protons.  Later studies (Belogurov et al., 2005) found it had an absolute 
requirement for Na+ and was more active in the presence of K+. Using steady-state 
kinetics it was shown that increasing Na+ concentrations led to increasing hydrolytic 
activity up to 10 µmol min-1 mg-1 in the absence of K+, but had an activity of 20 µmol 
min-1 mg-1 in the presence of 50 mM K+.  The role of this protein in the native organism 
has not been studied, but given the organisms proximity to undersea thermal vents, a low 
energy environment, it would need to maximise the use of the available energy.  This 
would be achieved by utilising PPi (a waste product of ATP-hydrolysis) as a secondary 
source of energy. The protein itself has been used for biochemical and structural studies 
(Kellosalo et al., 2012; Tsai et al., 2014) due to its high thermal stability, which allows 
for high temperature solubilisation, efficient purification and increased stability during 
room temperature assays. 
 
Pyrobaculum aerophilum is a species of thermophilic archaea found in extreme-
temperature marine environments.  As with Thermotoga maritima, this organism can 
survive extremely high temperatures, with optimal growth conditions around 100 degrees 
Celsius (Völkl et al., 1993). It is unique amongst other species of Pyrobaculum in that it 
can also respire aerobically alongside the usual anaerobic respiration indicative of this 
genus (Völkl et al., 1993). The M-PPase of P. aerophilum (PaPPase) was identified in 
1999 (Drozdowicz et al., 1999) where it was found to be a H+-PPase. Moreover, it was 
determined to be insensitive to K+, making it one of the first of the K+-independent H+-
PPases to be discovered. It provided a means of comparing the different types of M-
PPases, helping to determine the conserved core residues across all M-PPases. As with 
TmPPase, this protein has not been studied in the native organism, however it is logical 
to assume it fulfils a similar role to that of TmPPase, allowing the organism to survive 
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the extreme environment of undersea thermal vents by providing an extra means of 
generating proton gradients when in ATP-deficient environments. 
 
1.2.3 M-PPases in Protozoan Parasites 
In protozoan parasites, only the H+-PPases are present, although both K+-dependent and 
K+-independent variants can occur in the same species (McIntosh et al., 2001). This is 
characteristic of both parasites and plants, which have examples of both types of M-PPase 
within a single species.  This is likely due to the evolutionary similarities between many 
parasites and certain plant species, such as red algae (Lim & McFadden, 2010; McFadden, 
2000). However, the purpose of having two different variants has not been determined, 
possibly providing better regulation and control of the processes under different 
environmental and cellular conditions.  In parasites, M-PPases are localised primarily in 
the acidocalcisome organelle (Scott et al., 1998), although some are present at 
significantly lower levels in the Golgi apparatus and parasite cell membrane (Martinez et 
al., 2002).   
 
There are two broad categories of protozoan parasites that are important for studying M-
PPases. The first are the Apicomplexan phylum, including species such as Plasmodium 
falciparum and Toxoplasma gondii, the causative agents of malaria and toxoplasmosis.  
These are genetically distinct from other parasites and contain a unique organelle, the 
apicoplast (Lim & McFadden, 2010), believed to derive from the secondary 
endosymbiosis of photosynthetic algae and in which a truncated set of genomic DNA is 
still present.  Some apicomplexan species uniquely contain both K+-dependent and K+-
independent variants of the M-PPase, most notably the Plasmodium species, in which the 
M-PPases are commonly referred to as VP1 (Vacuolar Pyrophosphatase type 1, K+-
dependent) and VP2 (Vacuolar Pyrophosphatase type 2, K+-independent), respectively. 
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Figure 1.5: Overview of a Trypanosomatid parasite. 
Schematic representation of the epimastigote form of a generalised trypanosomatid parasite showing 
various organelles, including the membrane pyrophosphatase-containing acidocalcisome organelle.  
Figure redrawn from figure 1 of (Docampo et al., 2005).  
 
The second major group of parasites are the kinetoplastids, which include species of 
Trypanosoma and Leishmania, the causative agents of African sleeping sickness and 
Leishmaniasis, respectively. The Kinetoplastids are flagellated protozoan parasites, 
making them morphologically distinct from the Apicomplexans (Figure 1.5).  The main 
distinguishing feature with this class is the presence of the Kinetoplast, a dense granule 
of DNA located within the single mitochondrion of these parasites that contains many 
copies of the mitochondrial genome (Shapiro & Englund, 1995) (Figure 1.5). The only 
known type of M-PPase in these parasites is the K+-dependent H+-PPase found in many 
species of Leishmania (Rodrigues et al., 1999) and Trypanosoma (Scott et al., 1998). 
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1.2.3.1 Role of the Acidocalcisome in Protozoan Parasites 
The first parasites in which an acidocalcisome was discovered were Trypanosoma species 
(Docampo et al., 1995) and subsequently in a range of other protozoan parasites, 
invariably linked to the discovery of M-PPases in these organisms (Moreno & Zhong, 
1996; Pérez-Castiñeira et al., 2002; Scott et al., 1998). It is an acidic organelle, initially 
found to be an intracellular calcium store (Docampo et al., 1995) vital for normal cellular 
functions in parasites.  It was later found to be a store for a wider range of metal ions and 
also phosphorous in the form of phosphate, pyrophosphate and polyphosphate (Docampo 
& Moreno, 2011). In parasites, this organelle is also capable of regulating intracellular 
pH and is vital for osmoregulation due to its interaction with another organelle, the 
contractile vacuole (Figure 1.5). It was shown that a complex formed between these two 
organelles, with a resulting increase in acidocalcisome volume during periods of hypo-
osmotic stress, but only once the acidocalcisome had been energised via one of several 
integral-membrane cation pumps (Rohloff et al., 2004).  Disruption of normal 
acidocalcisome function was shown to prevent its role in maintaining cell homeostasis 
during periods of environmental stress (Lemercier et al., 2002; Lemercier et al., 2004). 
This is important due to extreme changes in the osmolarity of the external environment 
as the parasite transitions from the insect mid-gut, at low pH and high osmolarity to the 
host organism, which is a neutral pH and very low osmolarity.   
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Figure 1.6: Representation of Acidocalisome Transporters and Channels. 
Schematic overview of some of the transporters, channels and pumps of the acidocalcisome organelle found 
in protozoan parasites. Only key proteins are shown, including the H+-ATPase and H+-PPase (highlighted 
in red).  Figure redrawn and simplified from Figure 4 of (Docampo et al., 2005) 
 
The acidocalcisome contains a range of transporters, including the H+-PPase and a V-
type H+-ATPase, which also appears to energise the acidocalcisome via proton 
translocation  (Docampo & Moreno, 2011) (Figure 1.6).  Despite this, several studies 
have shown the importance of these proteins to parasite survival and infectivity.  One 
study used targeted RNA interference in Trypanosoma bruceii to generate inducible 
knockouts of the H+-PPase (Lemercier et al., 2002) in procyclic and blood-stage forms of 
the parasite.  The acidocalcisomes lost acidity, 90 % of the polyphosphate and could not 
release Ca2+. Moreover, the parasites could not adapt to changes in the extracellular pH, 
were slower to recover their intracellular pH and the parasites grew at a half the rate and 
only reached a cell density one fifth that of the wild type parasites. 
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Knocking out the M-PPase of Toxoplasma gondii left the tachyzoite stage of the parasites 
unable to attach to or infect new cells as well as disrupting osmoregulation (Liu et al., 
2014).  This loss of infectivity implies that M-PPases play an important role in driving 
infectivity in these parasites via their activation of the acidocalcisome, alongside the 
various ATPases and highlights the importance of these proteins as potential drug targets. 
 
1.2.4 M-PPases in Plants 
Plants contain similar variants of M-PPases as those found in protozoan parasites, 
including both the K+-dependent and K+-independent variants of the H+-PPases.  These 
are located in the vacuole and are particularly important for the survival of cells during 
abiotic stresses, such as during periods anoxia, coldness (Carystinos et al., 1995), high 
soil salinity (Gao et al., 2006) or drought (Brini et al., 2007; Venancio et al., 2014). In 
both these cases, overexpression of the M-PPase was found to greatly enhance the 
survival and viability of plants, leading to better growth compared to plants that had low 
or normal levels of the protein (Pasapula et al., 2011).   
 
Alongside the established stress-response role, the H+-PPase has also been strongly linked 
to several developmental roles in plants. Auxin transport is a major factor in plant organ 
development and general plant growth (J. Li et al., 2005). The overexpression of H+-
PPase was linked to the increase in auxin transport mechanisms and subsequently an 
increase in plant organ development and general growth. Another study of Arabidopsis 
development showed that if the H+-PPase was knocked out, the plants failed to grow post-
germination due to a toxic build-up of cytosolic PPi (Ferjani et al., 2011). It was possible 
to rescue the phenotype via expression of the S-PPase, suggesting a much greater and 
more general role for PPases in plant development.   
 
Vigna radiata, more commonly known as the mung bean, is another plant that has been 
studied in great detail with regards to M-PPases.  It is a member of the legume family of 
plants and an important food crop in Southern and Eastern parts of the world and has been 
shown to contain a K+-dependent H+-PPase (Shen-Hsing et al., 2009). The structure of 
this protein was determined via X-ray crystallography (Lin et al., 2012), making it one of 
the first structures of an M-PPase to be solved, alongside the Na+-PPase from Thermotoga 
maritima (Kellosalo et al., 2012). 
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1.2.5 Evolution of M-PPases 
The evolutionary lineage of M-PPases has been examined in detail to try to better group 
these proteins based on function and phylogenetic origin. It was proposed that the Na+-
PPases were the first type of M-PPase, originating from early Na+ transporters, with the 
transition from Na+ to H+ occurring over time (Luoto et al., 2011).  Some diverged into 
the dual Na+/H+-pumping and others became the H+-pumping PPases. The prevailing 
hypothesis is that each variant diverged separately from the early Na+-PPases rather than 
emerging gradually over time along a single evolutionary path.  This hypothesis is based 
on the evolutionary origins of the various types of ATPases (Mulkidjanian et al., 2008), 
whereby sodium-pumping preceded proton-pumping, due to difficulties for early proteins 
to maintain proton-impermeable membranes compared with sodium-impermeable ones.  
 
An alignment of several sequences from each type of M-PPase (Figure 1.7) revealed a 
high degree of similarity between the M-PPases of different species.  The highest 
similarity was seen for the 6 inner-ring helices (5, 6, 11, 12, 15 and 16) and is independent 
of the type of M-PPase.  The difference between K+-dependent and K+-independent 
variants is related to residues at position 12.46 and 12.49, which are invariably Lysine 
and Threonine in K+-independent variants, but are Alanine and Glycine/Alanine in K+-
dependent variants (Figure 1.7).  Even using the sequence alignment, it has not been 
possible to ascertain the specific residues involved with cation specificity in M-PPases.  
 
The parasite forms of M-PPases are more closely related to the plant M-PPases than any 
other variant, given that the sequence similarity is around 50-60%, compared with around 
a 30% similarity to bacterial forms of the protein.  This link between plants and parasites 
has been seen with numerous other proteins, including those found in the apicoplast 
organelle of apicomplexan parasites due to the evolutionary link between protozoan 
parasites and species of algae (McFadden, 2000).  This relationship between plants and 
protozoan parasites may also explain why these are the only eukaryotic organisms to 
possess M-PPases.  The role of M-PPases in plant development and stress responses 
(discussed above) shows why they are essential for these organisms, with presence of M-
PPases in parasites resulting from the common evolutionary lineage of these species.  
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1.3 M-PPases as Drug Targets 
The M-PPases of protozoan parasites are essential to infectivity (see above) and are thus 
a potential new drug target for combating deadly parasitic infections such as malaria, 
toxoplasmosis, leishmaniasis and trypanosomiasis (Docampo & Moreno, 2008).  The 
treatments for these diseases can present serious challenges, with a sharp rise in resistance 
to many drugs currently used. This is seen for the treatment of trypanosomiasis, where 
there is increasing resistance for the few drugs available (Delespaux & de Koning, 2007).  
Treatments for malaria are also hampered in a similar way, with drug resistance to 
frontline malarial drugs, such as chloroquine, pyrimethamine, quinine, mefloquine and 
artemisinin, reaching dangerously high levels (Dondorp et al., 2009; Fairhurst & 
Dondorp, 2016; Yuvaniyama et al., 2003).  
 
Drug design is often hindered by the intracellular localisation of protozoan parasites in 
host cells during infection, as it is difficult to get drugs across multiple membranes and 
remain active. These parasites also contain highly efficient efflux mechanisms that 
rapidly remove active drugs from the cytoplasm or cellular compartments. An example 
of this is the main mechanism of chloroquine resistance in Plasmodium parasites, where 
a mutation in the acidocalcisome transporters increases the active secretion of 
chloroquine before it can reach toxic levels (Krogstad et al., 1987). M-PPases represent 
a potential drug target to combat the rise in drug resistance towards malarial parasites.  
Drugs designed against these targets should significantly reduce the infectivity and 
longevity of the parasites in host cells.  Targeting of the acidocalcisome via the M-PPases 
would also diminish the parasites ability to cope with the sudden change in pH or 
osmolarity and interfere with calcium-mediated signalling pathways, described above 
(Section 1.2.3.1). 
 
Studies on PPi pathways in various organisms have highlighted their importance and the 
potential for new drug targets.  A previous study showed the viability of drug 
development against the PPi regulatory pathways of protozoan parasites (Francia et al., 
2011). This study looked at the NHE3 protein of Toxoplasma gondii, which was found to 
co-localise with the H+-PPase. When TgNHE3 was knocked out, the levels of PPi were 
greatly reduced, preventing the H+-PPase from functioning efficiently. This left the cells 
significantly more susceptible to hypo-osmotic shock and led to toxic levels of 
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extracellular sodium and calcium. Although not looking at the effects of specifically 
knocking out the H+-PPase, it highlights the importance of PPi in cells and shows that 
disruption of the related pathways can be fatal to the parasites during transition from the 
mid-gut of the insect vector to the host bloodstream, due to a rapid increase in pH and 
decrease in osmolarity.  
 
Several studies have also looked specifically at using M-PPases as drug targets, including 
the H+-PPase from the parasitic species of ringworm, Baylisascaris schroederi. This has 
been evaluated for use as part of a potential vaccine. Other studies on H+-PPases in T. 
gondii tachyzoites (Rodrigues et al., 2000) showed that by inhibiting PPi hydrolysis and 
proton pumping led to an increase in the concentration of intracellular PPi.  The level 
increased significantly above that of ATP and inhibited the growth of tachyzoites in tissue 
culture cells.  Experiments conducted using inhibitors of PPi hydrolysis and proton 
pumping showed that the tachyzoites could not grow in cell cultures. Based on these 
findings, it is clear that M-PPases are viable drug targets for protozoan parasites in various 
stages of the life-cycle. 
 
1.4 Structure and Function of M-PPases 
1.4.1 Ballesteros and Weinstein Numbering System 
During structural studies, it is useful to find a means of conveying uniformity in residue 
numbering, which often varies greatly between different species. The Ballesteros and 
Weinstein numbering system has been adopted for use with the M-PPases to try to solve 
this problem. This system has been extensively used to compare G-protein coupled 
receptors (Ballesteros & Weinstein, 1995) and allows for easy comparison of residues.  
This system labels each residue thusly: Xa.b, where ‘X’ represents the one letter code for 
the amino acid, ‘a’ represents the helical number on which the residue is present and ‘b’ 
represents the position upon that helix based on a highly conserved anchor residue 
common to all known M-PPases.  In this way, the residues can be compared with much 
greater convenience. 
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1.4.2 Previous Structural Studies of M-PPases 
So far, only three structures have been solved of M-PPases from two different species.  
These are the structure of a H+-PPase in plant cells from Vigna radiata (VrPPase) (Lin et 
al., 2012) and the structure of an Na+-PPase from Thermotoga maritima (TmPPase) 
(Kellosalo et al., 2012).  
 
1.4.2.1 Expression, Solubilisation and Purification of M-PPases  
The expression and purification of M-PPases was difficult, as it is with many integral-
membrane proteins. Poor yields, difficulty maintaining stability when solubilising the 
protein into detergent micelles and difficulties in obtaining a pure protein product are 
common issues when working with membrane proteins.  Despite this, expression was 
achieved for the M-PPases of Arabidopsis thaliana (Kim et al., 1994), Thermotoga 
maritima (Pérez-Castiñeira et al., 2001) and Vigna radiata (Hsu et al., 2009), all of which 
were expressed in yeast.  
 
In 2005, a new solubilisation and purification technique was utilised for M-PPases taking 
advantage of the thermostable properties of the M-PPase from T. maritima.  This method 
was referred to as the “hot-solve” purification technique (López-Marqués et al., 2005) 
and involved solubilising the expressed protein in detergents at an extremely high 
temperature (70-80 ˚C). This denatured any contaminating proteins, leaving only the 
thermostable TmPPase to bind to the Ni-NTA column. This resulted in high yields of 
pure protein samples suitable for testing and essential for crystallographic studies. 
 
1.4.2.2 Crystallisation of Membrane Proteins 
Crystallographic studies can be carried out using relatively high concentrations of protein, 
typically around 10 mg/ml and so requires high expression yields to carry out vast crystal 
screens.  Early stages involve crystallisation trials, where various buffer and 
environmental conditions are tested to find ones that lead to crystal formation.  These 
conditions generally involve the type and concentration of buffer and various salts or 
precipitants alongside changes in temperature and pH.   
 
Membrane proteins are unique in that they must be solubilised in a detergent micelle, 
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hydrophobic contact with the protein and hydrophilic contact with the surrounding 
solvent (Garavito & Ferguson-Miller, 2001). Micelles ensure the protein remains folded 
and stable in solution, but hinders crystallisation by reducing the number of crystal 
contacts. These contacts are required to form stable and well-ordered crystals and so 
detergent screens are carried out during crystallisation trials. 
 
The critical micellar concentration (CMC) determines the absolute minimum 
concentration of a detergent that is required to form stable micelles.  Varying the 
concentration of detergent above the CMC can have significant impacts on the 
crystallisation.  In addition, testing different types of detergent can also have significant 
effects on the crystallisation, as the chain length of various detergents can affect the size 
of the resulting micelle (Oliver et al., 2013).  Smaller detergent micelles allow for more 
crystal contacts to form, but the smaller-chained detergents tend to be more denaturing to 
the protein (Garavito et al., 1996). This means that many detergents must be screened to 
find the optimal one that will maintain the stability of the protein with as small a micelle 
size as possible.  
 
Membrane protein crystallisation can also generate detergent crystals, alongside salt 
crystals found in general protein crystallography. As with salt crystals, detergent crystals 
can be detected either using UV-imaging of the crystals, which reveals a negative 
fluorescence (detergent crystals appear darker than the well solution), or by the distinctive 
single-ring X-ray diffraction pattern.  Detergent crystals also have a fairly distinct 
morphology, appearing more rounded than salt or protein crystals. 
 
Data can be collected by subjecting the crystal to an X-ray or synchrotron beam and 
measuring the resulting diffraction pattern, consisting of a series of clearly defined spots. 
Crystals are rotated within the beam in small increments and multiple diffraction images 
are generated. In order to obtain the structure factors from the diffraction images, two 
pieces of information are required, the amplitude and phases. The amplitudes can be 
obtained from the intensities of the diffraction spots during indexing, allowing for 
calculation of the space group and unit cell parameters.  The phases can be determined 
either experimentally or using molecular replacement. 
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Experimental phase calculation can be carried out using heavy atom soaks, which alter 
the intensities of the diffraction spots.  Comparisons between the normal dataset and the 
heavy-atom dataset allow for the determination of the heavy atoms positions within the 
protein, providing the necessary phase information.  The alternative method is molecular 
replacement, in which the phases of a structure can be obtained from a related structure 
that has been previously solved.  If such a structure exists, then the phases can be used to 
acquire the structure factors for the new dataset. The resulting structure factors can be 
used to generate an electron density map, in which the model of the protein can be built.  
This is refined against the original data to ensure that that model best fits the available 
data. 
  
1.4.2.3 M-PPase Crystallisation and Structure Solution 
The crystal structures of both TmPPase and VrPPase have been solved in a range of 
catalytic states.  TmPPase has been solved in the resting state with magnesium and 
calcium ions occupying the hydrolytic centre (PDB ID: 4AV3)(Kellosalo et al., 2012) 
and also in a product-bound state with two phosphates and four magnesium ions in the 
active site (PDB ID: 4AV6)(Kellosalo et al., 2012).  In addition, the structure of VrPPase 
was solved in complex with Imidodiphosphate (IDP) (PDB ID: 4A01)(Lin et al., 2012), 
an analogue of PPi that cannot be hydrolysed by the enzyme.  This inhibits the protein by 
locking it into the substrate-bound form, allowing structures of this state to be observed. 
These structures have formed the basis for our current understanding of the structure, 
function and catalytic cycle of M-PPases. 
 
1.4.2.4  Overview of M-PPase Structures  
The overall structure of M-PPases appears to be common for both TmPPase and VrPPase 
and thus both H+ and Na+-PPases. The protein forms into a homodimer, with each 
protomer consisting of 16 transmembrane helices split into 2 observable ring structures 
(Figure 1.8a) (Kellosalo et al., 2012; Lin et al., 2012).  The outer ring structure (helices 
1-4, 7-10 and 13-14) forms the main dimer interface and interacts with the membrane, 
housing an inner ring of 6 helices (helices 5-6, 11-12 and 13-14) forming the central 
channel. This channel contains four distinct regions: the hydrolytic centre, a coupling 
channel connecting this to the ion gate and the exit channel (Figure 1.8b).  The hydrolytic 
centre is located on the cytoplasmic side of the protein, where the available pyrophosphate 
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is found. It is in this region that the hydrolysis of PPi into Pi2 occurs. Below this is the 
coupling channel, containing a series of charged residues, where it is proposed that 
ion/proton translocation occurs.  
 
Figure 1.8: Structural Overview of Membrane Pyrophosphatase Channel. 
M-PPase monomer (a) viewed from the cytoplasmic side showing the two-ring composition, with inner ring 
(helices 5, 6, 11, 12, 15 and 16) forming the central channel and (b) viewed from the side, showing the 
four-part composition of the channel, with the hydrolytic centre at the cytoplasmic side through to the exit 
channel on the exterior side of the membrane. 
 
The ion gate (Figure 1.8) ensures directionality of pumping by preventing backflow of 
ions. All three available structures show the gate in the closed conformation, as it only 
opens in time-scales too rapid to be detected via crystallography.  Below the gate is the 
exit channel that, once opened, will release the pumped ion to the outside. Following 
hydrolysis, the two phosphate molecules are sequentially released back into the 
cytoplasmic side of the membrane, as shown by the TmPPase:Mg4Pi2 and VrPPase:Mg2Pi 
structures.  
 
1.4.3 M-PPase Mechanism of Action 
The structure of the VrPPase protein in the substrate-bound form reveals the position of 
the substrate-analogue (IDP) alongside the various metal ions that coordinate the 
substrate around the nearby residues (Lin et al., 2012).  Several key residues were 
identified, including a series of aspartate, lysine and arginine residues (Figure 1.9). The 
resolution was also sufficient to observe a bound potassium ion in the active site alongside 
numerous water molecules, including one that was proposed to act as the attacking 
nucleophile.  Unlike the type-I and II S-PPases, this potential nucleophile was not found 
1
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to be coordinated by the metal ions, but instead by two aspartate residues D6.43 and D16.39 
located directly beneath the active site (Lin et al., 2012), more akin to the type-III active 
site coordination. In M-PPases, the metal ions play a role in the catalysis, by coordinating 
the substrate, stabilising the leaving group phosphate and negating the charge on the 
electrophilic phosphate group, allowing hydrolysis to take place via the nucleophilic 
water (Heikinheimo et al., 1996).  The specific mechanism behind the activation of this 
water nucleophile has not been studied in M-PPases so currently not much information is 
known. 
 
 
Figure 1.9: Overview of the Membrane Pyrophosphatase Hydrolytic Centre. 
Overview of the hydrolytic centre of the IDP-bound VrPPase structure (VrPPase:Mg5IDP, PDB ID: 4A01) 
showing bound Mg5IDP complex, bound K+, loop 5-6 packed over the active site and coordination of the 
nucleophilic water (red sphere) by D6.43 and D16.39. 
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1.4.3.1 Role of Metal Ions 
Various combinations of metal ions have been found in the active site of each of the 
crystal structures.  Given the functional similarities between the mechanism of hydrolysis 
in M-PPases to those found in S-PPases, it was proposed that there would be a similar 
requirement for metal ions in the activity of M-PPases.  It was determined that a series of 
magnesium or manganese ions formed a complex with PPi, similar to that seen in the S-
PPases (Cooperman et al., 1981; Heikinheimo et al., 1996). Two of these ions bound to 
the enzyme itself, as seen in the resting state structure of TmPPase (one metal ion being 
Ca2+ in the crystal structure).  Mg2+ was found to be the most potent activator of PPase 
activity but manganese could also activate the protein (Maeshima, 1991).  The same study 
found that calcium was a potent inhibitor of M-PPase and once bound, would prevent the 
MgPPi substrate from binding.  In this way, it is possible to lock the protein into the 
resting-state conformation with calcium.  The role of Mg2+ was described in section 1.4.3. 
In addition to the metal ions in the active site, there are additional ions that affect the 
activity of various types of M-PPase, such as K+ and Na+.  
 
1.4.3.2 Potassium Ion Dependence 
Two sodium binding sites were discovered in TmPPase (Belogurov & Lahti, 2002), one 
of which exclusively binds sodium. The other site can also bind potassium and in doing 
so increases the affinity for sodium ions at the other site. Mutants of the the ion gate were 
generated and it was determined that D16.46 was strongly involved in the binding of 
sodium to TmPPase and likely forms part of the binding site in this protein (Belogurov & 
Lahti, 2002). No additional information on the sodium-exclusive binding site was 
obtained from the TmPPase structures, however, the Na+/K+ site was identified in the 
VrPPase structure.   
 
K+ is visible in the active site at the proposed position near A12.46, providing a potential 
mechanistic explanation for K+-dependence. In K+-independent M-PPases this residue is 
a lysine. It is therefore proposed that the side chain amine group of the lysine occupies 
the same position as the potassium ion, substituting the positive charge. Indeed, this 
hypothesis is backed up by mutational studies in Carboxydothermus hydrogenoformans, 
a K+-independent H+-PPase (Belogurov & Lahti, 2002), in which A12.46K and A12.49T 
mutants were generated.  The A12.46K mutant was sufficient to abolish the K+-sensitivity, 
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with the resulting protein equally active in the presence of increasing K+ concentrations 
from 0 to 50 mM.  The A12.49T mutation did not generate a K+-independent protein, but 
instead increased the affinity for K+ three-fold. 
 
1.4.3.3 Cation Selectivity 
The basis for ion selectivity (H+ or Na+) has not been established in M-PPases, although 
it is clearly complex given the high degree of sequence similarity, notably in the 
percentage of conserved residues around the hydrolytic centre and at the ion gate (Figure 
1.7). The gate itself is comprised of either two or three charged residues. In VrPPase, 
D6.50 and K16.50 form an ion pair with a glutamate at position E6.57 (Lin et al., 2012) (Figure 
1.10). In TmPPase an ion triplet is formed with D6.50, D16.50, E6.53 interacting with K12.50 
(Figure 1.10). The glutamate is positioned a single turn up the helix (towards the 
cytoplasmic side) in TmPPase compared with VrPPase (Kellosalo et al., 2012). This 
change in position alters the interactions that form at the ion gate and thus seems a 
plausible mechanism to explain the ion selectivity.  
 
 
Figure 1.10: Overview of the Membrane Pyrophosphatase Ion Gate. 
Overview of the ion gate of (a) the VrPPase:Mg5IDP (yellow) and (b) TmPPase:CaMg (grey) structures 
showing key residues and structure of ion gate through interactions between K16.50 and surrounding 
residues. Labelling of E6.53 is based on TmPPase structure, E6.57 is based on VrPPase structure and S5.43 
from VrPPase represents the position of E5.43 in Flavobacterium johnsaniae M-PPase. 
 
 
However, it is clear that this motif is not conserved across all types of M-PPases. Indeed, 
the glutamate is found at position E6.53 for the majority of M-PPase types, both Na+-
PPases, H+-PPase and dual-PPases, only really differing for the K+-dependent H+-PPases 
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at position E6.57.  There are some notable exceptions, such as in Flavobacterium 
johnsaniae, in which this glutamate is positioned at E5.43. However, this is still predicted 
to occupy the same region in the structure based on models and mutational studies of this 
semi-conserved glutamate (Figure 1.10) (Luoto et al., 2011).  These found that if the 
glutamate of an Na+-PPase is moved from E6.53 to E6.57, as seen in the K+-dependent H+-
PPases, then there is a significant drop in hydrolytic activity and ion pumping, but no 
change in the ion selectivity is observed. Ultimately, this means there is no consensus on 
which residues are essential for ion selectivity. 
 
1.5 Studies of M-PPase Catalytic Cycle 
1.5.1 Catalytic Cycle from Multi-state Model 
A model of the M-PPase catalytic cycle had been proposed based upon the solved 
structures of TmPPase and VrPPase (Kellosalo et al., 2012; Lin et al., 2012; Tsai et al., 
2014), which covered many of the important catalytic states (resting state, substrate-
analogue-bound and product-bound).  This highlighted several interesting features about 
specific helices and residues, most notably a movement of helix 12 upon substrate 
binding. This has adopted a ‘’downwards’’ conformation having moved by around 2 Å 
and appears to have disrupted an ion pair between K12.50 and D6.43. This aspartate residue 
is involved with coordinating and activating the nucleophilic water in the active site, 
involved with hydrolysis of the substrate (Figure 1.9).   
 
Upon substrate binding, the 5-6 loop region closes the active site on the cytoplasmic side 
preventing the backflow of ions (Tsai et al., 2014). The hydrolysis of substrate occurs via 
the activation of the nucleophilic water. Two aspartate residues (D6.43 and D16.39), located 
just below the active site, coordinate the water nucleophile (Figure 1.10). The active site 
is comprised of a series of charged aspartate residues interacting with the Magnesium ion 
cage surrounding the pyrophosphate. This leads to a complex network of electrostatic 
interactions, whereby there is total coordination of all lone pairs in the substrate, requiring 
an additional magnesium ion with the substrate compared with the type-I S-PPases. The 
exact trigger for hydrolysis has yet to be determined, either occurring immediately upon 
substrate binding or only after cation pumping.  
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The movement of helix 12 is also involved with the coupling of the hydrolytic mechanism 
to the ion pumping mechanism, based upon the structures (Tsai et al., 2014) and on an 
extensive series of mutations made to the M-PPase of Streptomyces coelicolor (Hirono & 
Maeshima, 2009; Hirono et al., 2007). By mutating residues of helix 12, it was possible 
to partially decouple the enzyme, reducing the pumping activity to 25 % that of wild-type 
whilst maintaining hydrolytic activity between 75 and 150 %. An additional study on 
VrPPase (Asaoka et al., 2014) identified several residues of the coupling channel: I12.54, 
L12.64, N16.46, V16.54 and L16.57 that, when mutated, completely prevented proton-pumping 
activity, but maintained hydrolytic activity between 39 and 75 % that of wild-type.  
 
1.5.2 Chronological Ordering of Mechanism Coupling 
The model of the M-PPase catalytic cycle has raised several important questions with 
regards to the coupling of PPi hydrolysis with the pumping of Na+/H+. The most important 
of these is the order in which the two key mechanisms occur: substrate hydrolysis and 
Na+/H+ pumping.  There are currently three competing hypotheses as to which order the 
two events occur in (Figure 1.11).  The first was derived from the VrPPase and suggests 
that hydrolysis is the first step, leading to pumping of the cation (Lin et al., 2012).  The 
second hypothesis (the binding-change method) suggests that the pumping of the cation 
occurs first and that it is structural changes resulting from this that allows hydrolysis to 
occur (Kellosalo et al., 2012). The third involves the direct pumping of the proton 
abstracted from PPi during hydrolysis (Baykov et al., 2013). 
 
In the first model (Lin et al., 2012), hydrolysis of the PPi substrate would occur first, via 
the nucleophilic water. The resulting ion would be transferred down the coupling channel 
to the ion gate. The arrival of the cation at the ion gate would trigger the opening of the 
gate and result in release of the cation to the external side of the membrane (Figure 1.11a).  
In the binding change model, the binding of Mg2PPi generates a transient conformational 
state in which both the hydrophobic gate and exit channel are open, mediated by the 
downward motion of helices 11-12 (Kellosalo et al., 2012).  This allows an ion to exit the 
channel, reducing the charge in the region and generating a charge difference between 
the ion gate and active site. This charge difference leads to an increase in the basicity of 
the D6.43 and D16.39 that in turn activates the nucleophilic water and results in the 
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hydrolysis of PPi. In this method, only once the ion has been pumped will hydrolysis be 
possible, thus ensuring that the entire cycle is controlled and ordered (Figure 1.11b).  
 
The third model utilised a direct-pumping method (Baykov et al., 2013). The substrate 
would bind and be hydrolysed via the nucleophilic water, with the resulting abstracted 
proton being directly pumped out of the channel without passing along a Grotthuss chain 
mechanism (Figure 1.11c). This model is unlikely to be correct since it does not account 
for Na+-PPases. The mechanism is likely to be similar for both Na+ and H+-PPases, given 
the high sequence and structural similarities at the hydrolytic centre and ion gate (Figure 
1.7). The H+-PPases would likely utilise a Grotthuss chain mechanism (Agmon, 1995) to 
transfer the protons down the coupling channel. This involves the movement of protons 
along a ‘proton wire’ consisting of charged residues in the coupling channel. 
 
It is hoped that as new structures become available at a higher resolution, the exact 
mechanism by which the ions are transported can be fully elucidated, using a combination 
of structural and biochemical information to try to pin down the specific residues involved 
with the process. 
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Figure 1.11: Proposed Mechanisms of the Membrane Pyrophosphatase Catalytic Cycle. 
Overview of the three proposed mechanisms of the M-PPase catalytic cycle. (a) Mechanism proposed by 
Lin et al., 2012 showing hydrolysis before pumping. (b) Binding-change mechanism proposed by Kellosalo 
et al. 2012, showing ion pumping before hydrolysis. Both (a) and (b) utilising a Grotthuss chain mechanism 
for translocation of ions along the coupling funnel. (c) Direct-coupling method proposed by Baykov et al. 
2013, in which the proton abstracted from the hydrolysis of PPi is pumped directly without entering a 
Grotthuss chain. 
 
1.6 Aims and Objectives of the Thesis 
The first aim of my thesis was to try and crystallise the M-PPase from Thermotoga 
maritima in as many different catalytic states as possible. These structures will be used 
alongside data on conformational changes, obtained via tryptophan fluorescence, and 
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proton pumping studies carried out using the SURFE2R technique to generate and update 
the complete model of the catalytic cycle. This will be used to try and understand the 
specific mechanisms through which these proteins hydrolyse PPi, transport cations and 
couple these processes together. The second aim was to express, purify and crystallise the 
M-PPase from Pyrobaculum aerophilum and attempt to solve the structure of this protein 
using X-ray crystallography.  In addition, mutagenesis experiments will be carried out to 
try and better understand the K+-independence mechanism of this protein and to 
investigate the role of the C-terminus in protein structure and function.  This information 
will further our knowledge of transporters, particularly M-PPases, and allow for the 
comparison of the different types of M-PPases (Na+ or H+, K+-dependent/independent) to 
help understand the structural and functional differences between these mechanisms.  
This information also assisted in current drug discovery and drug design programmes, 
aiming to combat pathogens such as the Malaria-causing Plasmodium parasites and 
pathogenic prokaryotes that contain M-PPases.
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2 Chapter 2: 
Materials and Methods  
	 36	
 
2.1. Expression and Purification of M-PPases 
2.1.1. Cloning of TmPPase and PaPPase Genes into Expression Vector 
The yeast expression plasmid pRS1024 was used in all yeast expression experiments. The 
plasmid containing TmPPase (pMP649-Tm) was provided by Juho Kellosalo (University 
of Helsinki) and had been used previously to express TmPPase (Kellosalo et al., 2011).  
The TmPPase gene contained several thermostabilising mutations, V353L and S395G 
(loop 8-9 and 9-10, respectively), and the plasmid contained an N-terminal 6-His tag 
(Figure 2.1).   
 
Figure 2.1: Schematic Overview of TmPPase-containing Expression Plasmid. 
Overview of the pRS1024 yeast expression plasmid containing the 6-His tagged TmPPase, the PMA1 
constitutive promotor and terminator sequences, LEU2 yeast selective marker and Ampicillin resistance 
gene used for bacterial selection. 
 
Four different PaPPase constructs were generated (Pa A - Pa D) (Figure 2.2)(Table 2.1), 
two containing the signal peptide from Trypanosoma cruzi and two containing a GG-
linker between the His-tag and gene sequence.  The wild-type PaPPase gene was PCR 
amplified using primers containing the SalI and XbaI restriction sites (Table 2.2). Primers 
91 and 93 were used to PCR amplify the PaPPase gene with the GG linker between the 
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His-tag and gene sequence and primers 90 and 93 were used to PCR amplify the gene 
without the GG linker (Table 2.2).  Each set of primers was used on two different plasmid 
sources of the PaPPase gene. One plasmid contained the T. cruzi signal sequence 
upstream of the gene and the other did not. This signal sequence had previously been 
shown to improve the yield of protozoan parasite M-PPases expressed in yeast (Kellosalo 
et al., 2011).  The yield likely improved due to better localisation of the protein to the 
outer membrane, preventing it from saturating organelle membranes within the yeast 
expression host. The pRS1024 expression vector was linearised with XhoI and SpeI 
(isoschizomers of SalI and XbaI, respectively) restriction enzymes (Table 2.2) and the 
gene insert was ligated into the linearised vector using T4 DNA ligase and confirmed via 
colony PCR and sequence analysis using primers complimentary to the gene sequence 
(Table 2.2, primers 104-108). 
 
Table 2.1: PaPPase Construct Overview. 
List of all four constructs generated as part of the expression trials of Pyrobaculum aerophilum 
membrane pyrophosphatase, including presence or absence of signal peptide or GG-linker. 
Name of construct Trypanosoma cruzi signal 
peptide 
GG-linker 
Pa A No No 
Pa B No Yes 
Pa C Yes No 
Pa D Yes Yes 
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Figure 2.2: Schematic Overview of PaPPase-containing Expression Plasmids. 
Overview of the four tested PaPPase constructs (Pa A – D), containing different combinations of a 
glycine-glycine linker between the His-tag and gene and a signal peptide from Trypanosoma cruzi 
upstream of the His-tag.  All constructs were based on the pRS1024 yeast expression plasmid containing 
the PMA1 constitutive promotor and terminator sequences, LEU2 yeast selective marker and Ampicillin 
resistance gene used for bacterial selection. 
 
Mutants of PaPPase were generated using the Q5 site-directed mutagenesis kit (NEB) to 
test the potassium-dependence.  Primer pairs were prepared following the manufacturer’s 
protocols (NEB) (Table 2.2, primers 119-124) and contained the mutation of interest. 
These were used in a standard PCR to amplify the entire plasmid, mutating the desired 
nucleotide in the process.  The resulting constructs were digested with DpnI to remove 
remaining template DNA and the presence of the mutation was confirmed via sequence 
analysis. 
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Table 2.2: Cloning and Mutagenesis Primer List. 
List of primers used for cloning and sequencing of PaPPase constructs. Annealing temperatures are 
based on manufacturer’s guidelines for Q5 DNA polymerase (NEB).  Nucleotide sequences shown in 
lower case represent mutations to the wild-type gene sequence and underlined regions represent 
restriction sites. All sequences are shown 5’ to 3’. 
Primer 
No. 
Primer sequence Restriction 
sites 
direction Tm 
(˚C) 
Cloning primers 
90 ttt ttt GTC GAC ATG CAT CAC CAT CAC CAT CAC 
AAT ATG ATA AGC TAT GCC TTA CTA GG 
SalI F 59 
(Q5) 
91 ttt ttt GTC GAC ATG CAT CAC CAT CAC CAT CAC 
GGT GGA AAT ATG ATA AGC TAT GCC TTA CTA 
GG 
SalI F 59 
(Q5) 
93 ttt ttt TCT AGA TCA GAA AGG CAA TAG ACC TG XbaI R 59 
(Q5) 
Sequencing primers 
104 CG CAT TTT CTC GTT ACC A N/A R N/A 
105 AAT ATG ATA AGC TAT GCC N/A F N/A 
106 A GAT TTA GTT GGG AAG GT N/A F N/A 
107 ACT GTG CCT GTA AGC GGC N/A F N/A 
108 ATT GTC CTC CCC TTA ATA N/A F N/A 
Q5 site-directed mutagenesis primers 
119 C AAT ACC ACA gca GCC ACT ACT AAG GG N/A F 64 
120 CC GAC GGA GTC CAG TAC A N/A R 64 
121 A AAA GCC ACT gct AAG GGA TAT GC N/A F 65 
122 GT GGT ATT GCC GAC GGA G N/A R 65 
123 act gct AAG GGA TAT GCA ATA GCC AG N/A F 63 
124 ggc tgc TGT GGT ATT GCC GAC GGA N/A R 63 
InFusion cloning primers 
127 GCT GCC GCG CGG CAC N/A R N/A 
128 TCT AGT CGA GGG AAT TGT CAT T N/A F N/A 
129 CAC GGC GCG CCG TCG 
CATATGATAAGCTATGCCTTA 
N/A F N/A 
130 ATT CCC TCG ACT AGA tca CGC TAT ATT CGT 
AGA CAC GAT 
N/A R N/A 
 
C-terminal truncation mutants were generated using the In-Fusion cloning technique with 
primers specific to the N-terminus and 39 nucleotides upstream of the C-terminus region 
of the wild-type PaPPase gene (Table 2.2, primers 129-130). Each primer had a 15 bp 
overlap with the termini of the pRS1024 expression plasmid to allow for homologous 
recombination of the mutated gene into the plasmid. The pRS1024 expression plasmid 
was linearised using PCR with primers specific for each side of the multiple cloning site 
(Table 2.2, primers 127-128).  Presence of the mutation was confirmed via sequence 
analysis of the constructs. 
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2.1.2. Transformation of Expression Vector into Yeast 
S. cerevisiae BJ1991 yeast cells were first spread onto a yeast extract peptone dextrose 
(YPD) media plate and grown for 2 days at 28 ˚C.  Individual colonies were picked and 
cultured in 7.5 ml YPD media overnight. 1 ml of overnight yeast culture per 
transformation reaction was pelleted in a micro-centrifuge and resuspended in 0.15 ml 
PLATE solution (40 % PEG 3350, 0.1 M LiAc, 10 mM Tris pH 7.5 and 1 mM EDTA).  
10 µg of denatured fish sperm DNA (heated to 100˚C and cooled to room temperature) 
was added to each sample to reduce the degradation of the target DNA. 500 ng of target 
plasmid DNA was then added to each sample along with 10 µl DMSO, mixing briefly 
with a vortex mixer between each step. Samples were incubated at 28 ˚C for 15 minutes 
and then incubated at 42 ˚C for 20 minutes to heat-shock the yeast cells.  Samples were 
then pelleted, the supernatant discarded and the cells were gently resuspended in 100 µl 
TE buffer (10 mM Tris pH 7.5 and 1 mM EDTA).  The resulting mixture was spread onto 
plates containing Synthetic Complete Dropout, minus leucine (SCD-Leu) media and 
incubated for at least two days at 28 ˚C until colonies formed. 
 
2.1.3. Expression of TmPPase 
Yeast starter cultures were prepared from positive transformation colonies of the 
TmPPase-pRS1024 plasmid in Synthetic Complete Dropout minus leucine (SCD-Leu) 
media.  Standard expression experiments were carried out in 10 L batches, with starter 
cultures consisting of 3 x 850 ml SCD-Leu media.  These were inoculated with several 
loopfuls of yeast cells from the transformation plates and incubated at 30 ˚C for 24 hours, 
shaking at 200 rpm to maintain the cells in suspension. Starter culture was then inoculated 
into 10 x 750 ml Yeast extract Peptone Dextrose (YPD) media (250 ml culture per flask) 
and the protein was expressed by incubation at 30 ˚C for 8 hours.  Following expression, 
cells were harvested and spun at 2,000 x g for 5 minutes (JLA 8.1000 rotor, Beckman). 
Pellets were washed via alternating resuspension in ddH2O and spun at 2,000 x g for 5 
minutes. This was repeated several times to ensure the pellets were completely washed. 
Pellets were finally collected via removal of all liquid, weighed and then stored at -80 ˚C 
until required. 
 
2.1.4. Expression of PaPPase 
Small-scale PaPPase expression trials were carried out by inoculating 187.5 ml of either 
SCD-Leu media or YPD media with 62.5 ml of starter culture containing each PaPPase 
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construct.  These were incubated for 8 hours and the OD600 was monitored using a 
spectrophotometer (WPA Biowave II). Cells were harvested, washed and the pellets were 
stored at –80 ˚C, as described above.  Larger-scale PaPPase expression trials were carried 
out following a modified version of the standard expression protocol for TmPPase 
(section 2.1.3) in which the expression cultures were incubated for 10 hours instead of 8 
hours.  OD600 was monitored using a spectrophotometer and cells were harvested, washed 
and the pellets were stored at -80 ˚C, as described above. 
 
2.1.5. Membrane Extraction  
Cell pellets from the expression experiments were thawed and resuspended in 1 ml of 
Buffer A (0.2 M Tris, pH 7.5, 40 % glycerol, 10 mM EDTA, 2 mM DTT and 0.2 mM 
PMSF) per 2 g of dry cell weight.  Cells were lysed using 0.5 mm glass beads either in 
50 ml Falcon tubes (< 20 ml resuspended cells) or in the bead-beater (Biospec products) 
(> 20 ml resuspended cells).  1.5 g of ice-cold glass beads were added per 1 ml of 
resuspended cells and the Falcon tube or bead-beater chamber was completely filled using 
buffer B (10 mM Tris pH 7.5, 10 % glycerol, 5 mM EDTA and 1 mM DTT).  Cells were 
lysed via 12 x 1 minute mixing with the glass beads, interspaced by 1 minute cool-down 
on ice. Care was taken to ensure the samples remained cold at all times, to prevent 
damaging the proteins.  The lysate and bead sample was spun at 4,000 x g to remove 
beads and cell debris.  The supernatant was collected and spun at 42,500 rpm for 45 
minutes using a pre-cooled Ti-45 rotor (Beckman) to pellet the membranes.  Membrane 
pellets were collected and resuspended in buffer C (50 mM MES-NaOH pH 6.5, 20 % 
glycerol, 50 mM KCl, 5 mM MgCl2, 1.33 mM DTT, 0.336 mM PMSF and 2 µg/ml 
Pepstatin A) using a glass dounce homogeniser at room temperature. 
 
2.1.6. Bradford Assay 
The total protein concentration of the extracted membranes was calculated using the 
Bradford assay (Bradford, 1976), using bovine gamma globulin (BgG) as standard 
samples and a buffer control consisting of dilutions of buffer C.  Extracted membrane 
samples were prepared at 1/10, 1/50, 1/100, 1/500, 1/1000 and 1/5000 in ddH2O.  20 µl of 
each sample was added to a 96-well plate in triplicate followed by 180 µl of Bradford 
reagent.  The plate was incubated at room temperature for 20 minutes at which time the 
absorbance was measured at 600 nm.  The total protein concentration was calculated, 
factoring in the buffer control and ensuring the sample was within the standard range.  
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Once the total protein concentration of the membranes had been determined, aliquots 
were flash-frozen in liquid nitrogen and stored at -80 ˚C. 
 
2.1.7. Detergent Solubilisation of M-PPases 
2.1.7.1. Standard TmPPase Solubilisation Protocol 
Extracted membrane samples were diluted to 7.2 mg/ml total protein concentration using 
buffer C.  Solubilisation was carried out in batches of 30 ml diluted membranes.  100 µl 
of 100 mM Na2PPi was added to each 30-ml batch of diluted membrane sample to ensure 
the sample remained stable at high temperature.  Samples were pre-incubated at 75 ˚C 
along with 10 ml of solubilisation buffer (50 mM MES-NaOH pH 6.5, 20 % glycerol and 
5.34 % DDM) per 30 ml diluted membranes, for 15 minutes.  The ratio of extracted 
membranes to detergent was 1:3 to allow for efficient solubilisation to occur (López-
Marqués et al., 2005). After incubation, both samples were combined and incubated at 
75 ˚C for 1.5 hours, either shaking at 150 rpm or with manual inversion every 5 minutes. 
The resulting mix was spun at 4,500 x g for 5 minutes at room temperature to pellet the 
insoluble fraction and remove any remaining cell debris. The supernatant was then ready 
for column binding. 
 
2.1.7.2. Small-scale PaPPase Solubilisation Screen 
A small-scale solubilisation test was carried out for PaPPase using a commercial screen 
of 20 detergents (Table 2.3).  For each detergent, 200 µl of diluted membrane sample at 
5 mg/ml was used.  This was mixed with 66.6 µl of solubilisation buffer with 1 - 50 x 
CMC of each detergent and incubated at 70 ˚C for 1 hour, shaking at 1,000 rpm.  220 µl 
of each sample was then spun at 100,000 x g and 4 ˚C for 1 hour using a TLA-100 rotor 
(Beckman).  Each pellet was resuspended in 220 µl resuspension buffer (50 mM MES 
pH 6.5 and 50 mM KCl) and used for SDS-PAGE analysis and activity assay 
measurements. 
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Table 2.3: List of Detergents used for Solubilisation Tests. 
List of all detergents used during the small-scale solubilisation test of Pyrobaculum aerophilum 
Membrane Pyrophosphatase along with associated Critical Micellar Concentrations (CMCs) and acyl 
chain length. 
Name of detergent Abbreviated name Chain length CMC 
(%) 
7-Cyclohexyl-1-Heptyl-β-D-Maltoside CYMAL-7 7C + ring 0.0099 
n-Octyl−β−D-Thiomaltopyranoside OTM 8C + S 0.53 
n-Nonyl−β−D-Thiomaltopyranoside NTM 9C + S 0.15 
n-Decyl−β−D-Thiomaltopyranoside DTM 10C + S 0.045 
n-Undecyl−β−D-Maltopyranoside UM 11C 0.029 
n-Undecyl−β−D-Thiomaltopyranoside UTM 11C + S 0.011 
n-Dodecyl−β−D-Maltopyranoside DDM 12C 0.0087 
n-Dodecyl−β−D-Thiomaltopyranoside DDTM 12C + S 0.0026 
n-Tridecyl−β−D-Maltopyranoside TriDM 13C 0.0017 
n-Tetradecyl−β−D-Maltopyranoside TetraDM 14C 0.00054 
2,6-Dimethyl-4-Heptyl−β−D-
Maltopyranoside 
2,6-Dimethyl-4-
Heptyl−β−D-M 
9C (forked 
tail) 
1.2 
3-Cyclohexyl-1-Propyl-β-D-Glucoside CYGLU-3 3C + ring 0.86 
n-Nonyl−β−D-Glucopyranoside NG 9C 0.2 
Methyl-6-O-(N-Heptylcarbamoyl)-α-D-
Glucopyranoside 
Anameg-7 7C 0.65 
β-D-Fructopyranosyl-α-D-
Glucopyranoside Monododecanoate 
Sucrose 
monododeconoate 
X 0.016 
n-Heptyl−β−D-Thioglucopyranoside HTG 7C + S 0.85 
Tetraethylene Glycol Monooctyl Ether C8E4 X 0.25 
Pentaethylene Glycol Monodecyl Ether C10E5 X 0.031 
Hexaethylene Glycol Monooctyl Ether C8E6 X 0.39 
Octaethylene Glycol Monododecyl Ether C12E8 X 0.0048 
 
2.1.7.3. Large-scale PaPPase Solubilisation Test 
Large-scale solubilisation tests of PaPPase followed a modified version of the TmPPase 
solubilisation protocol (Section 2.1.7.1) in which DM, UM and DDM were used in place 
of just DDM. During solubilisation, 100 µl of 100 mM Na2PPi was substituted for 100 µl 
of 100 mM Na2IDP or 100 µl water. All other steps were the same as the standard 
TmPPase protocol (Section 2.1.7.1). 
 
2.1.8. Ni-NTA Purification of M-PPases 
2.1.8.1. Standard TmPPase Purification Protocol 
Nickel-Nitrilotiacetic Acid (Ni-NTA) resin columns were prepared by adding 0.5 ml of 
80 % Ni-NTA matrix slurry to every 40 ml of solubilised membrane sample. The slurry 
was washed with 10 x volume of buffer C supplemented with 0.2 % DDM, spun at 1,800 
x g and 4 ˚C for 3 minutes, after which the supernatant was discarded.  For every 40 ml 
of solubilised membrane sample, 32 ml of buffer C, 6 ml of 3.5 M KCl and 0.5 ml of 
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washed Ni-NTA beads were combined and incubated for 1.5 hours at 40˚C, shaking at 
100-150 rpm to ensure the beads remained in solution. 
 
Following incubation, the samples were added to 20 ml columns. The initial flow-through 
sample was collected for use in SDS-PAGE.  The column was washed with 2 x column 
volume (CV) of wash buffer (50 mM MES-NaOH pH 6.5, 20 % glycerol, 50 mM KCl, 5 
mM MgCl2, 1 mM Na2Pi, 30 mM imidazole, 0.02 % DDM, 1 mM DTT, 0.2 mM PMSF 
and 2 µg/µl pepstatin A) followed by one wash containing 2 x CV of elution buffer (50 
mM MES-NaOH, pH 6.5, 3.5 % glycerol, 50 mM KCl, 5 mM MgCl2, 1 mM Na2Pi, 400 
mM imidazole, 0.02 % DDM, 1 mM DTT, 0.2 mM PMSF and 2 µg/ml pepstatin A). The 
resulting samples were collected and used for SDS-PAGE analysis and concentration 
steps. 
 
2.1.8.2. PaPPase Purification 
During purification trials of PaPPase, an imidazole gradient was used to test the different 
PaPPase constructs following a modified version of the standard TmPPase purification 
protocol (Section 2.1.8.1).  Samples and columns were prepared following the standard 
protocol, but a series of wash buffers were prepared covering an imidazole gradient to 
final concentrations of 10, 20, 30, 40, 50, 100, 200 and 300 mM imidazole. Larger-scale 
purification of PaPPase was carried out following the standard TmPPase purification 
protocol except the concentration of imidazole in the wash buffer was 20 mM instead of 
30 mM. 
 
2.1.8.3. On-column Detergent Exchange 
Detergents were exchanged on the Ni-NTA column, as required.  PaPPase was exchanged 
from DDM into DM, OGNG, LMNG, OM, NM and NG by replacing DDM in the wash 
and elution buffers with 4 x CMC of each buffer. All downstream purification buffers 
then used the new detergent in place of DDM at 4 x CMC. 
 
2.1.8.4. Protein Concentration and Buffer Exchange 
Eluted samples from the Ni-NTA purification were concentrated via centrifugation of the 
sample through a 50 kDa vivaspin 2 (MWCO) protein concentrator (GE Healthcare), 
which allows the liquid to pass but not the protein or detergent micelles. The 
concentration of protein was determined from A280 readings using the DS11+ UV 
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spectrophotometer, blanked against the elution buffer and the protein was concentrated 
to between 10 and 20 mg/ml, suitable for downstream applications. 
 
Following concentration of the protein sample, buffer exchange was carried out to remove 
the imidazole. This was achieved using the micro bio-spin 6 columns (Bio-Rad), which 
were preloaded with the M-PPase crystallisation buffer (3.5 % glycerol, 50 mM KCl, 20 
mM MES-NaOH pH 6.5, 5 mM MgCl2, 2 mM DTT, 4 x CMC detergent), determined 
from previous crystallisation experiments of TmPPase (Kellosalo et al., 2013). To 
equilibrate the columns, 4 x 500 ml buffer was added to each and these were spun at 1,000 
x g for 1 minute between each addition.  Following this, 20 - 75 µl of concentrated protein 
was added and the column was spun at 1,000 x g for 4 minutes. The concentration of the 
buffer exchanged protein was determined by A280 method using the crystallisation buffer 
as a blank. The protein was then either directly used for experiments or was flash-frozen 
in liquid nitrogen and stored at -80 ˚C.  If alternative buffers were required, these were 
substituted in place of the crystallisation buffer. 
 
2.1.8.5. SDS-PAGE 
SDS-PAGE was carried out to check the purity of protein samples following purification 
and for carrying out Western Blot analysis.  Protein samples were prepared by adding 10 
µl of 4 x SDS sample buffer (200 mM Tris-HCl pH 6.8, 80 mg/ml SDS, 40 % glycerol, 
50 mM EDTA, 0.8 mg/ml bromophenol blue and 20 mM DTT) to each 30 µl protein 
sample. In the case of more concentrated samples, such as the extracted membrane 
samples, these were diluted 1:5 prior to addition of 4 x SDS sample buffer.  Precast gels 
(Biorad) were used and these were prerun at 120 V for 10 minutes with 1 x SDS running 
buffer (25 mM Tris, 192 mM glycine and 0.1 % (w/v) SDS) to ensure even distribution 
of SDS throughout the gel.  Samples were loaded into the gel alongside a protein ladder 
(Color protein standard, NEB) and BSA standards, where applicable. Gels were run at 
150 V for around 45 minutes, or until the dye front reached the bottom of the gel. Gels 
were then washed in ddH2O for 15 minutes on a shake platform, stained with quick 
Coomassie stain (Generon) for 30 minutes when bands became visible on the gel.  Gels 
were destained by washing in ddH2O for 1 hour on a shake platform and were imaged in 
the G:Box (Syngene) gel imaging system.  Gels used for Western blot analysis were not 
washed or stained but were immediately blotted instead. 
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2.1.8.6. Western Blot 
Western blot analysis was carried out to visualise specific protein bands using protein or 
tag-specific antibodies following SDS-PAGE analysis.  SDS-PAGE was carried out as 
described above and the gel was transferred to a 0.2 µM PVDF membrane (Bio-Rad) 
using the Trans-blot Turbo transfer system (Bio-Rad) set to 2.5 A and 25 V for 10 
minutes.  Following transfer, membranes were blocked with TBS-T (137 mM NaCl, 2.7 
mM KCl, 19 mM Tris and 0.1 % Tween 20) containing 3 % BSA for 1.5 hours, rolling at 
room temperature.  Rabbit Anti-M-PPase antibody was added at a 1:10,000 dilution and 
the membrane was rolled for 1 hour at room temperature.  The membrane was then 
washed three times with TBS-T buffer, rolling for 10 minutes during each wash and 
discarding buffer between.  Fresh TBS-T buffer containing 1:10,000 dilution of the 
secondary antibody (goat anti-rabbit) was added and the membrane was incubated for 1 
hour at room temperature on a rolling platform.  Membranes were washed three times 
again with TBS-T for 10 minutes each and then 1.5 ml of Clarity Western ECL substrate 
(Bio-Rad) was added per membrane to develop the bands.  Blots were imaged using the 
G:Box gel imaging system. 
 
2.1.9. M-PPase Hydrolytic Activity Assay 
2.1.9.1. Relipidation of Protein Samples 
2.1.9.1.1. Standard TmPPase Relipidation Protocol 
Prior to running the activity assay, protein samples must be relipidated to replace lipids 
lost during purification and so recover maximal activity.  TmPPase samples were 
relipidated by mixing 40 µl of 30 mg/ml soybean lecithin dissolved in 20 mM Tris-HCl 
pH 8.0 and 1 mM DTT (sonicated until clear) with 22.5 µl of 20 % DDM.  The solution 
was heated at 55 ˚C for 15 minutes, allowed to cool to room temperature before 35.5 µl 
of buffer C was added.  The solution was mixed and 2 µl of concentrated TmPPase was 
added and the solution kept on ice prior to activity assay measurements. 
 
2.1.9.1.2. PaPPase Relipidation Trial 
Several relipidation methods were tested for PaPPase based on modified versions of the 
standard TmPPase relipidation protocol (Section 2.1.9.1.1). The first method followed 
the TmPPase protocol.  The second method followed previous studies into PaPPase 
purification (Kellosalo et al., 2011) and involved addition of 47 µM soybean lecithin to 
the protein sample, with 20 % DDM replaced with additional buffer C.  The third method 
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also followed the standard TmPPase protocol except the 20 % DDM was replaced with 
additional buffer C, the soybean lecithin concentrations were kept the same as the 
TmPPase protocol. 
 
2.1.9.2. Standard TmPPase Activity Assay Protocol 
The main reagents were prepared in advance of the assay and consists of solution A (0.3 
g ascorbic acid added to 10 ml ice-cold 0.5 M HCl) and solution B (70 mg Ammonium 
heptamolybdate added to 1 ml ice-cold H2O). Both solutions are combined and kept on 
ice for at least 30 minutes, but no longer than 3 hours as the colour starts to develop even 
in the absence of protein.  A sodium arsenite solution, which stops the colour change once 
added, was also prepared by dissolving 5 g of sodium arsenite and 5 g of trisodiumcitrate 
in 100 ml of H2O. 5 ml of acetic acid was then mixed into the solution and this was taken 
to a maximum volume of 250 ml with H2O.  Care was also taken to ensure sufficient 
buffer was used to keep the detergent concentration of each sample above the critical 
micellar concentration (CMC) (the minimum concentration of detergent at which 
micelles will still form) usually aiming to keep it between 2 and 4 times above the CMC. 
 
Initial M-PPase activity assays were carried out in standard 1 ml cuvettes.  Each protein 
sample was prepared to a final volume of 240 µl in activity assay buffer (80 mM Tris-
HCl pH 8.0, 5 mM MgCl2, 120 mM KCl, 20 mM NaCl, 1 mM NaF) and used 0.2 µl and 
1 µl of relipidated protein.  Phosphate standards were prepared using Na2Pi and control 
samples were prepared using only activity assay buffer and these were run alongside 
protein samples. Solution A and solution B were mixed and kept on ice for at least 30 
minutes but no longer than 3 hours.  To carry out the experiment, each sample was placed 
into a 71 ˚C heat block in sequence, one tube every 15 seconds.  After 5 minutes, 10 µl 
of 10 mM Na2PPi was added to each tube in sequence, one tube every 15 seconds, and 
incubated for 5 minutes at 71 ˚C.  Samples were transferred to ice in sequence, one tube 
every 15 seconds, and incubated for 10 minutes.  300 µl of solutions A and B was added 
to each tube in sequence, every 15 seconds, and samples were kept on ice for 10 minutes.  
450 µl of sodium arsenite solution was added to each tube in sequence, every 15 seconds 
and the samples were incubated at room temperature for 1 hour.  Absorbance was 
measured at 860 nm and the total activity or specific activity was calculated.  
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2.1.9.3. High-throughput 96-well Plate Protocol 
A new method for measuring the hydrolytic activity of the protein was used for later M-
PPase activity assay measurements.  This method followed the same principle as the 
standard TmPPase activity assay protocol but used a 96-well plate and 8-tube PCR strips.  
Each sample was prepared as before, but only 40 µl of protein sample in activity assay 
buffer was added to each tube in the PCR strip. The same sequential addition of Na2PPi, 
solution A and B, and sodium arsenite solution was carried out, but on one PCR strip at 
a time instead of individual tubes. Strips were added to a 71 ˚C heat block, one strip every 
20 seconds, and these were incubated for 5 minutes.  10 µl of Na2PPi was added to each 
strip using a multichannel pipette in sequence, one strip every 20 seconds, and incubated 
for 5 minutes.  Strips were transferred to ice, one strip every 20 seconds, and these were 
incubated on ice for 10 minutes.  60 µl of solution A and B was added to each strip using 
a multichannel pipette, one strip every 20 seconds, and incubated on ice for 10 minutes.  
90 µl of sodium arsenite was added to each sample using a multichannel pipette, one strip 
every 20 seconds, and these were incubated at room temperature for 1 hour.  Samples 
were transferred from the PCR strips to the 96 well plate and the absorbance was 
measured at 860 nm using a plate reader. 
 
2.2. Structural Studies of M-PPases Using X-ray Crystallography 
2.2.1. Preparation of Crystallisation Screens 
2.2.1.1. Sparse Matrix Screens to Obtain Initial Hits 
Purified protein samples were exchanged into crystallisation buffer (3.5 % glycerol, 50 
mM KCl, 20 mM MES-NaOH pH 6.5, 5 mM MgCl2, 2 mM DTT) using previously 
described methods (Section 2.1.8.4) and used for protein crystallisation trials. Several 
commercially available sparse matrix screens were used, including MemGold 1 and 2 
alongside MemStart and MemSys screens.  These have been designed to include a range 
of conditions commonly associated with crystallisation of membrane proteins. 50 µl of 
the well solution from each screen was transferred to 96-well crystallisation plates (2-
drop MRC plates) and crystallisation plates were set up using the NT8 crystallisation 
robot (Formulatrix).  The sitting drop vapour diffusion method was used and drop sizes 
were 0.1 µl protein mixed with 0.1 µl well solution. Plates were stored in the RI1000 
plate imager and hotel (Formulatrix) and each drop was automatically imaged every few 
days with normal, UV-TPEF and SONICC imaging and the resulting images were viewed 
using the Rockmaker software (Formulatrix).   
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2.2.1.2. Optimised PaPPase Crystallisation Screen 
An optimised crystallisation screen was set up, based on the best hits observed from 
previous crystallisation attempts of PaPPase (Kellosalo et al., 2013).  This screen was 
split into two sections, the first had a pH range from 5.5 to 8.5 and contrasted this against 
PEG 400 concentrations from 29 % to 39 %, all using 0.1 M KCl as the only salt.  The 
other half of the screen kept the buffer concentrations constant at either 0.1 M MES-
NaOH, pH 6.5 or 0.1 M Tris, pH 8 and altered the salt types and concentrations, including 
0.01 M, 0.05 M and 0.2 M KCl, 0.1 M NaCl and combinations of CaCl2, LiSO4 and NaCl.  
This screen was designed using the Rockmaker software, prepared using the Formulator 
robot (Formulatrix) and was used in setting up crystallisation plates using the methods 
described above. 
 
2.2.1.3. Detergent Trials 
Many variations of the sparse matrix and optimisation screens were set up for PaPPase. 
Crystallisation plates were set up with protein concentrations ranging between 5 and 10 
mg/ml. The protein was exchanged into DDM, DM, LMNG, OGNG, OM, NM and NG 
during purification (Section 2.1.8.3) and crystallisation plates were set up for each, 
following the previously described methods (Section 2.2.1.1). When lipids were tested, 
these were prepared prior to setting up the crystallisation plates and following the same 
lipid:protein ratios found in the relipidation protocol (Section 2.1.9.1).  In addition, 
several additives were tested to try and lock the protein into various states of the catalytic 
cycle.  These included the addition of CaCl2 and the inhibitor imidodiphosphate (IDP), 
which were independently mixed with the protein sample to a final concentration of 2 
mM prior to setting up the crystal plates. 
 
2.2.2. Crystal Optimisation Methods 
2.2.2.1. High Lipid and Detergent (HiLiDe) Optimisation 
The “HiLiDe” (high lipid and detergent concentration) method (Gourdon et al., 2011) 
was also used to try and optimise crystals of PaPPase.  This technique differs from 
standard crystallisation as increasing concentrations of two different detergents are added 
to the crystallisation screen (Figure 2.3). This technique involved setting up 24-well plates 
of both hanging and sitting drop vapour diffusion plates.  Plates were prepared manually 
by adding 500 µl of the well solution to each well. The drop size was increased to 1 µl 
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protein plus 1 µl well solution.  Conditions were centred around the best crystallisation 
conditions observed during this study and involved increasing concentrations of PEG 400 
and various concentrations of KCl and Tris-HCl buffer. Where protein lipidation was 
used, this was carried out as described above (Section 2.1.9.1) using Soybean Lecithin. 
Increasing concentrations of DDM, DM and NM between 0 and 5 % were tested, and 
different combinations of these detergents were used.  Plates were manually visualised 
under a standard light microscope to observe any potential crystal growth. 
 
 
Figure 2.3: Schematic Overview of HiLiDe Crystal Optimisation Method. 
Comparison between the standard crystallisation technique and HiLiDe optimisation method, involving 
the addition of lipids and two different detergents to increasingly high concentrations (~6 %). The 
addition of specific concentrations of each detergents and lipid can form stable type-2 crystals that may 
improve diffraction. Figure redrawn from Gourdon et al. (2011), Figure 1.  
Solubilised
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Detergent 1
Removal
Lipid and 
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2.2.2.2. Crystal Dehydration Experiments 
Dehydration experiments were carried out by transferring crystals to solution containing 
mother liquor plus either 10 % glycerol or increased PEG 400 concentrations (final 
concentration 5-10 % higher than initial crystallisation conditions) and monitoring plates 
for signs of additional crystal growth. Another method was to add increased glycerol 
concentrations (to a final concentration of 10 %) to the well solution, resealing the plate 
and monitoring crystal development over the course of several days to see if this improved 
crystal quality and diffraction.  Additional methods of dehydration involved exposing the 
loops to the air during crystal picking or manually removing the excess liquid from the 
loop using blotting paper. This allowed for partial evaporation of the excess solution in 
the well and created a dehydrating effect on the crystals in the loop. 
 
2.2.3. Crystal Harvesting & Data Collection 
Crystal harvesting was carried out by manually picking crystals with either nylon, mesh 
or litholoops, appropriately sized to match each crystal, and these were immediately flash 
frozen in liquid nitrogen. Harvesting was carried out at 20 ˚C to limit unwanted 
evaporation of the drop solution. Crystals were either sent to beamline i04 or i24 at 
Diamond Light Source (DLS) or to beamlines ID23-1 and MASSIF-1 at the European 
Synchrotron Radiation Facility (ESRF) for data collection.   
 
2.2.4. Data Processing and Structural Refinement 
The highest resolution data sets from the synchrotrons were processed using a range of 
different software packages.  Initial processing of PaPPase diffraction images and 
generation of intensities was carried out in XDS (Kabsch, 2010). Pointless (P. Evans, 
2006) and Aimless (P. R. Evans & Murshudov, 2013), from the CCP4 software package 
(Winn et al., 2011), were used to scale and merge the data. For the TmPPase structural 
studies, X-ray diffraction data was supplied by Juho Kellosalo (University of Helsinki) 
and initial processing had been carried out in XDS.  One set had been acquired on 
beamline i04 at Diamond light source, based on crystals grown in 32 % PEG 400, 0.1 M 
Tris pH 8.5, 0.1 M MgCl2, 0.1 M NaCl and 2 mM DTT. The other set was from data 
collected for a previous publication (Kellosalo et al., 2012) wherein the data had been 
used for phasing other structures of TmPPase but had never been fully solved.  
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Molecular replacement was carried out for PaPPase using a modified search model based 
on the 2.6 Å resolution TmPPase resting state structure (PDB ID: 4AV3). This structure 
had been used to generate a homology model using the sequence of PaPPase. The 
TmPPase structures also used a modified version of the 2.6 Å model of TmPPase (PDB 
ID: 4AV3) as a search model, in which the metal ions and water molecules had been 
removed to prevent model bias. 
 
Initial rounds of jelly body refinement were carried out in Refmac (CCP4), but refinement 
of the models was predominantly carried out using the phenix.refine (Afonine et al., 
2012) program in the Phenix software package with manual model alterations made in 
COOT (Emsley et al., 2010).  Refinement was carried out using reference model restraints 
from the highest resolution VrPPase structure at 2.35 Å (PDB ID: 4A01) and secondary 
structure restraints. These were used alongside torsion-angle NCS restraints and tighter 
stereo-chemical weighting to maintain realistic geometry and to prevent over-fitting the 
data at these resolutions.   
 
The combined PaPPase dataset was generated from 7 individual datasets.  These were 
individually processed in XDS, using only the first few hundred images from each 
dataset. All datasets were in the same space group, had less than a 2 % deviation in unit 
cell parameters and all had positive density (Fo-Fc) at the expected position of the Mg5IDP 
complex, confirming the structures were in the same catalytic state. The individual 
datasets were merged and scaled using XSCALE and the resulting file was used for 
molecular replacement and refinement as described above. 
 
2.2.5. Comparisons of M-PPase Structures 
2.2.5.1. Structural Comparisons in PyMol and Coot 
Structural analysis was carried out on all available structures, including the previously 
solved structures: TmPPase:CaMg (PDB ID: 4AV3), TmPPase:Mg4Pi2 (PDB ID: 4AV6) 
and VrPPase:Mg5IDP (PDB ID: 4A01) as well as the structures I solved: 
TmPPase:Mg5IDP (PDB ID: 5LZQ) and TmPPase:MgWO4 (PDB ID: 5LZR) alongside 
those from our collaborators lab of VrPPase:Mg3Pi.  Structures were visualised, 
superimposed and analysis was carried out in COOT (Emsley et al., 2010) and Pymol. 
Structural figures were prepared and rendered in Pymol. 
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2.2.5.2. Hydrogen Bond plot (HBplot) 
The web server HBplot (Hydrogen Bond plot) (Bikadi et al., 2007), was used to  analyse 
the hydrogen bonding patterns of structures in the PDB format. HBplot generates a 
spreadsheet of the hydrogen bond network of the structure along with distances. The 
default settings of the server allowed for an overestimation of the number of hydrogen 
bonds as some of the search parameters for bonding distances can be unrealistically high 
(~ 4 Å). Therefore, the datasets were processed manually, removing outliers beyond the 
expected distances of hydrogen bonds and assigning the type of helix at each position 
(i.e. a, π, 310). The data were then compared and contrasted between the different catalytic 
states to observe how the hydrogen bond network changed across the catalytic cycle. 
 
2.2.5.3. BENDIX 
Bendix (Dahl et al., 2012), a plugin for the Visual Molecular Dynamics (VMD) software 
(Humphrey et al., 1996) was used to analyse regions of secondary structure, notably 
helices, from PDB models and measures the degree of curvature.  This was outputted as 
a visual representation with a list of the angles of helices in degrees.  This was carried out 
for all available structures and the information was manually checked, with comparisons 
made between specific helices of each structure, notably helices 6, 12 and 16 as these 
contains many of the important active site residues. 
 
2.2.5.4. Valence Test 
A valence test (Nayal & Di Cera, 1996) was carried out on a potential sodium ion via 
submission of the model file in PDB format to the WASP (Water Screening program) 
that analyses properties of placed water molecules and metal ions, scoring them on 
likelihood of being correct based on valences from the electron density.  (Note: This 
server has now been superseded by the CheckMyMetal server (Zheng et al., 2017), which 
carries out the same calculations. The original WASP server is no longer accessible) 
 
2.3. Biochemical Studies of M-PPases 
2.3.1. Tryptophan Fluorescence Experiments 
By subjecting protein samples to specific wavelengths of light it is possible to excite the 
tryptophan residues so that they emit light at wavelengths detectable with a fluorimeter.  
This can be a useful way of detecting conformational changes in proteins, although the 
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signal generated depends on the number of tryptophan residues and their location 
compared to the mobile parts of the protein. Furthermore, this signal can be enhanced 
through the use of a compound called 8-anilino-1-napthalene sulphonate (ANS).  This 
compound binds to hydrophobic regions of the protein, is excited by the emission 
wavelength of tryptophan fluorescence and will fluoresce at a different wavelength to that 
of tryptophan.  This leads to an exponential increase in the signal from tryptophan 
fluorescence, which is useful in cases where the original tryptophan signal is weak. 
 
2.3.1.1. Preparation of Samples for Tryptophan Fluorescence Experiments 
The buffers used for this assay were based on the optimal conditions of the hydrolytic 
activity assay.  This used Tris-HCl as a core buffer component with the appropriate metal 
salts (KCl, NaCl and MgCl2) added for each M-PPase protein.  Stock buffers were 
prepared for TmPPase (80 mM Tris-HCl, pH 8, 100 mM KCl, 5 mM MgCl2 and 20 mM 
NaCl), VrPPase (80 mM Tris-HCl, pH 8, 100 mM KCl and 5 mM MgCl2) and PaPPase 
(80 mM Tris-HCl, pH 8 and 5 mM MgCl2).  Protein samples were purified and exchanged 
into crystallisation buffer as described above.  
 
2.3.1.2. Tryptophan Fluorescence Experimental Procedure 
Protein samples were placed into a stirred cuvette in the fluorimeter (PTI) and left for 5 
minutes to equilibrate prior to experiments. For each experimental run, 140 µg protein 
was used in the appropriate fluorescence buffer to a final volume of 975 µl.  Total reaction 
volumes were 1000 µl, leaving 25 µl for the titrations, limiting the change in overall 
volume to 2 %.  Titrations were carried out using increasing concentrations of stock 
solutions of inhibitors (IDP) as required (Table 2.4).  Experiments were performed by 
adding the ligand, leaving the system to equilibrate for 30 seconds and then running an 
emission scan between 310 and 550 nm, with an excitation wavelength of 295 nm 
(tryptophan excitation wavelength). This scan covered any emissions of either tryptophan 
or ANS and was used to monitor changes to the ratios of these signals.  Emission spectra 
were analysed in GraphPad Prism to obtain binding curves and Scatchard plots for each 
protein to observe the change in fluorescence with increasing concentrations of inhibitors 
or ligands. 
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Table 2.4: Titration Protocol for Tryptophan Fluorescence Experiments. 
List of increasing concentrations and volumes of IDP needed for titration experiments of Membrane 
Pyrophosphatases for tryptophan fluorescence experiments.  Final concentrations of IDP cover the 
biologically relevant ranges of IDP for membrane pyrophosphatases. 
Stock [IDP] mM Volume to add (µl) Final [IDP] (µM) 
0 0 0 
1 1 1 
1 1 2 
1 3 5 
1 5 10 
10 1 20 
10 3 50 
10 5 100 
100 1 200 
100 3 500 
100 5 1,000 
 
2.3.2. SURFE2R Experiments 
The SURFE2R N1 (Nanion Technologies, Germany) is a machine capable of measuring 
the difference in charge across a membrane, thus being capable of studying various ion 
translocation and pumping through channels and transporters. This technique is based on 
standard solid-state membrane techniques, combining a lipid-coated gold-surface sensor 
with a pump to provide immediate and real-time measurements of transport that can be 
measured directly as a change in current, a schematic overview of the technique is shown 
in Figure 2.4.   
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Figure 2.4: Schematic Overview of the SURFE2R Experimental Method. 
Overview of the experimental protocol for the SURFE2R experiments showing a proteoliposome adhered 
to a membrane layer on a gold-surfaced sensor. (a) control buffer containing only the pumping substrate 
is added at time point zero to equilibrate the sensor (b) activating buffer containing the substrate or 
ligand of interest is added at one second time point. (c) after a short (ms) delay, pumping starts to occur 
into the liposome, showing as current on the graph (d) ion leakage from the membrane returns signal to 
baseline. Control buffer is added again at two second time point.  
 
2.3.2.1. Reconstitution of VrPPase into Liposomes 
SURFE2R experiments were carried out on VrPPase protein generously provided by Prof. 
Yuh-Ju Sun (National Tsing Hua University, Taiwan). The protein was received frozen 
at 1 mg/ml in elution buffer (25 mM MOPS-KOH pH 7.0, 20 % glycerol, 400 mM KCl, 
4 mM MgCl2, 1mM PMSF and 250 mM imidazole).   
 
To produce the liposomes, 120 mg/ml soybean L-α-phosphatidylcholine lipids were 
prepared. These were placed into an ice-water bath and sonicated at 30 % amplitude, 1 
second pulse time for 1 minute interspaced with 1 minute rest on ice. This was repeated 
until the sample appeared clear.  The protein sample was diluted to a final concentration 
of 0.05 mg/ml at 1 ml total volume using a reconstitution buffer (250 mM sorbitol, 1 mM 
MgSO4, 100 µl EGTA, 2 mM DTT and 10 mM Tricine-Na pH 7.5). 15 µl of sonicated 
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liposome sample was combined with the 1 ml protein solution and prewashed Biobeads 
SM-2 (Bio-Rad) at a final concentration 0.25 mg/µl.  The sample was mixed at 4˚C and 
1,200 rpm for 1 hour to ensure the beads remained in suspension.  Following this, the 
sample was desalted to remove residual glycerol and NaCl that might interfere with the 
experiments.  This was carried out using the Micro Bio-spin 6 columns (Bio-Rad) 
equilibrated with the VrPPase reconstitution buffer (250 mM sorbitol, 1 mM MgSO4, 100 
µl EGTA, 2 mM DTT and 10 mM Tricine-Na pH 7.5).  The resulting proteoliposome 
sample was divided into 20 µl aliquotes, flash frozen in liquid nitrogen and stored at              
-80 ˚C until required. Freeze-thawing of samples was strictly avoided to maintain the 
activity and stability of the liposomes. 
 
2.3.2.2. Preparation of SURFE2R Buffers 
Three buffers were needed (A, B and C) for each SURFE2R experiment (Table 2.5).  
Buffer A and B were the activating and non-activating buffers required for all 
experiments and, apart from the presence of substrate or a ligand in buffer A, are identical. 
Buffer C is used as a wash buffer and consists of only 0.1 M HEPES-KOH (pH 8) without 
any additional component such as salts or ligands.  A concentrated stock of buffer C was 
used to generate all three buffers and was prepared at a working concentration of 100 mM 
and contained only the core buffer used for wash steps.  A 10 x stock of buffer B was also 
prepared as this could be diluted down to a working stock of buffer B or, with the addition 
of substrate or ligand, could be made into a working stock of buffer A.  This would help 
to limit the ionic variation between the two buffers and thus avoid interfering with the 
results. 
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Table 2.5: Buffer Compositions for SURFE2R Experiments. 
List of ingredients for all three buffers used during the SURFE2R experiments of proton pumping in the 
membrane pyrophosphatase of Vigna radiata. The ‘x’ denotes that concentrations were experiment-
dependent. 
Ingredient Buffer A Buffer B Buffer C 
HEPES-KOH, pH 
8.0 
0.1 M 0.1 M 0.1 M 
MgCl2 5 mM 5 mM - 
KCl 50 mM 50 mM - 
PPi* x - - 
Pi** - x - 
* Both Na4PPi and K4PPi were tested 
** Both Na2HPi and K2HPi were tested during the ionic balance experiments 
 
2.3.2.3. SURFE2R Sample and Sensor Preparation 
SURFE2R experiments were carried out using proprietary sensor chips (Nanion 
Technologies) and were prepared using standard protocols from the company.  The chips 
were first washed and prepared via the addition of 50 µl sensor prep A2 (Nanion 
Technologies, proprietary buffer) directly to the gold surface of the sensor. This was 
incubated at room temperature for 15 minutes after which the liquid was removed. The 
sensors were washed with 3 x 100 µl isopropanol, removing the liquid in between each 
wash. The sensor surface was dried completely with nitrogen gas and 3 µl of the lipid-
containing sensor prep B (Nanion Technologies, proprietary buffer) was added directly 
to the gold surface of the sensor, followed immediately by 50 µl of SURFE2R buffer B. 
The sensors were incubated for 1 hour at 4 ˚C during which time the VrPPase 
proteoliposome sample was thawed on ice.  This was diluted 1/5 into buffer B and 
sonicated at 20 % amplitude for 10 seconds (pulse time = 1 second) using a UP50H 
compact lab homogeniser (Hielscher).  All remaining liquid was removed from the sensor 
after the 1 hour incubation and replaced with 50 µl of the sonicated proteoliposome 
sample.  This was spun at 2,500 x g and 4 ˚C for 30 minutes and then incubated for at 
least 1 hour at 4 ˚C prior to use in experiments. 
 
2.3.2.4. SURFE2R Experimental Protocol 
To carry out the experiments the sensor chips were placed into the SURFE2R N1 along 
with buffers A, B and C.  Buffer A was specific to each experiment, and contained 
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concentrations of K4PPi, Na4PPi or inhibitors at the desired concentrations for each 
experiment (5 – 100 µM).  When gramicidin or CCCP were used, these were added to a 
final concentration of 10 µM in all three buffers and only added after initial measurements 
had been taken with substrate or inhibitor.  Transfer of buffers was handled by the 
machine and the program was set up so that the surface of each sensor was initially 
washed twice with buffer C.  Buffer B was injected onto the sensor for 1 second followed 
by rapid switching to buffer A for 1 second and then back to buffer B for 1 second.  All 
measurements were taken twice, interspaced with two wash steps of buffer C and were 
measured as current (nA) over time (s). 
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3.1. Introduction to Expression and Purification of M-PPases 
The aim of this chapter was to express and purify the membrane pyrophosphatases from 
Thermotoga maritima (TmPPase) and Pyrobaculum aerophilum (PaPPase) for the 
purposes of downstream structural and functional characterisation. The TmPPase 
expressed and purified as part of this chapter was used to carry out functional 
characterisation, such as the Tryptophan fluorescence experiments, since structural 
studies were carried out on datasets collected by Juho Kellosalo (Helsinki). PaPPase was 
used for both structural studies and Tryptophan fluorescence experiments. Expression 
and purification of TmPPase had been carried out for previous studies and was expressed 
in yeast, following the “hot-solve” purification method (Kellosalo et al., 2011; López-
Marqués et al., 2005).  The protein is solubilised at 70 ˚ C to remove contaminants, leaving 
only the thermostable TmPPase protein, which can remain active above these 
temperatures.  This method was used to generate purified protein for the initial structural 
studies of TmPPase (Kellosalo et al., 2012), which was one of the first M-PPase structures 
to be solved, alongside the VrPPase (Lin et al., 2012).  Ensuring the efficient expression 
and purification of these proteins was vital for downstream applications, such as X-ray 
crystallography, which requires large amounts of highly pure protein. 
 
The “hot-solve” method was also used during the initial studies of PaPPase, in which the 
protein was expressed and purified alongside TmPPase (Kellosalo et al., 2011). A range 
of different detergents were tested for hydrolytic activity and crystallisation of the protein, 
but the best combination yielded crystals that diffracted to around 5.8 Å, insufficient to 
gain specific mechanistic information on the protein. It was hoped that these crystals 
could be improved upon by optimisation of the expression and purification of PaPPase to 
improve the yield, alongside optimisation of the crystallisation conditions to improve 
crystal diffraction. 
 
In addition to the optimisation of expression, purification and crystallisation of PaPPase, 
several mutants were also generated to test their biochemical effects on PaPPase.  The 
first mutant was made to test the effect of removing 13 C-terminal residues on the 
crystallisation and diffraction of the resulting crystals. The second group of mutations 
was made to test the potassium-dependence of M-PPases.  These mutants contained two 
key mutations found to be responsible for generating a potassium-independent mutant 
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from a potassium-dependent M-PPase in bacteria (Belogurov & Lahti, 2002).  By 
reversing these mutations in PaPPase, it was hoped to generate a potassium-dependent 
variant to verify the findings of the previous study and provide more information on the 
mechanisms of potassium dependence. This could potentially allow for more accurate 
understanding on the reasons for having both variants in certain species of plants and 
parasites. 
 
3.2. Expression and Purification of TmPPase 
TmPPase can be expressed and purified exactly following previously published protocols 
(Kellosalo et al., 2011). SDS-PAGE showed that the TmPPase samples from two Ni-
NTA columns were pure (Figure 3.1).  The main band was at the expected level for 
TmPPase, between the 58 and 80 kDa marker bands, with a single contaminating band 
level with the 245 kDa marker band, potentially representing aggregated or misfolded 
protein samples.  The total yield of protein was determined from A280 measurements and 
was 1.18 mg/L culture prior to buffer exchange, and 0.9 mg protein/L yeast culture 
following buffer exchange. The yield is less than those obtained in previous studies 
(Kellosalo et al., 2011) where a maximal yield of 2.5 mg/L was obtained.  However, this 
can be explained through variability between spectrophotometers when measuring 
absorbance at 280 nm.  The A280 reading of TmPPase purified in Helsinki was found to 
be 24 mg/ml, but the same sample measured in Leeds had a reading of only 12 mg/ml.  
Variability in measuring protein concentration could explain the difference in yield, since 
identical protocols were followed in both cases.  The specific activity of the purified 
TmPPase protein was also found to be lower than previously reported (Kellosalo et al., 
2011), with a specific activity of 1.5 nmol Pi µg protein-1 min-1 as opposed to 150 nmol 
Pi µg protein-1 min-1 due to the presence of Ca2+ in all water and glassware in Leeds (see 
below).  
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Figure 3.1: SDS-PAGE of TmPPase Purification. 
Coomassie-stained SDS-PAGE of TmPPase samples obtained from yeast expression experiments. 
Including extracted membrane sample, solubilised membrane sample (DDM) as well as flow-through, wash 
and elution samples and BSA standards. 
 
3.2.1. Overcoming Calcium Inhibition of Hydrolytic Activity 
During purification of TmPPase, the hydrolytic activity was 10-100x lower than seen in 
previous studies (Kellosalo et al., 2011). I investigated why this was occurring, and 
focussed on the complex interactions between the protein, pyrophosphate and magnesium 
ions.  All of these are required for maximal activity, but the ratios can vary depending on 
relative concentrations of each component or indeed on the pH.  Other divalent cations, 
such as calcium, have been shown to completely inhibit the activity of the protein 
(Maeshima, 1991).  This makes the addition of calcium a useful technique for structural 
studies as it can lock the protein in the resting state (Kellosalo et al., 2011) but can have 
significant effects on the activity of the protein during biochemical studies.  
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The first experiments looked at the role of magnesium-based compounds on the activity.  
Switching from MgCl2 to MgSO4 had no effect on the activity (Kellosalo et al., 2011), 
nor did the addition of increasing concentration of MgCl2 from 5 to 50 mM, with the latter 
having an inhibitory effect on the hydrolytic activity (Figure 3.2).  This inhibition is likely 
due to precipitation of the magnesium-pyrophosphate complex at higher concentrations, 
as the solubility decreases significantly.  This showed that the decreased activity 
compared with previous studies was not related to the source or concentration of 
magnesium.  
 
Relipidation of the sample was previously shown to improve the activity of TmPPase by 
replacing lipids lost during purification (López-Marqués et al., 2005). Relipidation alone 
was able to increase the activity 6-fold from the control sample (Figure 3.2). Adding 1 
mM MgCl2 to the relipidated sample led to a 3-fold increase in activity compared to the 
control sample, less than relipidation alone (Figure 3.2).  The highest activity was seen 
when relipidation was combined with the addition of 160 µM EGTA, which showed a 
17-fold increase in activity compared to the control sample (Figure 3.2). The use of 
EGTA, which is able to chelate free calcium with a much greater affinity than magnesium, 
implies that the primary cause of the decreased activity is calcium inhibition. Calcium is 
likely present in the water system in Leeds due to the geology of the area, since water in 
Helsinki is from granite (low pH and low Calcium) as opposed to the limestone of Leeds, 
which is high in calcium. The use of Milli-Q purified water and acid-washed glassware 
was insufficient to prevent loss of activity. Although these results were based on a single 
study without replication, the 16 x difference far exceed experimental error and a 
consistent hydrolytic activity was detected in future assays through the use of 160 µM 
EGTA. 
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Figure 3.2: Hydrolytic Activity Assay of TmPPase Testing Calcium Inhibition. 
Activity assay results for calcium inhibition experiments showing relative activity of samples compared 
with TmPPase sample with no supplements to the activity assay buffer. Chemical given in each lane 
represents either a substitution for MgCl2, alterations to the concentrations of MgCl2 or supplementation 
alongside MgCl2 already present in activity assay buffer. Results are based on N=1 so cannot provide 
statistical significance.  
 
3.3. Expression and Purification of PaPPase 
3.3.1. Small-scale Expression and Purification Tests  
3.3.1.1. Optimising Media Conditions for PaPPase Expression 
The expression and purification of PaPPase was optimised to try and improve the yield 
and purity of the samples for crystallographic studies.  Initially, four constructs were 
made, Pa A – Pa D (Table 2.1).  Pa C and D contained a signal peptide from Trypansoma 
cruzi, which in previous studies had improved the yield of M-PPases expressed in yeast 
(Kellosalo et al., 2011). Pa B and D contained a Glycine-Glycine (GG) linker between 
the His-tag and protein to try and improve column binding and elution during the 
purification stage. The Pa A construct, contained neither the signal peptide or a GG-linker 
and thus represented the construct used for previous expression experiments of PaPPase 
(Kellosalo et al., 2011).  Of these four planned constructs, only three were successfully 
generated (Pa A, Pa B and Pa C) and tested in expression trials.  Due to the lack of 
difference in the resulting expression between each of the constructs, no further work was 
carried out in generating the fourth construct (Pa D).   
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Initial tests were carried out on the type of media used during expression, with optical 
density measurements at 600 nm (OD600) used to measure the growth rate of PaPPase-
expressing yeast cultures. There was no noticeable change in OD for the first 3-4 hours 
of expression post inoculation (Figure 3.3).  In all expression samples the OD increased 
between 3 and 6 hours before reaching an apparent stationary phase at 6-7 hours at an 
OD600 of between 10 and 12. In cultures grown entirely in selective media (Figure 3.3a), 
the OD600 then decreased to a value between 6 and 8 until the point of harvesting, 8 hours 
post inoculation.  The cultures switched from selective to rich media (Figure 3.3b) 
showed a sharp increase in OD600 from the 6 to 8 hour time points, post inoculation, at 
which time the OD600 had reached 14.   
 
The secondary peak seen in the combined media method shows that after 6 hours the 
yeast culture enters a secondary exponential phase.  This could be due to the loss of 
selective pressure, which allows the yeast cells to remove the plasmid or otherwise 
inactivate expression of the gene of interest. Expression of M-PPases was not beneficial 
to the growth of the yeast cells, either diverting resources away from vital processes or 
simply due to the build-up of ion-translocating proteins in the yeast cell membrane, which 
can disrupt native ion gradients required for survival. It was highly likely that the yeast 
growing between the 6 and 8-hour time-point were no longer expressing functional 
PaPPase.  These results were from a single replication without repeat, so statistical 
significance cannot be determined for changes in expression. However, results of future 
experiments using only selective SCD-Leu media, provided sufficient selective pressure 
to maintain the PaPPase-containing plasmid within the yeast cells.  There was no apparent 
difference in the growth curves of each individual PaPPase construct within the same 
culturing conditions. Pa C, containing the T. cruzi signal sequence, did not express any 
better than the two constructs lacking this sequence (Figure 3.3). Therefore, only the Pa 
A and Pa B constructs were taken forward for purification trials. 
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Figure 3.3: Growth Curves for PaPPase Construct Expression Test. 
Growth curves of Pa A, Pa B and Pa C constructs involving overnight yeast cultures prepared in SCD-Leu 
media and transferred to (a) SCD-Leu media or (b) YPD media conditions for the 8-hour expression trial. 
Results are based on a single expression trial (N=1) so statistical significance cannot be determined. 
 
3.3.1.2. Testing PaPPase Expression Constructs 
Constructs Pa A and Pa B (without and with the GG linker) were expressed on a larger 
scale. Cell yields were roughly equal for both constructs (Table 3.1), but total membrane 
protein concentrations, measured by the Bradford assay, revealed a higher concentration 
in the Pa B sample over Pa A. The resulting protein was then subjected to an imidazole 
gradient to test the effect of the GG-linker during purification.  Previous studies had 
shown that the PaPPase protein did not bind well to the column, leading to elution at very 
low concentrations of imidazole (~30 mM) (Kellosalo et al., 2011).  The GG-linker was 
designed to increase the distance between the His-tag and protein, leading to stronger 
column binding such that elution only occurs at higher concentrations of imidazole.   
 
Table 3.1: Cell and Protein yields from PaPPase Construct Expression Test. 
Yield information for Pa A and Pa B variants of PaPPase expressed in yeast and purified via Ni-NTA 
purification. 
 Pa A Pa B 
Cell yield (g cells/L culture) 3.86 3.64 
Total membrane protein concentration (mg/ml) 57.5 123.8 
Protein yield (mg protein/L culture) 0.01 0.171 
 
Analysis of the samples by SDS-PAGE showed a band at the expected molecular weight 
of PaPPase, around 65 kDa, for both the Pa A and Pa B samples (Figure 3.4).  Comparing 
the purification of Pa A and Pa B, both samples start to elute in the 40 mM imidazole 
samples with the most prominent band in the 200 mM imidazole sample and with small 
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amounts present in the 300 mM imidazole eluted sample. Contaminating bands, present 
around the 25 kDa marker band, are still visible in the 30 mM imidazole sample but are 
not visible in the 40 mM or higher samples for both Pa A and Pa B.  An additional band 
is present around the 245 kDa marker band and likely represents either an aggregated 
sample or a dimer of PaPPase. This band was also seen during previous expression and 
purification of PaPPase both in SDS-PAGE and Western blot experiments (Kellosalo, 
personal correspondence). 
 
The final yield of protein obtained was 0.01 mg and 0.171 mg of Pa A and Pa B per litre 
of culture, respectively. Pa A had a lower overall yield than Pa B during solubilisation 
and purification. This could be due to issues encountered during yeast cell lysis, in which 
the Pa A sample was insufficiently cooled.  This led to a significant decrease in active 
protein throughout the purification procedure.  Following solubilisation any denatured 
protein would have been removed along with other aggregates during centrifugation steps 
and so other than the reduced yield, would not affect any other tests carried out on these 
protein samples, such as that of the imidazole gradient to test column binding.   
 
Yields obtained from the purification of Pa A and Pa B were also quite low, 100-fold and 
10-fold lower than TmPPase, respectively (Section 3.2).  The yeast cultures were scaled 
up for expression, however the times used were from the small-scale expression trials. 
The cultures reached a much lower OD600 at the point of harvesting and thus less protein 
was expressed.  This did not affect the testing of the constructs, but simply reduced the 
overall yield obtained. All subsequent cultures were grown for 10 hours, as opposed to 6 
to ensure there was sufficient time for optimal expression of PaPPase.  
 
Overall, the inclusion of the GG-linker did not improve the column-binding efficiency of 
these proteins during purification, however, after 2 washes with 20 mM imidazole there 
were no significant contaminating bands in either construct.  This meant that future 
experiments utilised a two-step wash and elution method during purification, wherein the 
protein sample would be washed twice with buffer containing 20 mM imidazole and then 
eluted with 300 mM imidazole.   
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Figure 3.4: SDS-PAGE of PaPPase Elution Test. 
Coomassie-stained SDS-PAGE showing elution test with an imidazole gradient from 20-300 mM imidazole 
during purification of Pa A and Pa B constructs. 
 
3.3.1.3. Relipidation Trials for Optimising Hydrolytic Activity of PaPPase 
Relipidation is a technique that has been used during the earlier purification studies on 
TmPPase and was required to replace lipids lost during purification, which were vital for 
the activity of the protein even in detergent micelles (López-Marqués et al., 2005). 
TmPPase was supplemented with a final concentration of 12 mg/ml Soybean lecithin and 
4.5 % DDM, leading to optimal activity following purification.  Several relipidation 
methods were tested during a hydrolytic activity assay for each of the PaPPase variants, 
Pa A and Pa B.  These included the method used above for TmPPase, a method used 
previously for the purification of PaPPase in which 0.036 mg/ml soybean lecithin was 
added (Kellosalo et al., 2011), and an additional method in which 12 mg/ml soybean 
lecithin was added without extra detergent.  
 
The specific activities of Pa A and Pa B without relipidation were 10 and 32 nmol Pi µg 
protein-1 min-1, respectively (Figure 3.5).  When supplemented with lipids and detergent, 
the activity increased to 11 and 42 nmol Pi µg protein-1 min-1, respectively.  However, 
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supplementation with only 47 µM lipids led to a decrease in activity to 3.4 and 5.4 nmol 
Pi µg protein-1 min-1, respectively.  The hydrolytic activity increased when the protein 
was supplemented with 12 mg/ml lipids, to 19.5 and 56.5 nmol Pi µg protein-1 min-1, 
respectively.  These results are from a single experiment without repeats and so the 
statistical significance of these results cannot be confirmed.  It is still clear that the Pa B 
construct had a higher activity amongst all samples compared with Pa A and future 
experiments using Pa B supplemented with 12 mg/ml lipids showed a consistently high 
hydrolytic activity. 
 
The Pa B variant consistently had a higher specific activity than Pa A and so was taken 
forward for subsequent experiments. It is possible this higher specific activity is due to 
the structural importance of the N-terminus on which the His-tag is located. It is possible 
that the His-tag prevents efficient folding of the N-terminus region. The addition of the 
GG-linker would then move the His-tag two residues further away and may allow for 
more efficient folding of the protein.  This could improve the interactions made by the N-
terminal residues to help stabilise the protein.  
 
These relipidation results also show that the addition of extra detergent with the lipids 
actually decreases the overall activity of PaPPase compared with using lipids alone 
(Figure 3.5). If these lipids are required for activity then the addition of extra detergent 
may prevent the lipids from binding to the protein, leading to a lower activity.  Based on 
the activity assay results, future expression and purification experiments were carried out 
using only the Pa B construct.  Moreover, PaPPase was supplemented with 12 mg/ml 
soybean lecithin, following purification, to recover the activity lost by the removal of 
lipids during purification. 
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Figure 3.5: Hydrolytic Activity Assay testing Relipidation of PaPPase. 
Activity assays results showing specific activity of Pa A and Pa B protein samples and comparisons with 
different post-purification relipidation methods. Results are from a single experiment without repeats 
(N=1). 
 
3.4. Optimisation of Solubilisation Conditions for PaPPase 
3.4.1. Pa B Large Scale Expression 
3.4.1.1. Expression of PaPPase in Yeast 
Large-scale expression of PaPPase was carried out in 10 L batches. OD600 was monitored 
for the cultures over the course of 10 hours (Figure 3.6).  This showed a linear increase 
in OD over the time course until the maximal value of 10 is reached at the 10-hour time-
point.  The cells were harvested and the total yield was 5.84 g cells/L culture. Following 
membrane extraction, the total protein concentration of the extracted membrane sample 
was determined to be 126.6 mg/ml using the Bradford assay.  
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Figure 3.6: Growth Curve for Large-scale PaPPase Expression. 
Growth curve showing OD600 for expression of Pa B construct (PaPPase) in 2 L shake-flasks over a 10 
hour time course. Results are from a single experiment without repeats (N=1) so no statistical significance 
can be determined. 
 
3.4.1.2. Detergent Screen for Solubilisation of PaPPase 
Solubilisation of PaPPase had previously been carried out in DDM (Kellosalo et al., 
2011) but only a handful of other detergents had been tested during crystallisation trials 
(Kellosalo et al., 2013). In this study, a screen of 20 different detergents was tested on 
PaPPase to see if these would yield a higher proportion of solubilised protein compared 
to DDM (Table 3.2).  From this screen, solubilisation was observed via Western blot for 
β-D-Fructopyranosyl-α-D-Glucopyranoside Monododecanoate (Sucrose 
monododeconoate), Tetraethylene Glycol Monooctyl Ether (C8E4), Hexaethylene 
Glycol Monooctyl Ether (C8E6), Octaethylene Glycol Monododecyl Ether (C12E8), n-
Dodecyl−β−D-Maltopyranoside (DDM), n-Undecyl−β−D-Maltopyranoside (UM), n-
Tetradecyl−β−D-Maltopyranoside (tetraDM), n-Decyl−β−D-Thiomaltopyranoside 
(DTM), n-Dodecyl−β−D-Thiomaltopyranoside (DDTM), n-Nonyl−β−D-
Thiomaltopyranoside (NTM), n-Octyl−β−D-Thiomaltopyranoside (OTM), n-
Undecyl−β−D-Thiomaltopyranoside (UTM) and n-Nonyl−β−D-Glucopyranoside (NG) 
(Figure 3.7). UDM and DTM provided the most efficient solubilisation (~80 %), with 
NTM, NG, OTM, tetraDM, C8E4 and C12E8 showing ~50 % solubilisation. A low 
degree of solubilisation (< 10 %) was observed for 3-Cyclohexyl-1-Propyl-β-D-
Glucoside (CYGLU-3), Methyl-6-O-(N-Heptylcarbamoyl)-α-D-Glucopyranoside 
(Anameg-7), n-Heptyl−β−D-Thioglucopyranoside (HTG), 7-Cyclohexyl-1-Heptyl-β-D-
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Maltoside (Cymal-7), n-Tridecyl−β−D-Maltopyranoside (TriDM) or 2,6-Dimethyl-4-
Heptyl−β−D-Maltopyranoside. The remaining detergents showed minor solubilisation 
(10-40 %) (Table 3.2; Figure 3.7).   
 
 
Figure 3.7: Western Blot for Detergent Solubilisation Screen of PaPPase. 
Western blot analysis of small-scale detergent solubilisation test using anti-mPPase antibody showing both 
the supernatant and pellet fractions following solubilisation at 70 ˚C. 
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Table 3.2: Detergent Solubilisation Screen of PaPPase. 
List of detergents used in the PaPPase solubilisation screen along with abbreviated names, degree of 
solubilisation as determined via Western blot analysis and relative hydrolytic activity. 
Name of detergent Abbreviated 
name 
Solubilisation (%) Relative activity 
compared to 
DDM (%) 
7-Cyclohexyl-1-Heptyl-β-D-
Maltoside 
CYMAL-7 < 10 109.0 
n-Octyl−β−D-Thiomaltopyranoside OTM ~ 50 94.8 
n-Nonyl−β−D-Thiomaltopyranoside NTM ~ 50 102.5 
n-Decyl−β−D-Thiomaltopyranoside DTM ~ 80 102.6 
n-Undecyl−β−D-Maltopyranoside UM ~ 80 109.1 
n-Undecyl−β−D-Thiomaltopyranoside UTM 10 – 40 100.1 
n-Dodecyl−β−D-Maltopyranoside DDM 10 – 40 100.0 
n-Dodecyl−β−D-Thiomaltopyranoside DDTM 10 – 40 99.9 
n-Tridecyl−β−D-Maltopyranoside TriDM < 10 95.7 
n-Tetradecyl−β−D-Maltopyranoside TetraDM ~ 50 96.8 
2,6-Dimethyl-4-Heptyl−β−D-
Maltopyranoside 
2,6-Dimethyl-4-
Heptyl−β−D-M 
< 10 111.5 
3-Cyclohexyl-1-Propyl-β-D-
Glucoside 
CYGLU-3 < 10 109.0 
n-Nonyl−β−D-Glucopyranoside NG ~ 50 94.6 
Methyl-6-O-(N-Heptylcarbamoyl)-α-
D-Glucopyranoside 
Anameg-7 < 10 105.2 
β-D-Fructopyranosyl-α-D-
Glucopyranoside Monododecanoate 
Sucrose 
monododeconoate 
10 – 40 110.6 
n-Heptyl−β−D-Thioglucopyranoside HTG < 10 100.6 
Tetraethylene Glycol Monooctyl Ether C8E4 ~ 50 104.1 
Pentaethylene Glycol Monodecyl 
Ether 
C10E5 10 – 40 103.3 
Hexaethylene Glycol Monooctyl Ether C8E6 10 - 40 25.1 
Octaethylene Glycol Monododecyl 
Ether 
C12E8 ~ 50 111.0 
 
All detergents, with the exception of C8E6, showed hydrolytic activity (Figure 3.8). 
UDM, 2,6-Dimethyl-4-heptyl-B-DM, CYGLU-3, Anameg-7, sucrose monododeconoate, 
C12E8 and CYMAL-7 have activity above the DDM-solubilised sample (105-110 % 
activity). TetraDM, TriDM, OTM and NG have activities below that of DDM (~90 %), 
with C8E6 having around 25 % activity compared to the DDM sample.  However, there 
are limitations to the hydrolytic activity assay carried out on solubilised membrane 
samples, since phosphate is used to stabilise the protein during solubilisation at 70 ºC and 
this can carry over into the activity assay and produce background signal that can mask 
the results. In addition, activity assay results were from a single experiment without 
repeats, meaning that statistical significance cannot be determined. However, all samples, 
with the exception of C8E6 had clearly similar activities and so no major conclusions 
could be drawn from this experiment regardless. 
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Figure 3.8: Hydrolytic Activity Assay for Detergent Solubilisation Screen of PaPPase. 
Activity assay results for detergent solubilisation screen of PaPPase samples showing relative activity 
compared with DDM-solubilised PaPPase protein. Results are from a single experiment without 
replication (N=1) so statistical significance cannot be determined. 
 
3.4.1.3. Larger-scale Solubilisation Tests of PaPPase 
Two of the best detergents from the small-scale solubilisation screen were chosen for 
scaling up, alongside DDM as a control. These were DM and UM and were chosen due 
to the high degree of solubilisation observed during the small-scale solubilisation test (70-
80 % solubilisation). Alongside testing the detergents, PPi and IDP were also used to try 
and test their effect on stabilising the protein during solubilisation at 70 ºC. This was 
carried out to try and mitigate the effect of phosphate crossing over into the activity assay 
carried out on solubilised protein samples. 
 
The total activity of each solubilisation sample showed that all samples solubilised in the 
presence of PPi had the highest activity (Figure 3.9). Samples solubilised without any 
phosphate compounds showed the lowest activity and those solubilised in the presence of 
0 20 40 60 80 100 120
C12E8
C8E6
C10E5
C8E4
HTG
Sucrose Monododeconoate
Anameg-7
NG
CYGLU-3
2,6-Dimethyl-4-Heptyl-DM
TetraDM
TriDM
DDTM
DDM
UTM
UDM
DTM
NTM
OTM
CYMAL-7
Relative activity to DDM-solubilised PaPPase (%)
	 76	
IDP had activity between the PPi and water samples.  Moreover, the samples solubilised 
in DM and UM both showed higher activity following solubilisation than those 
solubilised in DDM. This assay looked at total activity of the protein (nmol Pi . min-1) 
and does not factor in protein concentration as this is difficult to accurately measure at 
this stage of the purification.  This affected the comparisons made between each of the 
detergent-solubilised samples but did not affect any conclusions drawn between samples 
within the same detergent solubilisation group, as these all used identical samples for 
testing. 
 
 
Figure 3.9: Hydrolytic Activity Assay for Large-scale Solubilisation Test of PaPPase. 
Activity assay results for larger-scale solubilisation test of PaPPase using DDM, DM and UM alongside 
different phosphate-containing compounds to compare total activity between each sample. Results are from 
a single experiment without replication (N=1). 
 
The addition of a phosphate-containing compound was definitely required to keep the 
protein stable during solubilisation at 70 ºC. The increased activity seen in the PPi samples 
may also be due to cross-over into the activity assay buffer.  PaPPase will hydrolyse PPi 
during the solubilisation step as it has an optimal activity temperature of around 80 ˚C.  
Therefore, PPi or Pi present in the solubilisation buffer will also be present in the activity 
assay samples.  Since the activity assay measures Pi concentrations in the buffer, this 
artificially inflated the activity results over the samples tested with IDP or water.  
Moreover, the addition of IDP during solubilisation also carried over and would have had 
the opposite effect by inhibiting the activity of the protein.  Therefore, the rise in activity 
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seen with the IDP sample over the no-phosphate control (Figure 3.9) shows this increase 
was caused by a genuine stabilising effect of the phosphate-compound during 
solubilisation at 70 ˚C. 
 
Although this experiment was inconclusive on whether PPi or IDP was best for 
solubilisation, it highlighted the importance of ensuring that at least one of these 
compounds was added as activity was definitely lost during solubilisation in their 
absence. The results of this experiment mean that future solubilisation experiments were 
carried out using DM and using PPi to stabilise the protein, since IDP would also have a 
definite inhibitory effect on the activity as opposed to PPi. If activity assays are required 
on solubilised protein samples, the crossover of phosphate into these samples must be 
factored into the results obtained, as its addition is unavoidable. 
 
3.5. Optimising Purification of PaPPase 
3.5.1. Large-scale Expression and Purification of PaPPase in Yeast 
The final stages of purification optimisation involved exchanging PaPPase into various 
detergents in order to carry out multiple crystallisation trials. The detergent can be 
exchanged on the Nickel column by washing and eluting the protein in buffer containing 
the detergent of interest. A range of detergents had previously been tested for PaPPase in 
terms of hydrolytic activity and crystallisation, with the best combination found to be 
DM, producing crystals that diffracted to 5.8 Å (Kellosalo et al., 2013; Kellosalo et al., 
2011). A new set of detergents was selected to carry out additional studies, including 
DDM, DM, OGNG, LMNG, OM, NM and NG. These detergents were selected as they 
contained different overall structures, such as LMNG and OGNG or contained shorter 
acyl chain lengths that could potentially improve the crystallisation of this protein.  Cell 
yields from large-scale expression of PaPPase were between 4 and 6.6 g cells/L yeast 
culture (average 5.04 g/L). Samples were combined and membrane extractions were 
carried out with the resulting total membrane protein concentration found to be 161.1 
mg/ml using the Bradford assay.   
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Figure 3.10: SDS-PAGE of PaPPase Purification. 
Coomassie-stained SDS-PAGE gel of a large-scale purifications of PaPPase following two-step imidazole 
wash and elution. 
 
This sample was used for multiple purifications, being exchanged into the required 
detergents. SDS-PAGE of the DM-purified sample (Figure 3.10) showed the protein 
sample was pure, with only a single band at the expected molecular weight, between the 
58 and 80 kDa marker bands. PaPPase samples were also purified in a range of detergents, 
including OGNG, LMNG, DDM and DM (Figure 3.11), which had specific activities of 
90, 132, 98 and 40 nmol PO4 µg protein-1 min-1, respectively.  In addition, PaPPase was 
also exchanged into OM, NM and NG in preparation for crystallisation trials, with SDS-
PAGE showing a band at the expected molecular weight of PaPPase and another around 
the 245 kDa marker band, representing either aggregated or dimerised PaPPase 
(Kellosalo, Personal correspondence) (Figure 3.12).  As with TmPPase, the final yields 
of PaPPase in various detergents were lower than seen in the previous study (Kellosalo 
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et al., 2011), in which the maximal yield obtained was around 1 mg protein/L culture.  
The yields obtained in this study were between 0.4 and 0.5 mg protein/ L culture, within 
acceptable levels given the differences in estimating protein concentration using the A280 
method (Section 3.2). 
 
 
Figure 3.11: SDS-PAGE of Initial Detergent Exchange During PaPPase Purification. 
Coomassie-stained SDS-PAGE showing results of on-column detergent exchange of PaPPase into DM, 
OGNG and LMNG during purification. 
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Figure 3.12: SDS-PAGE of Additional Detergent Exchange During PaPPase Purification. 
Coomassie-stained SDS-PAGE gel showing results of on-column detergent exchange of PaPPase into OM, 
NM and NG during purification. 
 
3.6. Mutagenesis Experiments on PaPPase 
3.6.1. C-terminal Truncation Mutant 
A sequence alignment of PaPPase with other M-PPases had revealed the C-terminus of 
PaPPase was longer than both TmPPase and VrPPase, containing 13 extra residues. In 
TmPPase, these residues form stabilising interactions with the end of helix 14 and are all 
clearly visible in the structure (Figure 3.13) (PDB ID: 4AV3).  These residues are also 
close the dimer interface and so may also play a role in the stabilisation of the dimer in 
TmPPase. 
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Figure 3.13: Overview of C-terminus in TmPPase. 
Dimer representation of TmPPase:CaMg (PDB ID: 4AV3) showing the location of the C-terminus in 
chain A (grey) and an enhanced view of the C-terminus showing the final four residues of helix 16 and 
their interactions with L14.67. Loop residues are labelled with the TmPPase numbering system. 
 
These extra residues in PaPPase may reduce the efficiency of crystal packing if they form 
no interactions with other parts of the protein.  These residues were mutated out of 
PaPPase to see if this would improve the crystallisation and resulting diffraction of 
crystals compared with the wild-type.  In-Fusion cloning was used to remove the 13 
residues from the C-terminus of PaPPase and sequencing was used to confirm the 
presence of the PaPPase gene without the C-terminal residues.  After cloning, the protein 
was expressed and purified alongside the wild-type PaPPase and SDS-PAGE showed a 
band for this sample around the expected molecular weight, slightly lower than the wild-
type protein (Figure 3.14).  Additional bands were also visible in the gel at lower 
molecular weights than the expected PaPPase mutant.  These may be degradation 
products of PaPPase as these mutants may not be as thermostable as the wild-type protein.  
Since structures were not being sought of these mutants, functional assays were carried 
out on the mutant protein samples.  The protein yield was also calculated via the A280 
method and found to be 0.57 mg/L culture.  The specific activity of the wild-type and C-
terminal truncated mutant of PaPPase was found to be 447.2 and 39 nmol Pi µg protein-1 
min-1, respectively (Figure 3.15), a significant decrease in hydrolytic activity upon 
removing the C-terminal residues (P-value = 0.0067). 
 
L14.67
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Figure 3.14: SDS-PAGE of PaPPase mutant Purification. 
Coomassie-stained SDS-PAGE showing purification of PaPPase mutants, including C-terminal truncation 
mutant and K+-dependent mutants. 
 
The decrease in hydrolytic activity may show that the 13 C-terminal residues actually 
play an important role in the structure of the protein, stabilising it by forming interactions 
with other residues. This was observed in the structure of TmPPase (Kellosalo et al., 
2012), where it was shown that addition of purification tags to the C-terminal end of 
TmPPase disrupted folding and so produced unfolded and inactive protein (Kellosalo, 
personal communication). These residues may also be important for the thermostability 
of PaPPase, with the mutant becoming more susceptible to denaturation during 
solubilisation at 70 ˚C.  Since the protein is not active and potentially unfolded, 
crystallisation experiments were not carried out. However, future experiments could look 
into different lengths of C-terminal truncations to specifically see which residues are 
essential for stability of the protein and to see if any of these would help improve the 
crystal packing during crystallisation. 
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Figure 3.15: Hydrolytic Activity Assay of PaPPase C-terminal Truncation Mutant. 
Specific hydrolytic activity results for PaPPase wild-type against the C-terminal truncation mutant, 
following relipidation. Experiments were carried out in triplicate, without repeats. Error bars denote 
standard error and are present for both the wild-type and C-terminal truncation samples. 
 
3.6.2. K+-Dependent Mutants 
The study of potassium dependence in M-PPases is important to aid our understanding of 
how these proteins function. Several plant and parasite species include both potassium 
dependent and independent variants.  It was speculated that the presence of both was 
because of the need to generate proton gradients over a range of different environmental 
conditions (McIntosh et al., 2001).  A previous study had generated several mutants of a 
potassium-dependent H+-PPase, ultimately generating a potassium-independent variant 
(Belogurov & Lahti, 2002). This involved the mutations of A12.46 to a lysine. It was found 
that a further mutation of A12.49 to a threonine could modulate the affinity for potassium 
but did not itself generate a potassium-independent mutant.   
 
The reverse of the potassium independence mutations, K12.46A, T12.49A and a dual mutant, 
were generated in PaPPase and the presence of the mutations was confirmed via 
sequencing.  Proteins were expressed using the standard expression and purification 
protocols for PaPPase (Section 3.5). The resulting yields of the K12.46A, T12.49A and dual 
mutant were 1.32, 1.55 and 0.79 mg/L culture, respectively. SDS-PAGE of the mutants 
showed purified protein at the expected molecular weight of PaPPase (Figure 3.14). 
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The hydrolytic activity was measured both in the presence and absence of potassium 
alongside the wild-type for comparison.  The specific activity for the wild-type PaPPase 
was 447 ± 79 and 403 ± 38 nmol Pi µg protein-1 min-1 with and without potassium, 
respectively, showing no drop in activity in the absence of potassium (Figure 3.16). The 
same was found for the K12.46A mutant, with activities of 437 ± 102 and 455 ± 153 nmol 
Pi µg protein-1 min-1 in the presence and absence of potassium, respectively (Figure 3.16). 
This differs from previous work which found that the A to K mutation was sufficient to 
generate a potassium-independent M-PPase.  The activity of the T12.49A mutant in the 
presence of potassium is 300 ± 12 nmol Pi µg protein-1 min-1 and this drops to 203 ± 27 
nmol Pi µg protein-1 min-1 in the absence of potassium (Figure 3.16). This also shows no 
change in the potassium dependence and was consistent with the previous findings.   
 
The dual mutant had an activity of 205 ± 23 nmol Pi µg protein-1 min-1 in the presence of 
potassium (a statistically significant decrease compared to the wild-type with potassium, 
P-value = 0.04) and dropped significantly (P-value = 0.008) to 14 ± 14 nmol Pi µg protein-
1 min-1 in the absence of potassium. The dual-mutant was only active in the presence of 
potassium, which showed that this mutant had been changed from a potassium-
independent to a potassium-dependent M-PPase.  However, the maximal activity 
achieved was still less than the wild-type protein. It is unlikely the overall structure of the 
dual-mutant has been completely destroyed as the activity is only lost in the absence of 
potassium, but this implied that other residues are involved in the potassium-independent 
mechanism of PaPPase.  
 
The differences seen between the current and previous study (Belogurov & Lahti, 2002) 
could be for several reasons.  Firstly, these two studies were carried out on the M-PPases 
from two distinct organisms, one bacterial and one archaeal.  This means that the 
mutations made could alter any number of factors within these proteins, including affinity 
for substrate or even in some way uncoupling the hydrolytic and pumping functions, since 
the activity assay only measured hydrolytic activity.  Secondly, these mutations might 
also affect the biochemical properties and not just the structure, for example, altering the 
hydrogen bonding patterns of the central channel, which may affect the activity of the 
protein.  These results showed interesting preliminary findings that that both K12.46 and 
T12.49 are important for the potassium-independence of PaPPase. However, comparisons 
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of structural information with the wild-type structure would help to further validate these 
findings. In addition, a range of other mutations could also be tested on residues around 
this region of the protein, or mutations of K12.46/T12.49 to other residues with different 
biochemical properties such as non-polar or negatively charged residues, to see if these 
have other effects on the mechanism of potassium-independence. 
 
 
Figure 3.16: Hydrolytic Activity Assay of Potential K+-dependent Mutants of PaPPase. 
Specific hydrolytic activity results for the three potential K+-dependent mutants of PaPPase compared with 
the wild-type PaPPase. All experiments were carried out in triplicate without repeats and error bars denote 
standard error from the mean. 
 
3.7. Summary of M-PPase Expression and Purification  
The aim of this chapter was to express and purify TmPPase as well as optimise the 
expression and purification of PaPPase. This was carried out to ensure sufficient pure 
protein was available for downstream structural and functional characterisation of these 
proteins.  In addition, several mutational studies were carried out to test various 
biochemical effects, particularly looking at the potassium independence mechanism of 
PaPPase, as well as testing the removal of residues on the structural stability of this 
protein.  Overall, in this chapter I showed expression of both TmPPase and PaPPase in 
yeast, solubilisation of the proteins in various detergents and purification of them to 
remove any contaminating proteins.  In particular, the expression and purification of 
PaPPase was optimised to produce high concentrations of pure protein that were suitable 
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for crystallisation trials (see chapter 4).  The removal of 13 C-terminal residues had a 
significantly negative effect on the activity of PaPPase and mutations in both K12.46A and 
T12.49A also produced a potassium-dependent variant of PaPPase. 
 
Ultimately, both the TmPPase and PaPPase proteins were expressed and purified at 
concentrations suitable for continued crystallographic and biochemical characterisation. 
TmPPase was purified between 0.9 and 1.2 mg/L culture, providing sufficient protein to 
proceed to the Tryptophan fluorescence studies. PaPPase was found to remain pure and 
active when purified in a range of different detergents, including DDM, DM, OGNG, 
LMNG, OM, NM and NG, and was purified at concentrations between 0.4 and 0.5 mg/L 
culture, providing sufficient protein for crystallisation trials and tryptophan fluorescence 
studies.   Issues of hydrolytic activity due to calcium inhibition were overcome by the 
addition of EGTA, which will improve the accuracy and reliability of future purification 
and activity assays on M-PPases. In addition, mutated variants of PaPPase (K12.46A and 
T12.49A) highlighted important residues involved with the potassium-independent 
mechanism of PaPPase, providing additional information to help with future structural 
analysis. Overall, there was sufficient yields of pure protein to proceed on to structural 
studies of TmPPase and PaPPase using X-ray crystallography. 
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4.1. Introduction to M-PPase Structutral Studies 
The aim of the work in this chapter was to solve the structures of both TmPPase and 
PaPPase in as many different catalytic states as possible, such that I could make detailed 
comparisons and generate a model of the catalytic cycle. To this end, TmPPase had been 
expressed, purified and crystallised previous by Juho Kellosalo (Helsinki) and data 
collected was used in the current study to solve the TmPPase:Mg5IDP and 
TmPPase:MgWO4 structure. PaPPase was expressed and purified in yeast as part of the 
work in Chapter 3 and was used to carry out structural studies.  There were no previous 
structures of PaPPase or any K+-independent H+-PPases, and therefore any structural 
information obtained would provide valuable insight into the mechanism of K+-
dependence in M-PPases. These structures could provide additional evidence to explain 
previous mutational studies, wherein a K+-independent M-PPases could be generated via 
a single alanine-lysine mutation at position A/K12.46 (Belogurov & Lahti, 2002). 
 
The overall architecture of M-PPases was known using information from three X-ray 
crystal structures, including two of TmPPase, in the resting state and two-product bound 
state (Kellosalo et al., 2012), and one of the M-PPase from Vigna radiata (VrPPase) in 
the substrate-analogue-bound state with IDP in the active site (Lin et al., 2012). Despite 
this information, the specific mechanisms associated with each state of the catalytic cycle 
are still not completely understood. New structures of these proteins in other catalytic 
states will help us to understand the functional mechanisms of M-PPases and allow us to 
piece together a complete picture of the catalytic cycle.   
 
Protein used in the generation of the TmPPase structures was already expressed, purified 
and crystallised by Juho Kellosalo (Helsinki).  Two datasets had been collected and I 
processed these to obtain the final structures discussed in this chapter.  The first was of 
TmPPase, to which the inhibitor and substrate analogue imidodiphosphate (IDP) had been 
added to the crystallisation conditions. The other dataset had been used for phasing of 
higher resolution structures during a previous study (Kellosalo et al., 2012) but had never 
been refined or solved.  
 
The aim of this chapter was to try and solve the two TmPPase datasets to obtain new 
information that could assist in the generation of the catalytic cycle model. Using this 
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information to see if these structures correlated with the previously solved structures and 
see if any new information could be obtained from these datasets.  Moreover, it was hoped 
that the structure of PaPPase could be solved using X-ray crystallography, at a resolution 
that allows for comparison of both helical and residue changes between catalytic states 
and the different types of M-PPases. 
 
4.2. Structural Studies of TmPPase Using X-ray Crystallography 
4.2.1. Data Collection and Structural Refinement 
Two new structures were solved of TmPPase, one in complex with the inhibitor and 
substrate analogue (Mg5IDP) and the other in complex with the single-product-analogue 
(MgWO4). The data were collected by a former graduate student (Dr. Juho Kellosalo, 
University of Helsinki) and data processing and refinement was carried out by myself. 
The TmPPase:Mg5IDP crystals had been grown via the sitting-drop vapour diffusion 
technique at room temperature in 32% PEG 400, 0.1 M Tris (pH 8.5), 0.1 M MgCl2, 0.1 
M NaCl and 2 mM DTT. The TmPPase:MgWO4 crystals had been grown at 4 ˚C using 
the sitting-drop vapour diffusion technique in 19-22 % PEG 350 monomethylether, 0.1 
M MES-NaOH pH 6.5, 0.2 M CaCl2 and 2 mM DTT before being soaked in 10 mM 
Na2WO4. Datasets were collected on beamline i04 at Diamond Light Sourse (DLS) for 
TmPPase:Mg5IDP and id23-1 at ESRF for TmPPase:MgWO4.  Initial data processing 
was carried out in XDS to obtain merged and scaled data. Molecular replacement was 
carried out in Phenix.Phaser using the high resolution VrPPase:Mg5IDP structure as a 
search model (PDB ID: 4A01) with iterative rounds of refinement carried out in 
Phenix.refine using coot to make manual alterations to the model (for full refinement 
information, see methods). 
 
Following refinement, the R-factors for TmPPase:Mg5IDP were 24.8 %/27.5 % with 95.4 
% of residues in the preferred region of the Ramachandran plot.  The TmPPase:MgWO4 
structure had R-factors of 23.2 %/27.9 % with 93.4 % of residues in the preferred regions 
of the Ramachandran plot. Full data collection and refinement statistics can be found in 
(Table 4.1). 
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Table 4.1: Data Collection and Refinement Statistics for TmPPase Structures. 
Crystal TmPPase:Mg5IDP TmPPase:MgWO4 
Data collection   
   Space group P 212121 P 21 
   Cell dimensions   
      a, b, c (Å) 106.4, 106.8, 161.9 83.7, 108.9, 105.8 
      b (˚) 90 108.8 
   Source DLS-i04 ESRF ID23-1 
   Wavelength (Å) 0.9795 1.214 
   Resolution (Å)* 30-3.49 (3.70-3.49) 25-4.0 (4.1-4.0) 
   Rmerge (%)* 9.3 (140.8) 5.5 (42.6) 
   I/d* 15.83 (1.35) 14.3 
   Completeness (%)* 99.5 (98.6) 98.8 (92.8) 
   Redundancy* 8.8 (8.6) 3.8 (3.4) 
Refinement   
   Resolution (Å) 3.5 4.0 
   No. of reflections 23,904 29,597 
   Rwork(%)/Rfree(%) 24.3/27.3 23.2/27.9 
   No. of atoms 10,443 9,808 
      Protein 10,389 (1,450 residues) 9,794 (1,383 residues) 
      IDP or WO4 36 (2 IDP) 10 (2 WO4) 
      Mg2+ 10 2 
      Na+ 2 - 
   No. of chains/ASU 2 2 
   B-factors (Å2)   
      All atoms 131.0 134.9 
      Protein 130.9 133.0 
      IDP or WO43+ 167.8 (IDP) 198.5 (WO43+) 
      Mg2+ 134.9 151.6 
      Na+ 112.7 - 
   r.m.s.d.   
      Bond length (Å) 0.005 0.004 
      Bond angle (˚) 0.70 1.19 
*Values in parenthesis are for the highest resolution shell. 
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4.2.2. Analysis of TmPPase:Mg5IDP and TmPPase:MgWO4 Structures 
There was clear, continuous and unambiguous density for the helices in each model 
(Figure 4.1). There was additional density for many loop regions in the TmPPase:Mg5IDP 
structure, including the 5-6 loop over the active site. These loops were omitted from the 
TmPPase:MgWO4 structure, along with the side chains of many longer residues, such as 
lysine and arginine, due to a high degree of disorder in these regions resulting in no 
electron density for these entities. 
 
Figure 4.1: Representative Electron Density of TmPPase Structures. 
Fo-Fc density for a section of helix 1 representative of helical density within (a) TmPPase:Mg5IDP at 3.5 
Å resolution and (b) TmPPase:MgWO4 at 4.0 Å resolution. Residues are labelled in parenthesis as they 
are not conserved between M-PPases of different species. 
 
In addition, there was positive density from an Fo-Fc map (3 d) in the active sites for 
Mg5IDP and MgWO4 in each model, respectively (Figure 4.2).  The position of the 
Mg5IDP complex very closely overlays with the same complex found in the previous 
VrPPase:Mg5IDP structure (PDB ID: 4A01) (Figure 4.3a), with a similar closure of the 
active site helices when compared with the resting state TmPPase structure (PDB ID: 
4AV3) (Figure 4.3b). However, given the modest resolution of these structures (3.5 – 4.0 
Å), the position of the ligands is based on the unbiased positive Fo-Fc density but with 
comparisons made between the new structures and the position of the ligands in the 
(F)1.50 (F)1.50
(F)1.55
(L)1.48
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previous solved, higher resolution structures. This was seen by the movement of helices 
5, 6 and 11 between the TmPPase:CaMg and TmPPase:Mg5IDP structures (Figure 4.3b) 
to constrict the active site, a movement not seen between the TmPPase:CaMg structure 
and the TmPPase:MgWO4 structures (Figure 4.4). In the absence of loop 5-6 in the 
TmPPase:MgWO4 structure, the channel was open on the cytoplasmic side of the active 
site and there was very little interaction seen between the MgWO4 complex and the 
surrounding residues (Figure 4.2b, Figure 4.4).  This was due to the absence of visible 
water molecules, which would likely be filling the remainder of the active site but which 
cannot be fit to the density at this resolution (4 Å). 
 
Figure 4.2: Fo-Fc Density at the Hydrolytic Centre of TmPPase Structures. 
Positive Fo-Fc electron density (3 d) for (a) Mg5IDP complex in TmPPase:Mg5IDP and (b) MgWO4 in 
TmPPase:MgWO4. Mg5IDP and MgWO4 are superimposed over unbiased positive Fo-Fc observed prior to 
their addition to the model. Figure panels reused with permission (Supplementary Figure 2, (K. M. Li et 
al., 2016)).  
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Figure 4.3: Hydrolytic Centre Overview of TmPPase:Mg5IDP. 
Comparison of the active site residues between (a) TmPPase:Mg5IDP (blue carbon, orange IDP, green 
Mg2+) and VrPPase:Mg5IDP (yellow carbon, yellow IDP, salmon Mg2+) and (b) TmPPase:Mg5IDP and 
TmPPase:CaMg (grey carbon, cyan Ca2+, orange Mg2+).  
 
 
Figure 4.4: Hydrolytic Centre Overview of TmPPase:MgWO4 
Comparison of the active site residues between TmPPase:MgWO4 (beige carbon, marine WO43+, green 
Mg2+) and TmPPase:Ca:Mg (grey carbon, cyan Ca2+, orange Mg2+). 
 
There was strong positive density (Fo-Fc, 4.7 d) around the ion gate in protomer A of 
TmPPase:Mg5IDP (Figure 4.5).  A sodium ion was refined in this position and the 
resulting density fits this placement. The density alone was insufficient evidence to 
suggest a sodium ion, since water molecules also have similar electron density. The 
resolution was also insufficient to accurately identify this density as a sodium ion.  
Alternative methods were used to identify and correctly assign this density as a sodium 
ion.  The ion was penta-coordinated, with surrounding residues at distances between 2.39-
2.49 Å. The results of a valence test (Section 2.2.5.4) carried out at this position also has 
a score of 0.9, with scores over 0.7 showing a high probability of being a sodium ion. In 
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contrast, tests carried out on the magnesium ions in the active site and water molecules 
elsewhere in the structure (in positions known to be correct based on previous structural 
data) showed relevant scores for magnesium ions and water molecules, validating the 
presence of sodium ions at this position. Moreover, previous mutational studies on several 
residues in proximity to the ion gate found that D16.46 was essential for Na+-binding and 
activity of the protein (Belogurov et al., 2005). 
 
 
Figure 4.5: Coordination of Na+ at the Ion Gate of TmPPase. 
Positive Fo-Fc electron density for Na+ near the ion gate in TmPPase:Mg5IDP at 3 d. 2Fo-Fc density is also 
shown for surrounding helices (1 d). Na+ (purple sphere) is superimposed onto the unbiased positive Fo-Fc 
density and is shown prior to its addition to the model.  Figure adapted with permission (Supplementary 
Figure 2, (K. M. Li et al., 2016)). 
 
4.2.3. Identifying the Sodium Ion Binding Site 
The proposed sodium ion binding site in TmPPase:Mg5IDP consists of residues D6.50, 
E6.53, S6.54 and D/N16.46 (Figure 4.6a). There were three noticeable differences between 
this structure and VrPPase:Mg5IDP (Figure 4.6b). The first was the position of E6.53 in 
TmPPase, which is located one helical turn down in VrPPase (E6.57). The second is one 
of the ion gate residues, D/N16.46, which is an aspartate in TmPPase but an asparagine in 
almost all other M-PPases, including VrPPase. The third is the position of the lysine 
(K16.50). In VrPPase:Mg5IDP, the NH3 group of K16.50 occupies the same position as the 
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sodium ion in TmPPase:Mg5IDP.  It was previously thought the switch of glutamate 
position accounted for differences in the binding and pumping of sodium ions and protons 
(Tsai et al., 2014). However, this glutamate is located at position E6.53 for both Na+-
PPases and K+-independent H+-PPases, which implies the specific mechanisms of ion 
selectivity are still not known and are indeed complex. 
 
 
Figure 4.6: Ion Gate Overview of TmPPase Structures. 
Key ion gate residues for (a) TmPPase:Mg5IDP (blue carbon, purple Na+) and comparisons with (b) 
VrPPase:Mg5IDP (yellow), (c) TmPPase:CaMg (grey). (d) Comparison of ion gate residues between 
TmPPase:MgWO4 (beige) and TmPPase:CaMg (grey). 
 
The displacement of K16.50 was observed when comparing the TmPPase:Mg5IDP 
structure with the resting state TmPPase structure (TmPPase:CaMg) (Figure 4.6c). As 
with the VrPPase:Mg5IDP structure, the amine group of K16.50 occupies the position of 
Na+ in the TmPPase:Mg5IDP structure. D16.46 has also changed conformation in the 
resting state structure, moving in to coordinate the sodium ion upon binding. The position 
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of the ion gate residues in TmPPase:MgWO4 can be superimposed with those from 
TmPPase:CaMg.  
 
4.2.4. Comparison Between Previous and New M-PPase Structures 
The TmPPase:Mg5IDP structure very closely compared with the previous 
VrPPase:Mg5IDP structure (r.m.s.d. = 0.9 Å, comparing Ca of all residues) and showed 
perfect superimposition of the active site residues and overall secondary structure. The 
main differences were in the position of the ion gate residues brought about by minor 
sequence differences and the presence of a sodium ion in the TmPPase:Mg5IDP structure, 
which had altered the interactions of the ion gate residues between these structures.  The 
TmPPase:Mg5IDP structure deviated more from the TmPPase:CaMg structure (r.m.s.d. = 
1.6 Å, comparing Ca of all  residues), due to major differences upon substrate or inhibitor 
binding. The closing of the active site loops and constrictions of the helices around this 
region led to major conformational changes in the helices.  Additional changes near the 
ion gate, such as the displacement of K16.50, also plays an important role in forming the 
sodium binding site. 
 
Inversely, the TmPPase:MgWO4 structure more closely resembles the resting state 
TmPPase structure (r.m.s.d. = 0.4 Å, comparing Ca of all residues) than the 
TmPPase:Mg5IDP structure (r.m.s.d. = 1.7 Å, comparing Ca of all residues). Both the 
active site and ion gate are highly similar between TmPPase:MgWO4 and 
TmPPase:CaMg, with almost no difference between the residues and helices at these 
positions.  This was likely due to WO43+ being an analogue of the product-bound form of 
TmPPase (Pi). During the catalytic cycle this would be the last product released prior to 
reaching the resting-state and therefore the sodium ion would already have been pumped. 
This would leave the ion gate residues in the same conformation as the resting state 
structure and would also ensure that the active site loops had moved away from the active 
site and become disordered to allow for product release. 
 
4.3. Structural Studies of PaPPase Using X-ray Crystallography 
4.3.1. Crystallisation Trials of PaPPase 
Initial crystallisation trials of PaPPase were carried out in sparse matrix screens with 
protein in DDM and DM.  Multiple 96-well plates were set up containing commercially 
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available screens, such as MemGold 1 and 2 as well as MemStart & MemSys using the 
sitting-drop vapour diffusion method.  Very few crystals were obtained from these 
screens and these diffracted to around 15-20 Å, which was insufficient to obtain a correct 
indexing solution or to gain any useful structural information.  Alongside these trials, a 
new optimised crystal screen was set up based upon hits obtained in previous studies 
(Kellosalo et al., 2013). The optimised screen covered conditions from the best crystal 
hit (35 % PEG 400, 0.1 M Tris pH 8, 0.1 M KCl), which had yielded crystals diffracting 
to 5.8 Å.  Full details of this screen can be found in the materials and methods section, 
but essentially involved varying the concentration and pH of different buffers and PEG 
400 alongside trying alternative salts and salt concentrations. 
 
4.3.2. Initial Crystallisation Hits of PaPPase and 6.5 Å Dataset 
4.3.2.1. Collection of Initial PaPPase Datasets  
Using the optimised screen yielded numerous crystals of needle and plate morphologies 
that diffracted to < 10 Å, with the best hit from the initial crystal screens found at 6.5 Å 
with the protein in DM.  This crystal was grown in 30 % PEG 400, 0.1 M MES pH 6.5, 
0.05 M LiSO4 and 0.05 M NaCl using the sitting drop vapour-diffusion method (Figure 
4.7).  A full dataset was collected and indexed into the P 21 spacegroup (Table 4.2).  
 
Figure 4.7: Morphologies of 6.5 Å diffracting PaPPase crystals. 
Size and morphology of PaPPase crystals diffracting to 6.5 Å using (a) standard imaging and (b) UV-
TPEF imaging, where crystals showing UV fluorescence appear white. Red arrows indicate the crystal 
used to obtain the data set and resulting structure. 
 
30 µm 30 µm
a b
	 98	
 
Table 4.2: Data Collection Statistics for 6.5 Å PaPPase Structure. 
Crystal PaPPase (6.5 Å) 
Data collection  
   Space group P 21 
   Cell dimensions  
      a, b, c (Å) 106.6, 87.0, 116.3 
      b (˚) 108.4 
   Source  
   Wavelength (Å) 0.966 
   Resolution (Å) 48.7 - 6.5 (7.4 - 6.5) 
   CC(1/2) (%)* 94.7 (21.8) 
   I/d* 1.79 (0.38) 
   Completeness (%)* 95.5 (80.4) 
   Redundancy 3.2 (3.1) 
*Value in parenthesis are for the highest resolution shell. 
 
4.3.2.2. Processing of Initial PaPPase Dataset  
At this resolution, it was possible to solve the structure by molecular replacement using 
a homology model generated by Sculptor (part of the Phenix software package) based on 
the TmPPase resting state structure using the sequence of PaPPase. This model lacked 
the catalytically important loop regions (loop 5-6), all water molecules and metal ions 
and all residues had been truncated to alanine as side chain density would not be visible 
at this resolution.  The resulting structure showed a dimer, with each protomer containing 
16 transmembrane helices (Figure 4.8).  The helical positions most closely matched those 
of the IDP-bound forms of M-PPases, but no positive density (Fo-Fc) could be seen in the 
active site, nor was it possible to see density for the 5-6 loop or any side chains throughout 
the protein. Due to the limited resolution, the structure was not solved and no further 
refinement was carried out following the initial observation of the electron density maps.   
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Figure 4.8: Representative Electron Density of 6.5 Å PaPPase Structure. 
Representative 2Fo-Fc density for helix 2 of the 6.5 Å PaPPase structure. Side chains have not been added 
to the model due to the lack of density at this resolution. 
 
4.3.2.3. Structural Observations of the 6.5 Å PaPPase Structure 
Despite the low-resolution electron density maps, it was possible to observe crystal 
packing for this structure (Figure 4.9).  It appears that the contacts form more closely in 
two directions, with the cytoplasmic side of protomer A forming contacts with the 
cytoplasmic side of protomer B from the neighbouring dimer.  This explains the crystal 
morphology, since the lack of contacts on one axis leads to poor crystal formation along 
this axis, resulting in the formation of plate and needle crystal morphologies.  This third 
axis is likely weaker at forming contacts due to the position of the detergent micelles, 
which are found around this portion of the protein.  Therefore, it may be possible to switch 
to a detergent with a smaller micelle size or to try reducing the concentration of detergent 
to improve crystal formation.  Moreover, dehydration experiments may lead to tighter 
crystal contacts and thus better crystal formation and diffraction.  Contacts between the 
protomers at the exterior side of the channel were also not visible, as the poor crystal 
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contacts had left the side chains disordered, generating poor electron density at these 
regions. 
 
Figure 4.9: Crystal Packing of the 6.5 Å PaPPase Structure. 
Crystal packing of the 6.5 Å PaPPase dataset shown (a) along the x-axis and (b) along the y-axis. 
 
4.3.3. Optimisation of PaPPase Crystals to Improve Diffraction 
4.3.3.1. Optimisation of PaPPase Crystallisation Conditions 
Following on from the initial 6.5 Å dataset, hundreds of crystals were obtained and tested, 
leading to dozens of additional datasets at the same resolution. Different detergents were 
tested, including DDM, DM, NM, OM, UM and C8E4 at 10 - 20 x CMC, but none of 
these produced crystals diffracting better than the initial 6.5 Å hit. Multiple other 
detergents had been tested in previous studies to see what effect these would have on 
crystallisation, including OG, CHAPSO, Cymal-5 and 6 and also OGNG, but none of 
these led to better diffracting crystals. 
 
The type of detergent used was likely not the main deciding factor on how the crystals 
formed or how well they diffracted.  Likewise, the well conditions of the optimised screen 
were varied, including different concentrations of buffer, pH as well as the type and 
concentration of salts. Moreover, the original sparse matrix screens had yielded no 
additional hits than those found in the original crystallisation studies of PaPPase.  Thus, 
a b
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it seemed that alternative methods of optimisation were required to further improve the 
resolution. 
 
4.3.3.2. “HiLiDe” Optimisation Technique 
One such optimisation method was the “HiLiDe” method (High Lipid and Detergent), 
which involved the addition of increasing concentrations of lipids and detergents in a grid 
to find an optimal combination that could significantly improve the growth and diffraction 
of crystals (Section 2.2.2.1).  Initial screens were based on conditions from the best 
diffracting crystals (30 % PEG 400, 100 mM MES, pH 6.5, 50 mM LiSO4 and 50 mM 
NaCl).  Initial trials involved increasing concentrations of DDM between 1 and 6 % 
alongside increasing PEG 400 concentrations from 30-38 %. Other plates involved 
increasing concentrations of DM and NM between 0 and 3 %.  Crystals obtained from 
this method were of a thin needle morphology (~10 µm width) and did not diffract better 
than 15 Å. Indexing was unsuccessful given the lack of clear spots on the diffraction 
images and so no additional information could be gained from these crystals.  Given the 
lack of any improved crystals, dehydration experiments were set up to try and improve 
crystal formation and diffraction. 
 
4.3.3.3. Dehydration Experiments of PaPPase Crystals 
The additional 96-well crystallisation plates set up using the PaPPase optimisation screen 
reliably produced crystals that diffracted to 6.5 Å, which were used for a series of 
dehydration experiments. Dehydration experiments can sometimes improve crystal 
diffraction by reducing the water content of the crystals, creating better crystal packing 
and thus stabilising the crystal, leading to better diffraction.  I used two main methods.  
The first was the transference of fully formed crystals into solution containing the mother 
liquor with added concentrations of glycerol and/or PEG 400. The second was to add 
glycerol or PEG 400 directly to the well solution. In both cases the hope was to dehydrate 
the crystal or the drop and allow it to form a more tightly packing crystal that would show 
improved diffraction. However, neither method improved the diffraction of the crystals 
as the best one obtained still diffracted to around 6.5 Å. 
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4.3.3.4. Reduced Detergent Concentration in Crystallisation of PaPPase 
Another method of optimisation was to try and reduce the concentration of detergent 
present at the point of crystallisation.  This method would lower the free detergent 
concentration as well as lower the number of empty detergent micelles in the sample, 
reducing the number of detergent crystals whilst increasing the number of protein-protein 
crystal contacts, improving diffraction of the resulting crystals. This was achieved by 
adding lower concentrations of detergent during the detergent exchange step of 
purification from 20 x CMC to 4 x CMC.  In doing so, this would reduce the final 
concentration of detergent in the protein sample following the protein concentration step 
of purification. However, as with other optimisation methods attempted, multiple crystals 
were collected and tested but there was no improvement in crystal diffraction as data sets 
obtained were at 6.5 Å or worse. 
 
4.3.4. Improved PaPPase Datasets and 4.3 Å Structure 
4.3.4.1. Crystallisation Conditions and Data Collection of 4.3 Å Dataset 
During data collection, one crystal was found that diffracted to 4.3 Å. I noted that most 
of the solvent in the loop was absent, effectively dehydrating the crystal. This crystal had 
been grown in 33 % PEG 400, 0.1 M MES pH 6.5, 0.05 M LiSO4 and 0.05 M NaCl via 
the sitting drop vapour diffusion method (Figure 4.10).  The crystal in question had been 
grown with several dozen more as part of the dehydration experiments, but was a control 
crystal for comparison to the dehydrated crystals.  The crystallisation conditions 
themselves were only marginally different from the ones used to obtain the 6.5 Å dataset 
(33 % PEG 400 instead of 30 % PEG 400) and indeed these conditions had been tested 
previously, with only 6.5 Å-diffracting crystals found. The only difference to previous 
attempts was that the solvent in the loop had mostly evaporated, leaving the crystal in 
dehydrating conditions. 
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Figure 4.10: Morphology of 4.3 Å diffracting PaPPase Crystals. 
Size and morphology of PaPPase crystals diffracting to 4.3 Å using (a) standard imaging and (b) UV-
TPEF imaging, where crystals showing UV fluorescence appear white. Red arrows indicate the crystal 
used to obtain the data set and resulting structure. 
 
 
4.3.4.2. Data Processing and Structural Refinement of 4.3 Å Dataset 
A full data set was collected from this crystal (Table 4.3).  The data were processed in 
XDS and a molecular replacement solution was found using a PaPPase homology model 
based on the TmPPase:Mg5IDP structure with flexible loop regions removed.  The data 
underwent limited initial refinement, with the R-factors being 37.8%/43.8%, but a full 
refinement was not carried out due to the collection of higher resolution data (Section 
4.3.5).  The overall helical density was much improved compared with the 6.5 Å dataset 
(Figure 4.11). At this resolution, electron density was visible for some of the side chains 
and allowed for more accurate fitting of the helices compared with the 6.5 Å structure.  
Despite this, there was still missing density, particularly around the active site. No density 
could be seen for the Mg5IDP complex or for loop 5-6, which was observed packing over 
the active site in both the TmPPase and VrPPase IDP-bound structures.   
 
45 µm 45 µm
a b
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Figure 4.11: Representative Electron Density for 4.3 Å PaPPase Structure. 
Representative (2Fo-Fc) density (1 d) for helix 2 of the 4.3 Å PaPPase structure. 
 
In the 4.3 Å PaPPase structure, it was noted that the final 11 residues of the C-terminus 
were absent from the model due to a lack of electron density in these regions (Figure 
4.12a).  This was in contrast to the TmPPase structures (Figure 4.12b), in which these 
residues are all visible and form vital interactions across the dimer interface, maintaining 
the overall structure of TmPPase.  The lack of electron density for these residues implied 
a degree of disorder in this region of the protein, but the C-terminal truncation mutant of 
PaPPase (Section 3.6) showed a significant decrease in hydrolytic activity compared with 
the wild-type protein. Therefore, despite the lack of electron density, these regions were 
clearly still important to the overall structure and function of these proteins, particularly 
during solubilisation at 70 ˚C.  Another explanation for the lack of electron density is the 
possibility that the expressed PaPPase protein lacks the C-terminal residues, since the 
purification gel shows another band directly above the main purification band (Figure 
3.12). However, this is unlikely to be the case, since sequence-confirmed expression and 
purification of the C-terminal truncation mutant of PaPPase was almost entirely inactive 
(10-fold lower than the wild-type PaPPase.  If the C-terminal residues were missing, the 
activity would decrease and no difference would be seen between the wild-type protein 
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and the C-terminal truncation mutant.  It is therefore more likely that the residues are 
either disordered or not resolvable at this resolution. 
 
Figure 4.12: Overview of the PaPPase C-terminus.   
(a) 2Fo-Fc electron density (3 d) for the C-terminal of the 4.3 Å PaPPase structure showing the absence of 
density for the final 13 residues and (b) comparison between the C-terminal residues of the 4.3 Å PaPPase 
structure (cyan) with the TmPPase:CaMg structure (yellow).  
V16.64
V16.64
F16.69
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Table 4.3: Data Collection and Refinement Statistics of the 4.3 Å PaPPase Structure. 
Crystal PaPPase (4.3 Å) 
Data collection  
   Space group P 21 
   Cell dimensions  
      a, b, c (Å) 107.5, 88.5, 117.1 
      b (˚) 107.2 
   Source  
   Wavelength (Å) 0.966 
   Resolution (Å) 47.5 - 4.3 (4.5 - 4.3) 
   CC(1/2) (%)* 98.9 (29.9) 
   I/d* 3.9 (0.6) 
   Completeness (%)* 99.1 (98.9) 
   Redundancy 3.4 (3.4) 
Refinement  
   Resolution (Å) 4.3 
   No. of reflections 48,261 
   Rwork(%)/Rfree(%) 37.8 / 43.8 
   No. of atoms 9,440 
      Protein 9,440 
      IDP  0 
      Mg2+ 0 
   No. of chains/ASU 2 
   B-factors (Å2)  
      All atoms 29.97 
      Protein 29.97 
      Ligand X 
   r.m.s.d.  
      Bond length (Å) 0.01 
      Bond angle (˚) 1.68 
*Values	in	parenthesis	are	for	the	highest	resolution	shell.	
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4.3.5. Merging of Multiple PaPPase Datasets and the 3.8 Å structure 
4.3.5.1. Data Collection from Multiple PaPPase Crystals 
Once crystals had been found that diffracted to 4.3 Å, I could repeatedly obtain these 
crystals by dehydrating them during crystal picking. This was achieved by leaving the 
crystals in the air for 10-30 seconds once picked prior to flash-freezing in liquid nitrogen. 
I screened dozens of crystals using the 96-well optimisation plates and from this I 
obtained 7 full datasets each between 4.0 and 4.5 Å resolution.  In each case the space 
group and unit cell parameters were almost identical (Table 4.4). Molecular replacement 
and a single round of refinement was carried out to obtain electron density maps. All 
structures showed identical crystal packing and positive density (Fo-Fc) in the active site 
at the position of the Mg5IDP complex in the TmPPase and VrPPase IDP-bound 
structures. 
 
Figure 4.13: Morphology of Crystals used to Generate the 3.8 Å PaPPase Structure. 
Size and morphology of one of the PaPPase crystals containing data to 3.8 Å using (a) standard imaging 
and (b) UV-TPEF imaging, where crystals showing UV fluorescence appear white. Red arrows indicate 
the crystal used to obtain the data set that was used during merging of data and used to solve the 
structure. 
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4.3.5.2. Data Processing and Merging of PaPPase Datasets 
During data processing in XDS, it was noted that the first few hundred images (10-40˚) 
of each dataset contained higher resolution data (~ 3.8 Å) but with a lower overall 
completeness (~40-70 %). The datasets were reprocessed using only a select number of 
images (Table 4.4). Since each dataset had identical space groups and very similar unit 
cell parameters, it was possible to combine these partial datasets.  Datasets were merged 
using XScale and the merged dataset could be cut at a resolution of 3.8 Å without 
significant loss of completeness and with a CC(1/2) of around 30 % (Table 4.5).  
 
Table 4.4: Data Collection and Processing Statistics from Multiple PaPPase Crystals. 
Data processing statistics for truncated datasets of PaPPase used to create combined dataset used to obtain 
3.8 Å structure. 
Dataset 1 2 3 4 5 6 7 
Beamline DLS-i04 DLS-i04 DLS-i04 DLS-i04 ESRF 
MASSIF-
1 
ESRF 
ID23-1 
DLS-i24 
Image Range 
(0.1˚ / image) 
1-400 1-180 1-200 1-150 1-180 1-300 1-200 
Spacegroup P21 P21 P21 P21 P21 P21 P21 
a (Å) 109.5 113.3 112.1 109.6 110.1 111.1 106.9 
b (Å) 89.2 89.9 89.2 88.7 90.9 89.5 88.7 
c (Å) 118.9 119.4 117.8 116.8 121.1 120.4 116.6 
a (˚) 90 90.1 90.1 90.1 91.1 90.3 89.9 
b (˚) 106.7 107.2 107.3 107.5 107.2 106.7 107.1 
g (˚) 90 90.1 90 90.4 89.7 89.9 90.6 
Resolution 
(Å) 
3.96 4.35 4.12 3.99 4.01 3.94 3.84 
Completeness 
(%)* 
67.6 
(68.6) 
49.5 
(46.5) 
51.6 
(50.3) 
39.3 
(39.1) 
52.1 
(48.2) 
45.9 
(38.5) 
48 (47.6) 
I/d* 3.6 (0.4) 4.2 (0.6) 4.9 
(0.51) 
2.5 
(0.24) 
2.7 (0.31) 3.8 (0.5) 2.5 (0.5) 
CC(1/2) (%)* 99.8 
(29.0) 
99.9 
(14.7) 
100 
(31.5) 
99.9 
(28.4) 
99.7 
(25.9) 
99.5 
(27.3) 
99.7 (25.9) 
*Values in parenthesis are for the highest resolution shell. 
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Table 4.5: Refinement Statistics of the Merged 3.8 Å PaPPase Structure. 
Crystal PaPPase (3.8 Å) 
Data collection  
   Space group P 21 
   Cell dimensions  
      a, b, c (Å) 107.2, 88.0, 116.8 
      b (˚) 107.0 
   Source  
   Wavelength (Å) 0.96860 
   Resolution (Å) 20 - 3.8 (3.9 – 3.8) 
   CC(1/2) (%)* 97.5 (28.6) 
   I/d* 3.6 (0.7) 
   Completeness (%)* 95.1 (82.5) 
   Redundancy 6.1 (3.9) 
Refinement  
   Resolution (Å) 3.8 
   No. of reflections 19,166 
   Rwork(%)/Rfree(%) 34.8 / 39.4 
   No. of atoms 9,486 
      Protein 9,456 
      IDP  18 (2 IDP) 
      Mg2+ 10 
   No. of chains/ASU 2 
   B-factors (Å2)  
      All atoms 117.2 
      Protein 117.2 
      Ligand 118.5 
   r.m.s.d.  
      Bond length (Å) 0.003 
      Bond angle (˚) 0.685 
*Values in parenthesis are for the highest resolution shell. 
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4.3.5.3. Refinement of the 3.8 Å PaPPase Structure  
The merged 3.8 Å dataset was used for molecular replacement and refinement, and the 
structure was partially solved with R-factors of 34.8 %/39.4 % (Table 4.5). This showed 
a vast improvement in electron density over the 4.3 Å structure, with clearer density seen 
for the longer side chains, such as tyrosine, arginine and phenylalanine compared with 
the 4.3 Å structure (Figure 4.14).  Despite the low resolution, more structural information 
could be observed compared with the 4.3 Å structure.  
 
 
Figure 4.14: Representative Electron Density of the 3.8 Å PaPPase Structure. 
Representative 2Fo-Fc (3 d) electron density for helix 2 of the 3.8 Å PaPPase structure. 
 
4.3.5.4. Comparisons with Previous Structures at the Hydrolytic Centre 
Electron density (2Fo-Fc) was observed in the active site at the position of the Mg5IDP 
complex in both the TmPPase and VrPPase IDP structures (Figure 4.15a).  This was 
added to the model and refined in place: the resulting electron density was able to 
accommodate the IDP and three of the magnesium ions, the remaining two magnesium 
ions did not produce negative density (Fo-Fc), but did not fit the 2Fo-Fc density (Figure 
4.15b). Comparison between the position of the Mg5IDP complex in the 3.8 Å PaPPase 
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structure and VrPPase:Mg5IDP showed that the position of the complex itself was quite 
similar, with only minor differences in the position of Mg2+ (Figure 4.16).  
 
Figure 4.15: Electron Density at the Hydrolytic Centre of the 3.8 Å PaPPase Structure. 
2Fo-Fc electron density (3 d) for (a) the active site and surrounding residues of the 3.8 Å PaPPase structure 
following molecular replacement and (b) the active site of the same structure including Mg5IDP complex 
at the end of refinement.  
 
 
Figure 4.16: Hydrolytic Centre Overview of 3.8 Å PaPPase Structure. 
Comparison between the hydrolytic centres of VrPPase:Mg5IDP (yellow carbon, yellow IDP, salmon 
Mg2+) and 3.8 Å PaPPase:Mg5IDP (maroon carbon, blue IDP, cyan Mg2+) structure. 
 
4.3.5.5. Comparisons with Previous Structures in Helical Conformations  
There was a noticeable difference in helix 5 of the inner ring helices, wherein it formed a 
more restricted channel opening at the cytoplasmic side in PaPPase:Mg5IDP compared 
with VrPPase:Mg5IDP (Figure 4.17).  Moreover, 3 of the outer ring helices (helices 2, 13 
and 14) also appeared to be in different conformations to the VrPPase:Mg5IDP structure.  
This could explain the difficulty in the refinement of these structures as the homology 
model was based on the placement of the helices in TmPPase:Mg5IDP and 
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VrPPase:Mg5IDP structures. These helices were repositioned during refinement to better 
fit the density and therefore represented a significant structural feature of PaPPase.  The 
reasons for these differences are not known, but may be involved in the mechanism of 
potassium-independence in PaPPase. Higher resolution structures of PaPPase, or new 
structures of additional K+-independent M-PPases would be needed to confirm this 
hypothesis. 
 
Figure 4.17: Comparison of Helix Conformations Between PaPPase and VrPPase 
Comparisons between the helical conformations of 3.8 Å PaPPase:Mg5IDP structure (maroon) and 
VrPPase:Mg5IDP (yellow) showing (a) the top down view of the cytoplasmic side and (b) the side view of 
the proteins. 
 
4.3.5.6. Comparisons with Previous Structures at the Ion Gate 
As expected, there was no extraneous electron density at the ion gate of the PaPPase 
structure (Figure 4.18a), 2Fo-Fc density was observed for D6.50 and S6.54 but there was no 
observable electron density for N16.46, K16.50, E6.53 or R5.50 and so the conformations of the 
side chains are based purely on the stereochemical properties of these residues (Figure 
4.18).  A comparison was made of residues at the ion gate region of PaPPase:Mg5IDP 
and VrPPase:Mg5IDP (Figure 4.18b). The position of helix 6 had moved by around 0.5 
Å from the cytoplasmic side in PaPPase:Mg5IDP but the overall position of the residues 
of the ion gate was very similar, with differences in resolution, and the resulting lack of 
electron density, likely the cause of the discrepancies.  
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Figure 4.18: Ion Gate Overview of 3.8 Å PaPPase Structure. 
Ion gate region of the 3.8 Å PaPPase:Mg5IDP, showing (a) 2Fo-Fc density (3 d) following refinement and 
(b) a comparison between ion gate residues of PaPPase:Mg5IDP (maroon) with VrPPase:Mg5IDP (yellow). 
 
4.3.6. Potassium-Independence of PaPPase 
4.3.6.1. Structural Analysis and Identification of Potassium Independence 
Mechanisms 
Previous mutational studies of K+-dependent H+-PPases (Belogurov & Lahti, 2002) had 
shown that the mutation of an alanine to a lysine in helix 12 could produce a K+-
independent mutant, with a modulatory effect seen with a glycine-to-threonine mutation 
one turn down the helix. Both the lysine and threonine are present in PaPPase at positions 
K12.46 and T12.49, respectively.  There is electron density (2Fo-Fc) for both residues 
suggestive of side chain conformations (Figure 4.19a).  A comparison was made of this 
region between the PaPPase:Mg5IDP and VrPPase:Mg5IDP structures (Figure 4.19b). 
From this it appears K12.46 might be functionally replacing K+.  Although the NH3 group 
does not directly occupy the same position as K+, both interact with the IDP (Figure 
4.19b). The limited resolution of the PaPPase:Mg5IDP structure means that water 
molecules are not visible, but these coordinate K+ in the VrPPase structure and it is highly 
likely that they would fulfil a similar role in the PaPPase structure. 
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Figure 4.19: Overview of K12.46 in 3.8 Å PaPPase Structure. 
(a) 2Fo-Fc density for K12.46 of the 3.8 Å PaPPase structure following refinement. (b) comparison of the 
potassium binding site of VrPPase:Mg5IDP (yellow carbon, orange IDP, purple K+, red water) with the 
K12.46 residue of the 3.8 Å PaPPase structure (maroon carbon, purple IDP). Mg2+ and water molecules not 
interacting with K+ were removed for the sake of clarity. 
 
The previous chapter (Section 3.6) showed that single mutations of either K12.46A or 
T12.49A in PaPPase were not sufficient to generate a K+-dependent mutant (Figure 4.20). 
However, a dual mutant of both residues was K+-dependent. Using the structural 
information obtained from the PaPPase:Mg5IDP structure, it was possible to speculate on 
what was happening at K/A12.46 and T/A12.49 in each of the mutants.  In the original study, 
the M-PPase of Carboxydothermus hydrogenoformans (ChPPase) had two alanine 
residues in place of the lysine and threonine found in most K+-independent M-PPases. In 
PaPPase, T12.49 is interacting with D11.50 on helix 11. This residue therefore plays a role 
in stabilising PaPPase but is not present in any of the K+-dependent M-PPases, including 
ChPPase. In K+-dependent variants, the potassium ion is located in the active site, where 
it interacts with the electrophilic phosphate group of the substrate/inhibitor, as seen in the 
VrPPase crystal structures (PDB ID: 4a01).  It was speculated that the NH3 group of K12.46, 
conserved in all K+-dependent variants, is a substitute for K+ (Belogurov & Lahti, 2002).  
Therefore, it was interesting to discover that the K12.46A mutation alone did not appear to 
generate a K+-dependent variant of PaPPase in this study. 
 
K12.46
K/A12.46
N12.43
a b
2.3 Å
3.3 Å
2.9 Å
3.4 Å
2.8 Å
3.4 Å
2.9 Å
3.4 Å
	 115	
 
Figure 4.20: Overview of the Potassium-Independence Mechanism of PaPPase. 
Positions of the two tested residues of K+-independence (K/A12.46 and T/G12.49) and interactions made with 
neighbouring residues in PaPPase:Mg5IDP (maroon carbon, purple IDP) and VrPPase:Mg5IDP (yellow 
carbon, orange IDP, Purple K+). 
 
4.3.6.2. Comparison of PaPPase Structure with Previous Mutagenesis Results 
Given the total conservation of K12.46 in K+-independent M-PPases and its absence in all 
K+-dependent variants, it is clear this residue has a crucial role in K+-stimulated selection. 
Previous studies on generating a K+-independent variant from the K+-dependent ChPPase 
found that in the absence of K+, Wild-type and the A12.49T mutant of ChPPase showed no 
detectable proton pumping activity (Belogurov & Lahti, 2002). Increasing concentrations 
of K+ from 0.1 to 100 mM increased the activity from 0 up to around 7 µmol min-1 mg-1. 
Inversely, the A12.46K mutant had a constant activity of 4 µmol min-1 mg-1 across the same 
range of K+, showing activity even in the complete absence of K+. A later study of Na+-
PPases, all of which are K+-dependent, showed hydrolytic activity of 20 µmol min-1 mg-
1 in the presence of 50 mM K+ and at least 1 mM Na+ (Belogurov et al., 2005).  The 
activity was only 0.5 µmol min-1 mg-1 at K+ concentrations of 0.004 mM when Na+ 
concentrations were below 1 mM. However, activity increased with increasing 
concentrations of Na+ between 1 and 100 mM, at which the activity was around 10 µmol 
min-1 mg-1. Further study on the Na+-PPase from Methanosarcina mazei (MmPPase) 
confirmed that K+-dependent M-PPases could be activated by Na+, even in the absence 
of K+ (Malinen et al., 2007). 
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4.3.6.3. Potential Role of Sodium Ions in Potassium Independence 
Based on all the available data, Na+ can substitute K+ in K+-stimulated PPase activity.  
The activity assay results for the PaPPase mutants are likely thrown off by the presence 
of Na+ in the buffers (Figure 3.15).  The structure of PaPPase confirms the presence of 
K12.46 around the K+-binding site seen in previous structures (Kellosalo et al., 2012; Lin 
et al., 2012) (Figure 4.19, Figure 4.20).  Therefore, it is likely that K12.46A has Na+ 
occupying the K+-binding site, compensating for the loss of the NH3+ group of the lysine.  
The additional interactions made between T12.49 and D11.50 provide a stabilisation 
mechanism that maintains the integrity of the K+-binding site. This interaction maintains 
full activity in the wild-type and K12.46A mutant of PaPPase, by allowing the lysine or 
Na+ to interact with the substrate.  The loss of this interaction in the T12.49A mutant 
reduces the stability of the K+-binding site. The lysine therefore cannot interact as well 
with the substrate, so the overall activity is reduced, but K+ or Na+ was still not required 
for activity.  The dual mutant lacks the NH3+ substitution for K+ but also lacks the 
stabilising effects of the T12.49-D11.50 interactions.  The overall activity is therefore 
significantly reduced compared with wild-type. It is possible that the K+ in the K+-positive 
sample buffer of the activity assay provides the increased monovalent cation 
concentration required to recover activity in the dual mutant, as seen in the previous 
studies of K+-dependence (Belogurov et al., 2005; Malinen et al., 2007).  It could mean 
the K+-dependent effect seen here is not a true effect and is related to the increasing 
monovalent cation concentration.  Future experiments on the PaPPase mutants, without 
the presence of any monovalent cation, will be needed to fully confirm the role of the 
K12.46A mutation in the generation of K+-dependence in PaPPase and to confirm the 
original findings by Belogurov and Lahti (2002) that this residue alone can account for 
K+-stimulated selectivity. 
 
4.3.6.4. Alternative Mechanisms to Explain Potassium Independence 
The effects of Na+ substitution for K+ were only studied in Na+-PPases and not H+-PPases. 
Since the mechanism of cation dependence between Na+ and H+ has not been identified, 
it is also possible that Na+ cannot substitute K+ in H+-PPases. Therefore, hydrolytic 
activity retained in the K12.46A mutant may represent a genuine effect of K+-
independence.  It is possible that the stability of the T12.49-D11.50 interactions allows the 
protein to compensate for the loss of K+ and K12.46 by the substitution of this charge with 
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other nearby positively-charged residues, such as K16.38, located 3.6 Å from the substrate 
(Figure 4.20).  Conformational changes in the side-chain of this lysine residue may 
provide a compensatory mechanism that allows the protein to remain active even in the 
absence of K+.  The conformational changes may not be possible in the dual mutant with 
the loss of the stabilising effects of the T12.49-D11.50 interaction.  The loss of stability would 
affect the overall activity of this mutant, but would allow K+ to bind still at the expected 
K+-binding site, recovering the activity.  This means the K+-dependent effect seen for the 
dual-mutant could be a genuine effect. 
 
The results above show that the structure of wild-type PaPPase alone cannot explain the 
K+-dependence mechanism of M-PPases.  Future work will need to be carried out on the 
mutants generated in this study, ensuring a complete absence of Na+ from the buffers.  
This could confirm if Na+ can substitute K+ in the K12.46A mutant and potentially confirm 
the previous findings that this lysine is the sole determinant of K+-dependence in M-
PPases (Belogurov & Lahti, 2002).  Crystal structures of the two PaPPase mutants could 
also provide valuable information on whether the compensatory mechanism was true or 
could provide additional confirmation that Na+ was substituting K+. 
 
4.4. Summary of M-PPase Structural Studies 
My aim was to carry out structural studies on TmPPase and PaPPase, generate structures 
in multiple catalytic states and use this information to understand how the protein 
functions on a mechanistic level, related to ion pumping, hydrolysis and K+-dependence. 
In this way, I could compare, contrast and combine the new structures with the previously 
solved structures to generate a complete model of the catalytic cycle to allow for more 
in-depth analysis. 
 
I solved two new structures of TmPPase and structures of a new M-PPase, the PaPPase.  
The new structures of TmPPase were in two new states compared with the previously 
solved structures of TmPPase (Kellosalo et al., 2012). This means there are now four 
complete states including the resting state, substrate-analogue-bound state (IDP), 2-
product-bound state (Pi2) and the single product-analogue bound state (WO43+). The 
structures solved by our collaborators, both previously (Lin et al., 2012) and in line for 
this project and publication (K. M. Li et al., 2016) were of VrPPase in the substrate-
analogue bound state (IDP) and now in the single product-bound form (Pi). 
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The TmPPase:Mg5IDP structure may be a subtly distinct sub-state of the substrate-bound 
state of the protein.  The hydrolytic centre of both TmPPase:Mg5IDP and 
VrPPase:Mg5IDP, were very similar, including the position and coordination of the 
Mg5IDP complex and the overall position of the helices. There was a noted “downwards” 
motion of helix 12 by 2 Å away from the cytoplasmic side when comparing the resting 
state structure to the IDP-bound structures. Indeed the only significant different between 
TmPPase:Mg5IDP and VrPPase:Mg5IDP was at the ion gate, where a sodium ion was 
bound in the TmPPase structure. 
 
The TmPPase:MgWO4 structure shares a high degree of similarity to the previous 
TmPPase resting state structure (Kellosalo et al., 2012). The unique feature is the 
presence of the MgWO4 complex in the active site, which occupies the same position as 
the single-product bound structure (K. M. Li et al., 2016). Overall it is clear that both the 
TmPPase:MgWO4 and VrPPase:Mg5Pi represent the same state, whereas 
TmPPase:Mg5IDP and VrPPase:Mg5IDP clearly represent two distinct sub-states of the 
overall substrate-bound state. These structures, along with the previously solved 
structures (Kellosalo et al., 2012; Lin et al., 2012) will be analysed in much more detail 
in chapter 5. 
 
Initial crystallisation attempts of PaPPase produced crystals that diffracted to around 20 
Å. Through optimisation of conditions, attempts using different types and concentrations 
of detergents and various forms of dehydration experiments, the resolution was steadily 
improved down to 3.8 Å. As the resolution improved more structural and mechanistic 
information became available.  Helices 13 and 14 showed a noticeable change in position 
compared with the previous IDP-bound structures of TmPPase and VrPPase.  Although 
the reasons for this are unclear, they may have a role in the K+-independence mechanism 
of PaPPase.  
 
Despite the presence of positive density (Fo-Fc) for the Mg5IDP complex, the 5-6 loop, 
which packs above this in the TmPPase:Mg5IDP and VrPPase:Mg5IDP structures, was 
only partially visible in the PaPPase:Mg5IDP structure.  Indeed, the entire cytoplasmic 
side of the protein appears to form less contacts than the previous structures, accounting 
for the lack of electron density for these regions as they are disordered.  Improving the 
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crystal packing and increasing the resolution of the structure will be necessary to gain 
more detailed mechanistic information about PaPPase.  However, the current structure 
provides the first major overview of this protein including the key catalytic residues of 
the active site and some of the residues around the ion gate.  This will allow for a detailed 
comparison with the currently available TmPPase and VrPPase structures during the 
generation of the catalytic cycle model in chapter 5. 
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5.1. Introduction to the M-PPase Catalytic Cycle 
The novel crystal structures of TmPPase and VrPPase described in chapter 4 have 
provided new insights into the different catalytic states of M-PPases. There now exists 6 
structures of TmPPase and VrPPase with most of these in different catalytic states. By 
comparing differences in each of these static snapshots, a model of the complete M-PPase 
catalytic cycle could be generated to provide useful information on how these proteins 
function.  Three previously solved structures exist; TmPPase in the resting state and 
product-bound (Mg5Pi2) state and VrPPase in the substrate-bound state (IDP).  I was able 
to solve two new structures of TmPPase (Chapter 4), in the substrate-bound state (IDP) 
and product-bound state (MgWO4).  An additional structure of the VrPPase, in the 
immediate product-bound state (Mg5Pi2), was simultaneously solved by our collaborators 
from the Sun lab (Taiwan).  Through the work described in this chapter, I analysed these 
structures and compared the residue side chains and helical positions, looking at the 
helical geometry and hydrogen bonding patterns between structures of the various 
catalytic states.  Previous catalytic schemes had been proposed for M-PPases and the new 
structural information was used to try and better understand the cycle. 
 
I also carried out tryptophan fluorescence and proton translocation studies to try and 
understand the states that are difficult to resolve using static crystallographic snapshots, 
such as the high-energy transition state.  This state involves the opening of the ion gate 
with cation release from the channel, but currently no structural or mechanistic 
information exists on how this occurs. Crystal structures show a state containing the 
substrate-analogue with the proton/sodium ion bound, but the next structure shows 
product bound but no ion/proton.  This means the order of events during this transition 
state was not known, nor was the mechanism of gate opening or ion/proton release.  
Measuring the change in tryptophan fluorescence upon substrate binding would show 
potential changes in conformational states. If the measured change was large enough, this 
would confirm the possibility of using stopped-flow fluorescence experiments to measure 
changes in conformation throughout the entire catalytic cycle.  Measuring both the change 
in fluorescence upon substrate binding and ion pumping provided some time-resolved 
data to piece together what was happening during the catalytic cycle and, more 
importantly, what was happening during the transition state. 
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5.2. ANS Fluorescence Experiments to Study Conformational Changes in M-
PPases 
To better understand the catalytic cycle, I sought more time-resolved methods to observe 
various conformational changes occurring over time and try to link these to different 
states of the catalytic cycle. The hope was to find states that corresponded to the crystal 
structures and potentially identify new ones that could not be found by standard 
crystallographic techniques, such as the high-energy transition state. I studied the 
tryptophan fluorescence of the M-PPases, as this technique can be used to show changes 
in overall protein conformations. Initial tests were done using a standard fluorimeter and 
titrations of the substrate-analogue IDP as this was known from the crystal structures to 
cause the formation of the closed conformational state. 
 
The transition from open to closed state was predicted to be the largest conformational 
change and was thus tested as a proof-of-concept. If a sufficient change in fluorescent 
signal was observed, it might be possible to carry out stopped-flow experiments to try 
and observe conformational changes occurring over the millisecond timescale using real-
time fluorescence measurements.  To try and boost the signal generated by tryptophan 
fluorescence, 8-anilino 1-naptholenesulphonate (ANS) was used, which fluoresces when 
activated by the emission peak of tryptophan (maximal 370 nm) and has a maximal 
emission peak at 450 nm.  This compound binds to any hydrophobic region of the protein 
and significantly amplifies the fluorescent signal as there are orders of magnitude more 
ANS present per dimer than tryptophan residues in the protein.  However, since it is only 
activated by tryptophan fluorescence emission, if there is no signal present to start with, 
it cannot amplify it and so no signal will be seen. Any change in fluorescence signal will 
either be caused by changing conformations of tryptophan residues or due to additional 
displacement/binding of ANS as the overall conformation of the protein changes.  This 
means there are several causes for a change in fluorescent signal during the experiments, 
but all of them imply a degree of conformational change, which was the rationale for the 
experiments. 
5.2.1. Fluorescence Studies on TmPPase 
I carried out initial fluorescence experiments on DDM-purified TmPPase (Chapter 3), 
starting with titrations of the inhibitor and substrate analogue imidodiphosphate (IDP). 
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Experiments were carried out using biologically relevant concentrations of IDP (0-500 
µM) (50 x the expected Kd) and magnesium (5 mM) (Figure 5.1, Figure 5.2), during which 
no change in the fluorescence signal was observed. This was backed up by the binding 
curve (Figure 5.2), which also shows no change in fluorescence quench with increasing 
concentration of IDP. It was therefore not possible to calculate Kd values for IDP binding 
to TmPPase using tryptophan fluorescence techniques.  Structural analysis of the four 
TmPPase structures revealed seven tryptophan residues per protomer. Between the open-
state (PDB ID: 4AV3) and the closed-state (TmPPase:Mg5IDP, current study), none of 
these were in positions undergoing significant conformational changes between these two 
states.  Therefore, it stands to reason that no fluorescent signal would be detected during 
these experiments.  
 
 
Figure 5.1: Tryptophan and ANS Fluorescence of TmPPase 
Imidodiphosphate titrations at biologically relevant levels during TmPPase fluorescence experiments 
showing emission spectra of ANS following excitation of tryptophan residues at 295 nm. 
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Figure 5.2: Effect of IDP concentration on ANS Fluorescence in TmPPase. 
Percentage of fluorescence quenching of TmPPase against biologically relevant concentrations of 
imidodiphosphate in the prescence of 5 mM MgCl2, 
 
5.2.2. Fluorescence Studies on VrPPase and PaPPase 
An analysis of the amino acid positions in VrPPase and PaPPase showed that tryptophan 
residues were present in regions of the protein that undergo significant conformational 
changes throughout the catalytic cycle (based on comparisons of expected residue 
positions between the TmPPase resting-state and IDP-bound states). Moreover, in 
VrPPase one of these tryptophan residues was located in the 5-6 loop, known to undergo 
extensive conformational changes as it forms the main mechanism through which the 
protein seals the channel upon substrate binding. 
 
I carried out tryptophan fluorescence experiments on samples of purified PaPPase 
(Chapter 3) and VrPPase (provided by the Sun lab, Taiwan). In PaPPase, the fluorescence 
signal changed by around 4-5 % when IDP was titrated over a biologically relevant range 
(0-500 µM) (Figure 5.3). The Kd had not been determined previously for PaPPase, but 
was found to be 5.7 µM, around the observed level for other M-PPases (~12 µM) (Baykov 
et al., 1993).  Since this change in fluorescence signal is linked to IDP concentration this 
likely represents conformational changes in the protein. However, the percentage change 
in fluorescence signal is too weak for use in future stopped-flow experiments, as the 
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signal from smaller or more subtle changes in conformation would be drowned out by 
background noise. 
 
Figure 5.3: Effect of IDP concentration on ANS Fluorescence in PaPPase 
Percentage of fluorescence quenching of PaPPase against biologically relevant concentrations of 
imidodiphosphate in the prescence of 5 mM MgCl2. 
 
The results from the VrPPase experiments showed a change in fluorescence signal linked 
to the titration of IDP (Figure 5.4). The maximum change in fluorescence signal was 
determined to be around 8 %, with a Kd value of 6.9 µM, around the same level previously 
identified for R. rubrum M-PPase (Baykov et al., 1993).   
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Figure 5.4: Effect of IDP concentration on ANS Fluorescence in VrPPase 
Percentage of fluorescence quenching of VrPPase against biologically relevant concentrations of 
imidodiphosphate in the prescence of 5 mM MgCl2. 
 
5.2.3. Summary of Tryptophan Fluorescence Results 
In M-PPases, the largest predicted conformational change was the initial substrate 
binding and closure of loop 5-6. The initial fluorescence experiments were carried out to 
see if this conformational change could be detected through measurements of tryptophan 
fluorescence upon binding of the inhibitor, IDP. The maximal change in fluorescence 
observed was on the borderline required to gain a clear signal above background during 
stopped-flow experiments. TmPPase and PaPPase would not be suitable for future 
fluorescence experiments due to the weak or absent change in fluorescence signal, but 
VrPPase showed a change of 8 %, which might allow for stopped-flow fluorescence 
analysis. Due to time constraints, the stopped-flow experiments could not be carried out 
as part of this project.  However, the VrPPase sample represents the best opportunity of 
the three proteins tested, to see conformational changes occurring using the stopped-flow 
fluorimeter.  These future experiments would involve titrations of PPi to see if multiple 
conformations could be detected. If so, it would then be possible to start assigning these 
to known catalytic states using kinetic information to generate a detailed model of the 
catalytic cycle, supplementing currently available structural information. 
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5.3. Nanion SURFE2R Experiments to Study Proton Pumping in M-PPases 
The SURFE2R is a relatively new technique developed by Nanion Technologies 
(Germany) and is a modified form of solid-support membrane (SSM) based 
electrophysiology.  It is designed to study charged transport by proteins reconstituted into 
liposomes.  The technique works by adhering proteoliposomes to a membrane layer 
affixed to a gold sensor chip.  The experiments typically occur over a 3 second time 
period. The buffer can be rapidly switched from a control buffer to an activating buffer, 
containing the substrate or ligand of interest. The activating buffer is added at the 1 second 
time point, there is a short (~0.1 second) delay during which the buffer exchange occurs, 
substrate or ligand binds and pumping of charged molecules starts to occur into the 
liposomes. This charged pumping can be measured directly as current, an overview of the 
technique is given in Figure 2.4. 
 
These experiments were carried out on the proton-pumping VrPPase protein (purified 
protein provided by the Sun lab, Taiwan).  This was reconstituted into liposomes 
following previously described protocols used during earlier patch-clamp studies on 
VrPPase (Nakanishi et al., 2003), where the PPi-induced ion pumping signal was 
observed, that was inhibited by IDP. It was hoped that the SURFE2R technique would be 
a less complicated alternative to study ion pumping in M-PPases, allowing us to compare 
kinetic data under different buffer conditions or using different mutants of important ion 
pumping residues. Initial experiments involved testing VrPPase on the system to see if a 
proton-specific signal could be observed. 
5.3.1. Proton Pumping Studies of VrPPase 
5.3.1.1. Initial Characterisation of the Proton Pumping Signal in VrPPase 
Initial experiments were performed to characterise VrPPase on the SURFE2R, using the 
PPi substrate to see if a signal could be generated.  Results were calculated as a change in 
current measured as the subtraction of the maximal peak, obtained from proton pumping, 
from the baseline prior to activating buffer addition.  K4PPi was used in the first instance 
and a change of current of 3.13 nA (+/- 0.39 nA) was detected when it was added at 50 
µM to the activating buffer (Figure 5.5). Variants of the substrate, such as Na4PPi, yielded 
a change in signal of 2.87 nA (+/- 0.4 nA), which showed no statistically significant 
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difference to K4PPi using an unpaired T-test (Figure 5.12). This showed that the 
accompanying cation was not important for activity (Figure 5.5)  
 
 
Figure 5.5: Effect of Substrate Type on Proton Pumping in VrPPase Proteoliposomes. 
Initial SURFE2R results showing current over time following addition of the activating buffer at 1 second, 
containing either K4PPi or Na4PPi, and return to control buffer at the 2 second time point. 
 
In addition to the experiments with PPi in the activating buffer, control experiments were 
carried out with Pi-containing compounds or water in the activating buffer.  The addition 
of equal volumes of water to the activating buffer yielded no signal, implying the signal 
in the main experiment was due to a PPi-induced effect on the protein and not due to any 
kind of signal generated by the transition of charged molecules across the sensor during 
the buffer exchange.  The use of Pi in the activating buffer generated a much smaller 
change in current of 0.067 nA (+/- 0.03 nA), significantly below that seen for even the 
lowest concentrations of PPi tested (Figure 5.6, Figure 5.12). This represents the 
background signal, accounting for any potential current generated via the buffer exchange 
step (movement of charged molecules).  This signal does not represent proton pumping 
as this does not occur during binding of Pi to the active site. The crystal structures show 
that Pi can induce a closed conformational state, making it a good negative control for 
these experiments (Kellosalo et al., 2012).  Moreover, the phosphate was added at 4 x the 
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maximal concentration of PPi used to ensure that this background effect was accounted 
for.   
 
Figure 5.6: Confirmation of Proton Pumping Signal in VrPPase Proteoliposomes. 
SURFE2R results showing current over time following the addition of (a) increasing concentrations of 
K4PPi substrate to VrPPase proteoliposome samples, (b) substrate and inhibitor to empty liposome 
samples, (c) K4PPi substrate with and without the protonophore, CCCP and (d) K4PPi with and without the 
inhibitor, etidronate.  All compounds were added to the activating buffer and injected into the system at 1 
second, control buffer was returned to the system at the 2 second timepoint. Phosphate control samples 
substituted substrate in the activating buffer of (a), (b) and (c). 
 
Additional control experiments were also performed on sensors containing empty 
liposomes.  Experiments were run with PPi, Pi and water and no signal was observed, 
even with 100 µM PPi (Figure 5.6b).  This shows that the signal seen in the main 
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experiments was not only a PPi-specific signal, but also a protein-specific signal, since 
the PPi-only experiments did not yield any current in the absence of protein.  The next 
step was to verify that the signal produced was due to proton pumping and not any other 
PPi-induced effect on the protein.  To achieve this, several ionophores were used. These 
compounds dissipate the membrane potential by allowing specific ions to pass across the 
membrane.  The initial compound used was gramicidin, which completely dissipates the 
membrane potential by allowing the passage of different cations across the membrane.  
Experiments were also repeated with a proton-specific ionophore, Carbonyl cyanide m-
chlorophenyl hydrazine (CCCP), in place of gramicidin. 
 
The ionophores were added to a final concentration of 10 µM to all buffers during the 
experiment and the resulting signal caused by the addition of PPi was significantly 
reduced from 3.13 nA (+/- 0.38 nA) to 0.65 nA (+/- 0.01 nA) (Figure 5.12), but not 
abolished (Figure 5.6c). This might be caused by the rate of proton pumping exceeding 
the rate of proton leakage from the liposomes, generating a signal despite the presence of 
the protonophore in the membrane.  These experiments show that the signal is indeed due 
to cation pumping and not due to the effects of charged residues moving during 
conformational changes or due to signal generated by the effect of adding charged 
molecules during buffer exchange. These results show conclusively that the observed 
signal is generated by proton pumping and not any other indirect effect of PPi binding to 
the protein. 
 
In SURFE2R experiments, small differences in the ionic balance of the two buffers can 
generate background signal that would drown out weaker signals.  Therefore, my early 
experiments on VrPPase sought to test different buffering conditions. These included the 
addition of K2HPi to the control buffer at concentrations that would ionically balance the 
activating buffer (e.g. 100 mM K2HPi to 50 mM K4PPi). The addition of K2HPi in the 
control buffer leads to a weaker signal of around 2.5 nA instead of 3.0 nA seen when no 
buffering component is added (Figure 5.7). One possible explanation is that the lack of a 
buffering compound leads to a 0.5 nA increase in signal generated solely by the binding 
of the charged PPi molecule to the active site of the protein.  It could also represent an 
inhibitory effect of the phosphate on the activity of the protein, as phosphate would 
compete with pyrophosphate for binding in the active site. Results from the SURFE2R 
experiments do not represent specific activity of the protein as the concentration of 
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correctly orientated protein cannot be quantified. Therefore, it did not matter which 
method was used for future experiments, as long as it was kept consistent. 
 
 
Figure 5.7: Ionic Balance Test of SURFE2R Buffers. 
ionic balancing experiments for the SURFE2R results showing current over time following the addition of 
K4PPi in the activating buffer and samples with and without K2HPi in the non-activating buffer.  Non-
activating buffer was added at the 0 second timepoint, followed by activating buffer after 1 second and 
back to non-activating buffer at the 2 second timepoint. 
 
5.3.1.2. Proton Pumping Studies using Inhibitors of M-PPases 
The SURFE2R system had been tested and there was strong evidence to suggest that 
proton pumping could be observed via the addition of the PPi substrate to the activating 
buffer. Follow-up experiments were carried out using various pyrophosphate-analogues 
and inhibitors of the enzyme in place of the PPi substrate in the activating buffer to see 
what effect these would have on proton-pumping. The first inhibitor tested was 
imidodiphosphate (IDP), which had been used for the crystallisation experiments.  A 
change in signal of 0.29 nA (+/- 0.06 nA) was observed following the addition of 50 µM 
IDP (Figure 5.8), which represented a statistically significant difference to both the K4PPi 
(P = and K2HPO4 samples (Figure 5.12). This was a repeatable signal that was observed 
across multiple sensor chips. Background signals generated by the substitution of IDP 
with K2HPi generated a signal of only 0.067 nA (+/- 0.03 nA) (Figure 5.8). The addition 
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of gramicidin or CCCP to the IDP-containing buffer reduced the signal to 0.07 nA (+/- 
0.03 nA), which was around the background level  (Figure 5.8, Figure 5.10, Figure 5.13). 
Addition of etidronate alongside IDP in the activating buffer led to a reduction in the 
signal generated (Figure 5.9). Moreover, no signal was generated when the same 
concentration of IDP was used in the activation buffer on the no-protein control (Figure 
5.6b). This confirms that the signal generated was also due to proton-pumping and not 
any indirect effect such as buffer exchange or the movement of charged residues of the 
protein during conformational changes.  Since IDP is non-hydrolysable, this provides 
preliminary evidence to suggest that proton pumping is occurring prior to hydrolysis in 
the catalytic cycle. In order to test this hypothesis, additional inhibitors were tested (Table 
5.1). 
 
Figure 5.8: Inhibitor Studies with IDP and etidronate on Proton Pumping in VrPPase Proteoliposomes. 
SURFE2R results from inhibitor experiments showing current over time following the addition of (a) IDP 
with and without gramicidin, (b) etidronate with and without gramicidin, all compounds were added to the 
activating buffer and injected into the system at 1 second.
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Table 5.1: Pyrophosphate and Analogues Used during SURFE2R Experiments. 
Name Formula Structure 
Pyrophosphate (PPi) O3P-O-PO3  
Imidodiphosphate 
(IDP) 
O3P-NH-PO3  
1-hydroxyethane 1,1-
diphosphonic acid 
(etidronate) 
O3P-C(CH3)(OH)-PO3  
Methylene 
diphosphonate 
(MEDP) 
O3P-CH2-PO3  
 
The inhibitor 1-hydroxyethane 1,1-diphosphonic acid (HEDP), also known as etidronate 
(Table 5.1), was also tested in the activating buffer. This inhibitor contains a methyl and 
hydroxyl group off the central atom joining the two phosphates.  During the experiments, 
no signal was seen above background, in the presence or absence of ionophores (Figure 
5.8). The compound was modelled into the IDP-containing crystal structure of VrPPase 
in place of the IDP (Figure 5.11). The methyl and hydroxyl groups in etidronate would 
form steric clashes with D15.61 and one of the magnesium ions required for the binding of 
the substrate.  In this model, it would not be possible for the 5-6 loop to close correctly 
over the active site.  If the loop cannot close then the enzyme would be completely 
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inactive, as the catalytic cycle would not be able to proceed in order to prevent the 
backflow of ions. 
 
Figure 5.9: Effect of Etidronate on IDP-Induced Proton Pumping in VrPPase Proteoliposomes. 
SURFE2R results from inhibitor experiments showing current over time following the addition of IDP with 
and without etidronate. All compounds were added to the activating buffer and injected into the system at 
1 second and returned to the control buffer at the 2 second timepoint. 
 
 
Figure 5.10: Effect of CCCP on Inhibitor-Induced Proton Pumping in VrPPase Proteoliposomes. 
SURFE2R results from inhibitor experiments showing current over time following the addition of IDP with 
and without the protonophore, CCCP and (e) MEDP with and without the protonophore, CCCP.  All 
compounds were added to the activating buffer and injected into the system at 1 second, control buffer was 
returned at the 2 second timepoint.. 
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Methylene diphosphonate (MEDP) is another inhibitor of M-PPases that is structurally 
very similar to IDP and PPi, and contained a carbon atom linking the two phosphate 
molecules. This inhibitor was also tested in place of PPi in the activating buffer of the 
SURFE2R experiments on VrPPase. This compound also produced a change in signal of 
0.24 nA (+/- 0.06 nA), which is similar to the IDP-induced proton pumping signal (Figure 
5.13). signal when added as part of the activating buffer and again this signal was 
dissipated after adding CCCP or gramicidin (Figure 5.10).  Since IDP and MEDP are 
structurally similar to PPi (Table 5.1), they can still bind correctly at the active site (as 
seen in the crystal structure for IDP). This means loop 5-6 can still pack in over the active 
site to seal the channel, allowing the enzyme to proceed through the catalytic cycle up 
until the point of hydrolysis, at which point it will stall.  These results therefore provide 
the first biochemical data to help in updating the catalytic cycle model, specifically 
providing information of the order of events during the catalytic cycle.  The evidence of 
proton pumping in the presence of the non-hydrolysable inhibitor implies that proton-
pumping is the first mechanism to occur, followed by hydrolysis of the substrate. The 
specific mechanism that couples ion pumping to hydrolysis cannot be ascertained from 
this information, but the information was invaluable in updating the model of the catalytic 
cycle, discussed in Chapter 6. 
 
Figure 5.11: Model of Etidronate in the Hydrolytic Centre. 
Modelled binding of the M-PPase inhibitor, etidronate in the active site of VrPPase.  Inhibitor was 
modelled in place of the IDP molecule from the VrPPase:Mg5IDP crystal structure (PDB ID: 4A01). 
Carbon atoms are shown in yellow, magnesium ions in green, water molecules in red and phosphorous in 
orange. Figure reused with permission (Supplementary figure 8, (K. M. Li et al., 2016)) 
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Figure 5.12: Effect of Different Compounds on Proton Pumping by VrPPase. 
Effect of the substrate and various inhibitors on the proton pumping signal generated in VrPPase 
following their respective addition to the activating buffer at the 1 second time point of SURFE2R 
experiments.  The change in current is determined by subtracting the maximum peak value obtained from 
proton pumping measurements from the baseline prior to addition of the activating buffer.  All results are 
from multiple replicates carried out on multiple sensor chips and error bars denote standard deviation. 
 
Figure 5.13: Effect of Inhibitors on the Proton Pumping Signal of VrPPase. 
Effect of various inhibitors on the proton pumping signal generated in VrPPase following their respective 
addition to the activating buffer at the 1 second time point of SURFE2R experiments.  The change in 
current is determined by subtracting the maximum peak value obtained from proton pumping 
measurements from the baseline prior to addition of the activating buffer.  All results are from multiple 
replicates carried out on multiple sensor chips and error bars denote standard deviation. 
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5.4. Structural Comparison of M-PPases 
5.4.1. Comparing all Crystal Structures of TmPPase and VrPPase 
5.4.1.1. Investigating Hydrogen Bonding Patterns Between Catalytic States 
Investigations were carried out between all the available crystal structures of M-PPases 
to study the differences and changes between different catalytic states. The TmPPase and 
VrPPase structures were analysed to investigate changes in the hydrogen bonding patterns 
and in the helical geometry.  The webserver, HBplot (Bikadi et al., 2007), identifies all 
the hydrogen bonding partners by analysing distances between atoms of a PDB structure. 
 
At lower resolutions (> 3.0 Å), assignment of hydrogen bonding patterns may not be 
accurate, as atomic positions can vary quite significantly. However, the three main 
structures tested were the TmPPase:CaMg structure (2.6 Å), VrPPase:Mg5IDP (2.35 Å) 
and TmPPase:Mg5IDP (3.5 Å).  Assignment of hydrogen bonding patterns could be 
trusted for the TmPPase:CaMg and the VrPPase:Mg5IDP structure as these were at a 
higher resolution. Structural comparisons between TmPPase:Mg5IDP and 
VrPPase:Mg5IDP (Chapter 4) have also shown that helices and key residue side chains 
were in highly similar positions, meaning that the hydrogen bonding patterns of 
TmPPase:Mg5IDP could also be trusted. 
 
The Hbplot server was used on all the M-PPase structures and showed how the hydrogen 
bonding pattern changed between different states of the catalytic cycle, most notably in 
helix 6. In the TmPPase:CaMg (resting state) structure, the region between N6.44-V6.48 
formed a small section of π-helix, differing from the standard a-helical geometry 
elsewhere on the helix. In both of the IDP-bound structures, the geometry of this region 
had changed, now forming a standard a-helical pattern. This represents quite a significant 
change, since D6.43 has been previously linked to coordination of the water nucleophile 
responsible for hydrolysis of the substrate (Tsai et al., 2014).   
 
5.4.1.2. Investigating Changes in Helical Conformations Using BENDIX 
A plugin for the Visual Molecular Dynamics (VMD) software (Dahl et al., 2012), Bendix, 
was used to further study the geometry of helix 6. This software calculates the degree of 
curvature in each helix of a protein from the Ca trace. In the resting state structure of 
TmPPase, the region around D6.43 was highly distorted with a bend angle of 22˚ (next 
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highest peak 14˚) (Figure 5.14), dropping to 11˚ in the IDP-bound structure and remaining 
at this level in both product-bound structures.  In VrPPase, the available structures (IDP 
and product-bound) all show bend angles around 8-12˚, in line with the TmPPase 
structures. The absence of a resting state structure for VrPPase limits the comparisons 
that can be made just for the VrPPase structures, but the similarities between the 
TmPPase:Mg5IDP and VrPPase:Mg5IDP structures does not rule out the possibility that 
the region around D6.43 undergoes a similar change in VrPPase as well.  This decrease in 
helical curvature implies that there is a release of torsional strain energy in this region of 
helix 6 upon substrate binding, causing the helix to adopt a more energetically favourable 
conformation.  To try to understand this change, additional analysis was carried out on 
the structures, paying close attention to the region of helix 6 around D6.43. 
 
Figure 5.14: Analysis of Helix 6 Curvature Between Catalytic States of M-Ppases. 
BENDIX results for structural analysis of helix 6 between (a) all four states of TmPPase from current 
crystal structures and (b) resting state and IDP-bound state of TmPPase alongside IDP-bound and 
product-bound states of VrPPase. All graphs depict the degree of helix curvature against the residue 
number in helix 6. 
 
5.4.1.3. Structural Comparisons to Investigate Mechanisms of the Catalytic 
Cycle 
In previous studies, differences had been noted between TmPPase resting state structure 
and the IDP-bound structure of VrPPase. In particular, a “downwards” motion of helix 
12 upon substrate binding, leading to the breakage of a set of interactions at the base of 
the hydrolytic centre (Tsai et al., 2014). However, since each structure was from a 
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different species and type of M-PPase (Na+-PPase and H+-PPase), it was not known how 
significant these differences were.  The newly solved TmPPase:Mg5IDP structure 
provides the means for an accurate comparison between the resting state and substrate-
bound states from the same type of M-PPase. Comparison of both TmPPase structures 
shows that the 2 Å “downwards” motion of helix 12 still occurs upon substrate binding 
(Figure 5.15).  This is likely due to the presence of several aspartate residues on helix 12 
at the active site, which move to interact with the substrate or inhibitor upon binding, 
drawing the entire helix down by around 2 Å. Moreover, the TmPPase:Mg5IDP structure 
confirms that the movement of helix 12 breaks the interactions between K12.50 and D6.43 
at the base of the substrate-binding pocket in the hydrolytic centre.  
 
In TmPPase:CaMg, K12.50 interacts with D6.43 and D16.39 on helices 6 and 16 (Figure 
5.15b), the same can be seen in VrPPase:Mg3Pi2 (Figure 5.15d). Upon substrate binding, 
the motion of helix 12 moved the lysine out of interaction range with D6.43 (Figure 5.15).  
This led to a conformational change in D6.43, which has flipped around towards the base 
of the active site and the bound substrate. This motion is also seen in VrPPase:Mg5IDP, 
where the resolution was sufficient to resolve water molecules in the channel and around 
the bound substrate. In VrPPase:Mg5IDP, D6.43 and D16.39 both interact with a water 
molecule that is in turn interacting with the bound substrate (Figure 5.15d).  This 
represents an important aspect of the hydrolytic mechanism as this water molecule was 
previously proposed as the nucleophile that hydrolyses the substrate. Both D6.43 and D16.39 
are required for activity, with D6.43G mutations generating a completely inactive enzyme 
in Streptomyces coelicolor M-PPase (Hirono et al., 2007).  As such, the motion of helix 
12, which allows D6.43 to flip round and form interactions with the substrate, appears to 
be a vital mechanism to prepare the enzyme for hydrolysis to occur. 
 
The altered conformation of D6.43 upon substrate binding potentially explains the 
mechanistic basis behind substrate specificity in these proteins.  As shown in the 
SURFE2R experiments, the structure of the substrate or inhibitor is vital to the closing of 
the 5-6 loop. Only the substrate or structurally similar inhibitors, such as IDP and MEDP, 
were able to bind and allow the protein to continue to pump protons, implying the 5-6 
loop had closed. This could be explained by the resulting movement of helix 12, which 
would only occur if the substrate had bound correctly.  Without this movement, the region 
of helix around D6.43 would not rotate around from π-helical geometry to a-helical 
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geometry, D6.43 would not coordinate the nucleophilic water and hydrolysis would 
therefore not be possible. 
 
Figure 5.15: Structural Analysis of Hydrolytic Mechanisms in M-Ppases. 
Structural comparisons between (a) helix 12 conformations of IDP-bound (blue), resting state (grey) and 
WO4-bound (beige) structures of TmPPase (b) conformational states of D6.43 in TmPPase:Mg5IDP (blue) 
and TmPPase resting state (grey), (c) helix 12 conformations of VrPPase:Mg5IDP (yellow) and 
VrPPase:2Pi (orange) and (d) conformational states of D6.43 in VrPPase:Mg5IDP (yellow) and 
VrPPase:Mg5Pi2 (orange). Water molecules are displayed as red spheres. 
 
The TmPPase:Mg5IDP and VrPPase:Mg5IDP structures, are globally very similar.  They 
both represent the substrate-bound state of the catalytic cycle, in which the 5-6 loop is 
positioned above the hydrolytic centre sealing the cytoplasmic side of the channel.  In 
both structures, there is a high degree of sequence conservation at the hydrolytic centre, 
with similar patterns of coordination seen for the Mg5IDP complex (Figure 5.16). In 
VrPPase:Mg5IDP, a potassium ion can be found in the hydrolytic centre along with water 
molecules that help to coordinate the Mg5IDP complex. Given the positions of the 
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residues and Mg5IDP complex in TmPPase:Mg5IDP compared with those in 
VrPPase:Mg5IDP, it is likely K+ and the water molecules are present, but not observed at 
this resolution.  
 
Figure 5.16: Structural Analysis of Hydrolytic Centre in M-PPases. 
Structural comparisons of the hydrolytic centre showing (a) the interactions with the substrate, nucleophilic 
water and D6.43 and (b) interactions between the substrate and residues of loop 5-6 between 
TmPPase:Mg5IDP (blue carbon atoms, orange IDP and green Mg2+) and VrPPase:Mg5IDP (yellow carbon 
atoms, yellow IDP and pink Mg2+). Water molecules are displayed as red spheres. 
 
The similarity between the TmPPase and VrPPase structures was expected as the 
hydrolytic machinery was predicted to be the same in all M-PPases, despite differences 
in the type of M-PPase (H+ or Na+-pumping). VrPPase is a potassium-dependent H+-
PPase whereas the TmPPase is a K+-dependent Na+-PPase, with notable differences at 
the ion gate. A glutamate residue is located one helical turn down on VrPPase (E6.57) 
compared with TmPPase (E6.53) (Figure 5.17).  The position of this glutamate was initially 
believed to play a role in the ion selectivity at the ion gate (Tsai et al., 2014), being located 
at E6.57 for all H+-PPases and at E6.53 for all Na+-PPases. However, analysis of the various 
M-PPase sequences revealed that K+-independent H+-PPases (such as PaPPase) also had 
the glutamate located at position E6.53, the same as the Na+-PPases. 
 
In the resting state TmPPase structure the ion gate is formed from interaction between 
K16.50 and D6.50, E6.53 and S6.54. However, this gate structure was different in the 
TmPPase:IDP structure (Figure 5.17) as K16.50 has moved down and become less ordered, 
with no electron density visible for the NH3+ group.  In its place, a sodium ion was bound 
around the ion gate (Figure 5.17), occupying the position of the NH3+ group of K16.50. 
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E6.53 appears to form part of the sodium binding site, coordinating Na+ alongside D6.50, 
S6.54 and D/N16.46 (Aspartate residue in TmPPase, but an asparagine in almost all other M-
PPases). Previous mutagenesis experiments had linked D6.50 to sodium binding and the 
structural information obtained from the TmPPase:IDP structure seems to back up this 
evidence.  Since TmPPase is an Na+-PPase, this sodium represents the ion bound at the 
ion gate prior to being pumped across the membrane.  As a result of this information, 
residues surrounding D6.57 in the VrPPase structure were checked to see if there was 
evidence of proton binding around this region. 
 
In VrPPase:Mg5IDP, E6.57 has moved away from K16.50 when compared with the product-
bound structure (VrPPase:Mg3Pi), in which K16.50 directly interacts with E6.57 (Figure 
5.17b). This glutamate may have become protonated, leading to a loss of interactions with 
the NH3+ group of K16.50 and instead forming new interactions with the backbone carbonyl 
of K16.50 (Figure 5.17a).  The difference between the two IDP-bound structures is due to 
cation specificity, with the charged sodium ion located above K16.50 at the ion gate in 
TmPPase:Mg5IDP and below K16.50 in VrPPase:Mg5IDP. These structures show two 
subtly distinct sub-states in which the ion or proton is passing through the ion gate prior 
to being pumped.  These structures provide an interesting insight into the mechanism of 
ion translocation, particularly through the ion gate, and helps to provide more information 
on specific mechanisms occurring during the overall catalytic cycle that allowed for the 
model of the catalytic cycle to be updated (Chapter 6). 
 
Figure 5.17: Structural Analysis of the Ion Gate of M-PPases. 
Structural comparison of the ion gate region of (a) TmPPase:Mg5IDP (blue) alongside VrPPase:Mg5IDP 
(yellow) and (b) TmPPase resting state (grey) and VrPPase:Mg4PI2 (orange). 
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5.5. Summary of Biochemical and Structural analyses of M-PPases 
Through the work in this chapter, I was able to analyse all available structures of M-
PPases, both those from the current study and those solved previously.  By comparing the 
structures from different catalytic states, I was able to find specific information about the 
mechanisms of M-PPases, particularly relating to the hydrolytic and ion pumping 
machinery. I also collected biochemical data from tryptophan fluorescence and ion 
pumping experiments, providing further evidence to back up the structural data and help 
in the generation of the complete catalytic cycle model that will be discussed in chapter 
6. 
 
The ANS fluorescence data obtained showed the usefulness of this technique for studying 
conformational changes, but was not without its issues.  The original data for the 
TmPPase protein showed a change in fluorescence signal with increasing inhibitor 
concentration. However, it was later determined that this change in fluorescence signal 
was generated by unfavourable interactions between magnesium and high concentrations 
of inhibitor, with no change in fluorescence signal detected at biologically relevant 
concentrations of IDP.  When tested under optimal conditions, there was a clear change 
in fluorescence signal for both the VrPPase and PaPPase proteins with increasing 
concentrations of IDP. The VrPPase provided the greatest change in fluorescence, up to 
10 %, which means it would be suitable for taking forward to stopped-flow experiments 
to measure conformational changes in real-time. This will be work carried out as part of 
the future directions of the project. 
 
The SURFE2R experiments were used to study ion pumping in VrPPase. The protein 
seemed to work well on the system, producing a repeatable signal up to 3 nA in the 
presence of substrate.  Controls with no protein, without substrate and in the presence of 
ionophores confirmed that the signal was due to proton pumping and not an artefact of 
the technique itself. It was possible to detect a signal above background levels by 
substituting the substrate for various analogues, IDP and MEDP, which are both 
structurally similar to the pyrophosphate substrate. Inversely, etidronate, which contains 
an extra methyl and hydroxyl group, did not produce a signal above background.  
Ionophores were used to confirm that this signal was caused by proton pumping and 
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provided preliminary data to suggest that ion pumping occurs before hydrolysis during 
the catalytic cycle.  
 
Analysis of the current M-PPase crystal structures also highlighted several interesting 
features that provided insight into the mechanisms of these proteins.  The main 
mechanism identified involves the priming of the enzyme for hydrolysis, which occurred 
upon substrate binding via the downwards motion of helix 12 by around 2 Å.  This 
removed interactions between K12.50 and D6.43 at the base of the active site, released 
torsional strain energy around a single turn of helix 6 and changed the hydrogen bonding 
pattern around D6.43 from π-helical geometry to a-helical geometry. In doing so, the 
position of D6.43 changed to coordinate the nucleophilic water alongside D16.43.  In this 
way, the binding of substrate can prime the enzyme for hydrolysis. This mechanism also 
accounts for substrate specificity and provides an explanation of how this might be 
achieved in M-PPases.   
 
The structural analysis also identified differences between the two substrate-bound states 
from VrPPase and TmPPase. There was evidence to suggest that a sodium ion was bound 
at the ion gate in TmPPase:Mg5IDP, where it had disrupted the ion gate architecture by 
displacing K16.50. It was proposed that E6.57 in VrPPase:Mg5IDP had become protonated, 
meaning the ion being pumped is located above K16.50 in TmPPase:Mg5IDP, but below 
K16.50 in VrPPase:Mg5IDP.  These structures represent two distinct sub-states in which 
the ion is transitioning through the ion gate prior to being pumped.  Using all of this 
information, it is possible to generate a model of the complete catalytic cycle, which will 
be discussed in greater detail in chapter 6.
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6 Chapter 6: 
Overall Conclusions, 
Discussion and Future 
Directions  
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6.1. Discussion and Key Findings from the Project 
Overall, I have been able to achieve the aims of my project, to update the model of the 
complete catalytic cycle of M-PPases using new structural and biochemical information.  
As shown in chapter 3, both TmPPase and PaPPase were expressed in yeast following 
modified versions of the original “hot-solve” solubilisation and purification method 
(López-Marqués et al., 2005).  TmPPase was expressed using the modified protocol 
from previous crystallisation experiments (Kellosalo et al., 2011), but PaPPase required 
optimisation to obtain sufficient yields of pure protein for crystallisation experiments.  
Several constructs were tested, based on the presence of linkers between the His-tag and 
protein, to test the binding and elution of the protein from the Ni-NTA column, and 
signal sequences from Trypanosoma cruzi, to try and improve the yield. Ultimately, the 
presence of a “GG” linker between the His-tag and protein improved the yield and so 
was used for all subsequent experiments.  The use of selective SCD-Leu media showed 
the highest level of expression, as non-selective media led to the removal or inactivation 
of the plasmid from the yeast during expression.  Solubilisation and purification 
conditions were also optimised, based on the differing growth and activity temperatures 
of PaPPase (81 ˚C) compared with TmPPase (71 ˚C).   
 
Crystallisation experiments were carried out using PaPPase purified in DM, as this had 
yielded the best crystal in previous experiments (Kellosalo et al., 2013). Initial crystal 
hits diffracted to around 6.5 Å, providing only limited information about the 
arrangement of helices in the dimer.  Screening different detergents at different 
concentrations, during purification of PaPPase did not improve the diffraction of these 
crystals.  Initial dehydration experiments also did not improve the diffraction of the 
crystals. However, further dehydration experiments, in which the crystals were 
dehydrated in the loops during harvesting and freezing, yielded diffraction data to 
around 4.3 Å.  Using this technique, it was possible to reliably obtain crystals 
diffracting to between 4.2 and 4.5 Å.  These data provided useful information about the 
helical conformations and placement of some bulkier side chains was possible (Figure 
4.9). However, key information about the mechanism of potassium independence, 
K12.46, was not resolvable as there was no electron density for the side chain of this 
residue.   
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During early rounds of data processing in XDS, I noticed that the first few hundred 
images from each dataset had data going to a higher resolution (~ 3.8 Å). However, 
obtaining this higher resolution data led to poor completeness and redundancies for each 
individual dataset.  Since each dataset was in the same space group with very similar 
unit cell parameters, these seven datasets were processed using only the first 100-400 
diffraction images (10-40˚ rotation) and were then merged to obtain a single data file.  
The resulting dataset was at 3.8 Å resolution and the electron density maps provided 
much more information.  The inhibitor IDP could be seen in the active site, with density 
to support many of the complexed magnesium ions (Figure 4.12).  There was also 
density to fit more side chains compared with the 4.3 Å datasets (Figure 4.11) and there 
was also limited density to suggest a conformation for K12.46, which has been linked to 
the K+-independence mechanism of M-PPases (Figure 4.16).   
 
The new PaPPase:Mg5IDP structure also showed many similarities to the IDP-bound 
structures from VrPPase and TmPPase, solved previously and in the current study, 
respectively.  There were several differences in helical positions in PaPPase:Mg5IDP, 
including helices 13 and 14, which suggests a possible mechanism for K+-independence 
alongside the role of K12.46 (Figure 4.14). Moreover, mutational studies in PaPPase 
revealed that mutation of both K12.46 and T12.49 to alanine could generate a K+-dependent 
variant (Figure 3.15).  These findings differ from previous mutagenesis experiments in 
which a K+-dependent M-PPase from C. hydrogenoformans could be mutated into a 
potassium-independent variant solely via A12.46K mutation, with A12.49T only having an 
effect on the affinity for K+ (Belogurov & Lahti, 2002). PaPPase remained K+-
independent with only the K12.46A mutation, implying that either Na+ can substitute for 
K+ in H+-PPases and not just in Na+-PPases or that the mechanism of K+-dependence is 
more complicated than previously thought, potentially involving more residues than 
K12.46.  The resolution of the PaPPase:Mg5IDP structure provides some useful structural 
information to start to identify these other factors, but higher resolution information and 
structures of these mutants will be needed to fully confirm these findings. 
 
The new TmPPase:Mg5IDP and TmPPase:MgWO4 structures represented unique 
catalytic states of TmPPase and provide complementary information to the previously 
solved structures of TmPPase and VrPPase.  Comparisons between the 
TmPPase:Mg5IDP and VrPPase:Mg5IDP structures reveals a high degree of similarity 
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between the helices and side chain conformations of many of the key residues, with the 
closure of the 5-6 loop visible in both structures.  The composition of the hydrolytic 
centre, including bound Mg5IDP, is highly similar and provides evidence to suggest that 
the hydrolytic mechanism is identical in both proteins, despite differences in species and 
cation specificity (Na+ and H+) (Figure 4.3).  The only notable differences exist at the 
ion gate, in which a sodium ion is bound above K16.50 in TmPPase:Mg5IDP, with the 
binding site located around the previously identified D6.50 residue and E6.53 (Figures 
4.5).  This glutamate is located one helical turn down in VrPPase (E6.57) and in the IDP-
bound structure may be protonated, meaning the cation is located below K16.50.  This 
represents a subtle shift in the cation position across the ion gate and shows that these 
two structures represent two distinct sub-states of the substrate-bound state of M-PPases 
(Figure 4.6).  The TmPPase:MgWO4 structure represents an analogue of the single-
product bound state and is the last major state of the catalytic cycle before the return to 
the resting state.  The conformations of the helices are more similar to the resting state 
structure than to the substrate-bound or two-product bound states, with the 5-6 loop 
being highly disordered. 
 
To complement the structural data, I was also able to collect biochemical data in order 
to study conformational changes in various M-PPases. I was trying to identify different 
catalytic states, backing up the structural data on existing states and identifying 
previously unknown states, such as the high-energy transition state.  My studies on the 
tryptophan fluorescence of PaPPase (Figure 5.6) and VrPPase (Figure 5.7) revealed that 
conformational changes could be detected following the titration of IDP.  The positions 
of tryptophan residues in TmPPase meant that changes in conformation could not be 
detected using this method as they were in regions of the proteins that do not undergo 
significant conformational changes between the TmPPase:CaMg and TmPPase:Mg5IDP 
structures (Figure 5.5). These represent the largest known conformational change during 
the catalytic cycle.   
 
The change in fluorescence signal detected for PaPPase was around 5 %, which is too 
small to take forward to stopped-flow experiments as this signal would likely be lost to 
background noise. However, the signal obtained for VrPPase was around 8-10 %, which 
makes it suitable for future stopped-flow fluorescence experiments. Due to time 
constraints, these experiments could not be carried out as part of this project. However, 
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these would involve taking real-time measurements in the millisecond range using 
titrations of the PPi substrate.  The hope would be to try and map conformational 
changes to different states of the catalytic cycle and potentially identify new states that 
could not be identified through standard structural biology techniques. This will be 
discussed in more detail in section 6.2.2. 
 
To investigate ion pumping in M-PPases and try to understand how this fits into the 
model of the catalytic cycle, experiments were carried out on VrPPase using the Nanion 
SURFE2R N1. Initial experiments using the PPi substrate revealed a proton-specific 
signal up to 3 nA when 50 µM PPi was added to the activating buffer during the 
experiments (Figure 5.9).  When PPi was replaced with a variety of non-hydrolysable 
inhibitors in the activating buffer, a proton-specific signal was still observed.  The 
inhibitors, IDP and MEDP, produced a signal of 0.4 nA, significantly above the 
background signal when phosphate was used (Figures 5.11 & 5.13).  Both of these 
inhibitors are close structural analogues of PPi (Table 5.1) and would therefore allow 
loop 5-6 to close over the active site.  The use of the ionophores, gramicidin and CCCP, 
reduced this signal to the background level of 0.1 nA, implying the signal was generated 
via proton pumping and not any other factor (Figure 5.13).   Inversely, the inhibitor, 
etidronate, when added to the activating buffer in place of PPi, did not produce a signal 
(Figure 5.11). This inhibitor has structural differences from PPi, with the addition of a 
hydroxyl and methyl group that would form a steric clash with several key residues and 
magnesium ions in the active site, preventing correct closure of the 5-6 loop (Figure 
5.14).  Overall, these experiments provided preliminary evidence that ion pumping 
precedes hydrolysis during the catalytic cycle as proton pumping was observed in the 
presence of non-hydrolysable inhibitors.  
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6.1.1 Updated Model of the Complete Catalytic Cycle 
Using all the available data, both from the previous crystal structures and from the 
current studies (structural and biochemical), it has been possible to create a complete 
model of the catalytic cycle.  Several attempts had previously been made to do so, using 
the limited structural data available at the time.  Three main mechanisms had been 
proposed for the catalytic cycle (Figure 1.11).  The first was the “binding-change” 
mechanism, in which the binding of substrate drives a series of conformational changes 
that lead to ion pumping, the resulting charge difference between the ion gate and 
hydrolytic centre then drives hydrolysis followed by sequential product release 
(Kellosalo et al., 2012).  In the second mechanism, the substrate is hydrolysed upon 
binding, with the resulting conformational changes from this leading to ion pumping via 
a Grotthuss chain mechanism (Lin et al., 2012).  The key difference between these 
mechanisms is the order of ion pumping and hydrolysis upon substrate binding.  The 
third mechanism has substrate hydrolysis occurring first, with the resulting proton being 
directly pumped (Baykov et al., 2013).  This mechanism is unlikely to be correct as it 
does not account for sodium pumping, and the mechanism of each is predicted to be 
very similar (Tsai et al., 2014).  The evidence provided in this study backs up the 
“binding change” mechanism (Figure 1.11b), in which ion pumping precedes hydrolysis 
in the catalytic cycle.  Using all the available information, an updated model of the 
complete catalytic cycle was generated (Figure 6.1).   
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Figure 6.1: Overview of the Complete Catalytic Cycle Model for Membrane Pyrophosphatases. 
Simplified view of a generalised membrane pyrophosphatase during the catalytic cycle.  For clarity, only 
key helices and residues are shown and labelled. PDB IDs are given for previously solved structures and 
structures named in red represent structures solved as part of this project and related publication (K. M. 
Li et al., 2016). 
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The first state of this cycle is the resting state (Figure 6.1a, Figure 6.2), obtained from 
the TmPPase:CaMg  structure (PDB ID: 4AV3). In this state, the 5-6 loop is highly 
disordered and is not interacting with the hydrolytic centre, leaving the cytoplasmic side 
of the channel open.  The ion gate is closed and no cation can be observed in this 
region.  D6.43 interacts with K12.50 at the base of the hydrolytic centre and helix 6 is 
under torsional strain at this position. Substrate binding (Figure 6.1b) involves the new 
TmPPase:Mg5IDP structure.  Substrate binds at the hydrolytic centre leading to the 
closure of loop 5-6 via the interactions of E5.76 and D5.77 with the substrate complex 
(Figure 5.17).  Additionally, several aspartate residues on helix 12 start to form 
interactions with the substrate complex, leading to a downwards motion of this helix by 
around 2 Å away from the cytoplasmic side.  This movement breaks the interactions 
between D6.43 and K12.50, releasing the torsional energy in this region of helix 6 (Figure 
6.2). This changes the conformation of the helical region around D6.43 from π-helical 
geometry to a-helical geometry. This results in both D6.43 and D16.39 coordinating the 
nucleophilic water (Figure 5.16, Figure 6.2).  In doing so, the enzyme is now primed for 
hydrolysis, but another factor is needed for this to occur. The cation (Na+ or H+) has 
passed along the charged coupling funnel and is now bound at the ion gate, above K16.50   
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Figure 6.2: Overview of Substrate Binding Step of the M-PPase Catalytic Cycle. 
Substrate binding step of the M-PPase catalytic cycle showing the triggering of the “molecular 
mousetrap” following substrate binding. (a) excerpt from Figure 6.1 showing only the first two states 
representing substrate binding. (b) Bendix plot for helix 6 of TmPPase showing the degree of helix 
curvature for the four main catalytic states, including the resting state (grey) and substrate-bound state 
(blue). (c) Close-up structural view of the base of the hydrolytic centre comparing the interactions of 
K12.50 between the resting state (grey) and substrate-bound state (blue), showing the “molecular 
mousetrap” mechanism formed by D6.43. 
 
The next step in the catalytic cycle involves a subtle change in the position of the cation 
(Figure 6.1c, Figure 6.3).  The next available structure is the VrPPase:Mg5IDP (PDB 
ID: 4A01), in which the cation at the ion gate has moved from above to below K16.50.  
This represents a series of sub-states in which the cation transitions through the ion gate 
prior to being pumped.  The residues in the hydrolytic centre, including the positioning 
of the substrate complex, D6.43 and loop 5-6 are all in very similar positions between the 
two IDP-bound structures (Figure 4.3, Figure 6.3).   
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Figure 6.3: Overview of the Substrate-bound Sub-states of the M-PPase Catalytic Cycle. 
Comparison of the structural differences between the two substrate-bound structures of M-PPase. (a) 
comparison of the hydrolytic centre of the substrate-bound structures of TmPPase:Mg5IDP (blue carbon 
atoms, orange IDP and green Mg2+) and VrPPase:Mg5IDP (yellow carbon atoms, yellow IDP, pink 
Mg2+, purple K+). (b) excerpt from Figure 6.1 showing only the two substrate-bound states of M-PPases. 
(c) Overview of the TmPPase:Mg5IDP ion gate region, showing Na+ as a purple sphere, positioned above 
K16.50. (d) Overview of the VrPPase:Mg5IDP ion gate showing the possible protonated glutamate (E6.57), 
positioned below K16.50. 
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The next stage of the catalytic cycle is the high-energy transition state. It is known that 
both ion pumping and hydrolysis occur during this state, but all available structural data 
could not predict in which order these events occurred (Figure 6.1d).  No structural 
information was available for this state as it represented the gate-open state, which 
occurs at time-scales too quick to capture using standard crystallographic techniques. 
The Nanion SURFE2R data revealed that ion pumping occurs before hydrolysis during 
the catalytic cycle, providing evidence to back up the “binding change” mechanism 
(Figure 1.11b, Figure 6.4). A possible mechanism for this is via additional downwards 
motion of helix 12, leading to opening of the ion gate, cation release and immediate 
closure of the ion gate as helix 12 moves back up to prevent backflow of ions. This 
creates a charge difference between the ion gate and the hydrolytic centre, leading to a 
movement of cations down the coupling funnel to replace the lost charge at the ion gate.  
This leads to the activation of D6.43 and D16.39 at the base of the hydrolytic centre, in turn 
activating the water nucleophile and leading to hydrolytic attack on the substrate.   
 
Following substrate hydrolysis is the immediate product bound state (Figure 6.1e), in 
which the positions of the two phosphate molecules very closely matches those of the 
bound substrate, with the electrophilic phosphate positioned down towards D6.43 and 
D16.39. The overall structure is still highly similar to the substrate-bound state, with the 
only exception being the presence of the product in place of the substrate.  The next 
stages of the catalytic cycle (Figure 6.1e-g) involve opening of the 5-6 loop and 
sequential product release.  The first stage of this involves the dilation of the helices 
around the cytoplasmic side of the channel, this allows the two phosphate molecules to 
alter position within the hydrolytic centre.  Loop 5-6 then opens and the two phosphate 
molecules are released sequentially, with the electrophilic phosphate being released 
first, followed by the leaving group phosphate.  This returns the protein to the resting 
state and allows the cycle to continue.  
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Figure 6.4: Overview of the Transition State of the M-PPase Catalytic Cycle. 
(a) Excerpt from Figure 6.1 showing only the three states involved in the hydrolysis and ion pumping 
stages of the M-PPase catalytic cycle, the VrPPase:Mg5IDP structure, the proposed high-energy 
transition state and the immediate-product bound structure. (b) SURFE2R data showing the change in 
current (denoting a proton-pumping signal) when the listed inhibitors were added to the activating buffer 
for SURFE2R experiments of VrPPase proteoliposomes. Results are from replications of multiple samples 
carried out on multiple sensors, error bars denote standard deviation.  Red arrows indicate the proton-
pumping signal observed following addition of the non-hydrolysable inhibitor, IDP, and the phosphate 
control to the activating buffer. (c) Proton-pumping signal generated when IDP was added to the 
activating buffer during the SURFE2R experiments on VrPPase.  
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6.1.2 Summary of the Catalytic Cycle Model 
The updated model of the catalytic cycle provides the first evidence to suggest a 
specific order of events, notably the occurrence of ion pumping before hydrolysis, 
backing up the previously proposed binding change mechanism (Kellosalo et al., 2012). 
However, this information leaves several very important questions unanswered.  The 
SURFE2R data suggests that a single-turnover event can occur, in which a single ion 
can be pumped per protomer in the presence of a non-hydrolysable inhibitor, such as 
IDP.  This would require a complex series of energy transfer and storage steps, as ion 
pumping can still occur without hydrolysis. It is possible that the energy required for 
ion pumping to occur is stored in a series of conformational changes within the protein, 
such as the torsional energy that is released during the triggering of the “molecular 
mousetrap” of D6.43 upon substrate binding. Additionally, the larger movements of helix 
12, which moves down by around 2 Å during substrate binding, may provide an 
alternative mechanism of transferring energy required for ion pumping to occur before 
hydrolysis.   
 
Once ion pumping has occurred, it is the difference in charge between the ion gate and 
the hydrolytic centre that draws cations down the coupling funnel. The hydrolytic 
machinery has already been primed through the triggering of the “mousetrap” model 
and therefore the charge difference alone can lead to hydrolysis of the substrate.  The 
release of energy from hydrolysis is then used to reset the “mousetrap” mechanism, 
altering the conformation of helix 12 and the region around D6.43 to prime the 
“mousetrap” for binding of the next substrate. The energy is therefore stored in these 
energetically unfavourable conformational changes and in the process, the phosphate 
products are released when loop 5-6 opens.  
 
The model does not account for any potential cross-dimer effects that may influence the 
cycle. It is currently not known if allosteric regulation of the cycle, in which one 
protomer is activated by events from the other protomer.  This could have significance 
for the dual-pumping M-PPases, where the mechanisms of pumping protons and sodium 
ions has not been determined and allosteric regulation may play a part in determining 
which cation is pumped.  This would be difficult to investigate as it is currently not 
possible to measure the pumping of protons or sodium ions from individual protomers. 
The crystal structures show that each protomer is in an identical state, but these occur 
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under saturating conditions of substrate or product.  The location of the C-terminus near 
to the dimer interface provides suggests that these residues might work via stabilising 
the formation of the dimer.  This could explain why the C-terminal truncation mutant is 
inactive, as the dimer may not form correctly.  If so, this might suggest that there is 
some degree of allosteric effect from the dimer, which is unable to occur in the C-
terminal truncation mutant. 
 
The new structures and the updated model do not provide any insight into the 
mechanism of ion selectivity.  Previously this was believed to be related to the position 
of a “semi-conserved” glutamate (E6.53/6.57) (Tsai et al., 2014) that is different in K+-
dependent H+-PPases and Na+-PPases. However, sequence alignments show that this 
glutamate is in the same position for Na+-PPases as it is for K+-independent H+-PPases, 
ruling this residue out as a key selector for the cation.  In the TmPPase:Mg5IDP 
structure, E6.53 forms part of the sodium ion binding site, coordinating the bound sodium 
ion.  The low resolution of the PaPPase structure (3.8 Å) means that the side chain 
conformation of E6.53 cannot be determined and so nothing is known about its role in 
K+-independent H+-PPases.  Scans of the sequence alignment between the various types 
of M-PPase have also not provided any insight into the ion selectivity of M-PPases. 
 
6.2 Future Directions for the Project 
The work carried out as part of this thesis has provided updated structural and 
functional data that has allowed me to generate an updated model of the catalytic cycle. 
This covers previously uncharacterised states of the cycle, such as the high-energy 
transition state and provides initial structural information to start analysing K+-
stimulated specificity in M-PPases.  However, there is still much work to be done on M-
PPases to fully understand these proteins.  The model of the catalytic cycle could be 
refined using higher resolution structural data, as well as biochemical and 
computational data from a range of different types of M-PPase (H+, Na+ and Na+/H+-
PPases). They will also allow us to better understand the specific mechanisms behind 
cation specificity and can also be used for drug design against protozoan parasites and 
some pathogenic bacteria.   
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6.2.1 Structural Methods to Improve our Understanding of M-PPases 
Additional structural information from different types of M-PPase would help to refine 
the model of the catalytic cycle and allow for more detailed comparisons between Na+-
PPases and H+-PPases or K+-dependent and K+-independent variants.  These 
experiments involve trying to express, purify and crystallise the M-PPases from other 
species or involving other mechanisms of action. These include the dual-pumping M-
PPases from certain prokaryotic species, which are capable of pumping both sodium 
ions and protons under certain conditions. A structural understanding of the 
mechanisms involved in pumping both cations would be invaluable to the M-PPase 
field and, potentially, to other dual-pumping transporters.  The structures of protozoan 
parasite M-PPases or those from pathogenic prokaryotes would also provide extremely 
important information on these proteins and potentially provide information to assist in 
future drug design programmes. 
 
Structural information can be used to help drive drug discovery. The layout of the 
hydrolytic centre, for example, can be used for docking studies of existing compounds 
or can be used to direct large-scale compound screens. Any that show activity can be 
crystallised and this information can then be fed back to medicinal chemists to alter and 
improve the drugs based on the available information.  Work has already started on this 
using TmPPase as a model organism, given the high yield of expression, reliable 
purification method and high degree of sequence conservation between this and the M-
PPase from pathogenic species.  If the protozoan parasite M-PPases can be successfully 
expressed and purified, it may be possible to carry out inhibition assays on these 
proteins instead, to provide more reliable information on inhibition than testing on the 
TmPPase. 
 
Higher resolution structural information on the PaPPase will also be useful for studying 
the K+-dependence mechanism of M-PPases. There are several ways this might be 
achieved, including the additional screening of crystals in the current best crystallisation 
conditions. There is a great degree of variability in diffraction between crystals, even 
from the same drop, meaning that large amounts of crystals must be screened to find the 
best diffracting ones.  Moreover, improvement in the crystal picking technique may 
increase diffraction of the crystals.   
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The best diffracting crystals were of a thin plate morphology, meaning that physical 
stress on the crystals during picking was enough to crack or destroy the crystals, leading 
to poorer quality diffraction and thus a lower resolution of the datasets.  Possible 
solutions for this problem involve improving the technique and conditions when picking 
the crystals, such that the mechanical stress on the crystals is reduced and thus the final 
crystals are intact during data collection and so diffract better.  This could be achieved 
using different types of loops, specific to plate crystals, which reduce the mechanical 
stress when picking the crystals.  Alternatively, it might be possible to test room 
temperature diffraction using in situ data collection techniques available at 
synchrotrons. Another method would be to try and find alternative crystallisation 
conditions that produce crystals of a different morphology that diffract well and can 
survive the picking procedure.  These alternative conditions could be different buffers, 
salts, precipitants, etc or be changes to the protein itself to better aid in crystal packing.  
Although the C-terminal truncation mutant in this current study yielded protein with 
almost no activity, it is possible that modifications that remove fewer residues from the 
C-terminal could have the desired effect of improving the stability of the protein, 
leading to better crystal contacts, without reducing the activity and structure of the 
protein.  Alternative crystallisation methods could also be tested, such as using Lipidic 
Cubic Phase (LCP) to see if this could produce crystals that diffract better than those 
obtained in the current study. 
 
There are also other structural biology techniques that might be useful to study the M-
PPases.  Electron microscopy can be used to study the structure of membrane proteins 
in a more native environment and without issues such as crystal contacts distorting the 
structure. In recent years electron microscopy has been able to reach higher resolutions 
around 4 Å, allowing for the study of specific mechanisms within proteins of smaller 
molecular weights, such as the TAP transporter at 166 kDa (Oldham et al., 2016), 
which was solved via Cryo-EM. The issue with M-PPases is that they do not have any 
significant cytoplasmic domains and therefore are hard to differentiate from empty 
detergent micelles in EM.  Combining Cryo-EM with the reconstitution of the protein in 
nanodiscs or amphipols means that EM could be used to study various M-PPases in a 
very native environment, potentially identifying features of the proteins that would not 
be visible in crystallography.  Another method is to use LMNG during the purification, 
with no additional detergent added during the wash or elution steps on the Ni-NTA 
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column.  This should produce detergent micelles containing the protein, but should limit 
or completely remove the empty detergent micelles from the sample, allowing for easier 
picking of protein-containing particles during EM.  Since both TmPPase and PaPPase 
can be solubilised and purified in LMNG, this is a viable method to help overcome the 
limitations of differentiating particles containing empty micelles from those containing 
protein.  
 
6.2.2 Biochemical Studies to Improve our Understanding of M-PPases 
Alongside the structural work, there are additional biochemical techniques that could be 
tried to help better understand the M-PPases.  The tryptophan fluorescence experiments 
provided some initial data to suggest that it would be possible to study conformational 
changes in the VrPPase protein, showing that titrations of the IDP produced a change in 
fluorescence signal around 8 %.  If this sample was tested using a stopped-flow 
fluorimeter, it might be possible to observe conformational changes occurring over a 
millisecond timescale. These conformations could then be mapped to existing points on 
the catalytic cycle model or even identify states not seen from the crystal structures.  
This could also be a means of exploring the pre-steady state kinetics of the catalytic 
cycle, adding kinetic data to the model and potentially leading to more interesting 
observations about the opening of the ion gate. 
 
Alongside the tryptophan fluorescence work, it would also be possible to test the M-
PPases using small molecule Fluorescence resonance energy transfer (smFRET).  Work 
is currently underway to study mutants of TmPPase using this system.  This works by 
attaching fluorescence dyes to cysteine residues on the surface of proteins and 
measuring the distance between the dyes.  If measured in the presence of substrate, it 
might be possible to observe conformational changes and, much like with tryptophan 
fluorescence, allow for studies of the conformational changes in M-PPases in real-time.  
The disadvantage of this system over tryptophan fluorescence is the need for the 
fluorescence dyes, as these are often bulky molecules that are highly flexible. This 
degree of motion can sometimes drown out smaller changes in conformation. 
Additionally, it requires that any cysteines not involved in the experiments are removed 
to prevent unwanted dye binding.  In some proteins, this can inactivate the protein, but 
TmPPase can remain active with only one internal cysteine residue (Harborne, 
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unpublished), making it possible to carry out these studies. The advantage of this 
system is that it provides a greater degree of locations to place the dyes.  Tryptophan 
fluorescence experiments rely on the native positions of these residues, if they are not 
present in locations undergoing conformational changes (such as TmPPase), then no 
change in fluorescence signal can be detected.  
 
To back up the smFRET work, it is also possible to carry out molecular dynamics 
simulations to study how the protein might behave in specifically controlled 
environments.  This can be useful for studying the movement of key components of the 
M-PPase, such as the 5-6 loop, helix 12 or the interactions of residues at the ion gate. 
This information could be used to investigate key stages of the catalytic cycle, either 
backing up the data obtained in this study or provide alternative explanations for events 
during the catalytic cycle. 
 
Finally, the SURFE2R technique could be used to study other M-PPases.  This would be 
particularly useful if TmPPase or another Na+-PPase could be made to work on the 
system.  The issue with H+-PPases is that protons can never be removed from the 
system, and so it is not possible to accurately to study the effects of low protons 
concentrations on cation pumping. However, it is possible to measure ion pumping in 
low sodium concentrations, allowing for a much greater range of study on TmPPase, 
including mutational studies and their effects on sodium pumping.  Likewise, the K+-
dependent mutants of PaPPase could be tested on this system to study proton-pumping 
activity and provide more information to complement the hydrolytic activity assay 
results. 
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6.3 Final Conclusions & Significance of the Work to the M-PPase Field 
The initial aims of this project were to try to better understand the complete catalytic 
cycle of M-PPases by providing additional structural and biochemical information.  I 
have achieved this goal through the solving of two new TmPPase crystal structures and 
the accompanying ion pumping data from the SURFE2R.  This information, along with 
the previously solved structures of TmPPase and VrPPase, and the current work by our 
collaborators in the Sun lab (Taiwan), have provided key information allowing us to 
generate an updated model of the catalytic cycle.  This provides a clear and logical 
means by which M-PPases pump H+/Na+ and couple this to the hydrolysis of PPi. There 
is still much work to be done on M-PPases, as highlighted above, but this model 
provides invaluable information in the understanding of this family of membrane 
proteins and the structural information provides a mechanistic insight into how these 
proteins function.  Moreover, this structural information can now be used to help drive 
drug-design programmes to help target the M-PPases of pathogenic species, such as the 
malaria-causing Plasmodium parasites.  
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